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Introduction
One needs to control behaviour in a timely manner in order to survive and function 
successfully in our fast moving and information-dense world. For example, when you are 
driving in a car, you have to keep track of what happens in your surroundings and respond 
adequately to these events. If a car in front of you suddenly brakes, you have to cancel 
your ongoing action (driving) by letting go of the accelerator and replace it with another 
action (hitting the brake). Luckily it is often possible to anticipate an upcoming stop by 
looking at cues, for example inserting cars on an already busy road indicate a possible 
upcoming traffic jam. To function successfully, you not only have to respond instantly to 
your environment, some information requires an action some moments later. When your 
exit number is announced, you have to remember this information for a while, and recog-
nize it in order to take the correct exit when you reach it. Failing or executing any of these 
processes too late may result in unexpected moves, risking an accident. Unfortunately, 
people don’t always manage to behave optimally; for example when the external informa-
tion load exceeds their capacity or with healthy aging, when cognitive capacities naturally 
decline due to alterations in dopamine functioning. 
Cognitive control is the ability to adapt behaviour in a timely manner according to 
currently present or maintained information. In this thesis, two cognitive control sub-
component processes were studied: working memory and response inhibition. Both 
processes require immediate processing of information as well as maintenance of 
information for later use. The neurocognitive underpinnings of these cognitive control 
processes were studied and challenged by increasing information load, age and dopamin-
ergic interventions. 
Working Memory 
While driving to a destination, one needs to remember the announced exit number until 
it is listed again and at the same time, one must not be distracted by other announced 
exits. This information is stored and maintained in working memory. The definition 
‘working memory’ was firstly mentioned by (Miller et al, 1960) followed by the more 
elaborate ‘multicomponent model’ by (Baddeley and Hitch, 1974a).  The latter consisted 
of a short term memory module that stores items, further divided into a part processing 
visuo-spatial information (e.g. locations or shapes) and a part for verbal information. 
As both models emphasized, the key feature of working memory is to temporarily maintain 
and manipulate information (Baddeley, 1986). Items in working memory can be activated 
from long term memory or originate directly from external sensory experiences. 
For excellent reviews and extensions of the first working memory models, see e.g. 
(Baddeley, 2012; D’Esposito and Postle, 2015). The number of items or slots that can be 
(qualitatively) stored in working memory at any given moment is limited 
(Ma et al, 2014). Tasks such as the N-back (Jonides et al, 1997) and Sternberg task 
(Sternberg, 1966) measure this capacity by increasing the number of items that need to 
be stored. With each level, the length of the sequence from which an item is probed in-
creases and performance decreases accordingly, depending on working memory 
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capacity. Using the delayed-match-to-sample task (DMTS task), decay of working memory 
representations over time can be observed. In this task one or more items are presented, 
that are subsequently probed after a (variable) delay. Distracting information can also be 
presented during the delay, affecting the strength of a working memory representation. 
Neural architecture of working memory
Using the DMTS task, the neural architecture of encoding, maintaining and recognizing 
working memory items has been previously studied. The importance of the prefrontal 
cortex (PFC) (Figure 1) was evidenced by decreased working memory performance in 
primates with ablated PFC (Jacobsen, 1936). Sustained neuronal activity in the PFC of 
primates was observed in the delay period of a DMTS task (Funahashi et al, 1989; Fuster 
and Alexander, 1971; Goldman-Rakic, 1987). Hereby, a neural implementation of psycho-
logical working memory models was provided. Subsequently, intact performance was 
observed when these PFC ablated monkeys were placed in a dark room without any visual 
distraction (Malmo, 1942). This suggested that in absence of the PFC, working memory  
representations were no longer protected against interfering stimuli. Indeed, increased 
distractibility by irrelevant sensory input was also observed in humans with PFC lesions 
(Chao and Knight, 1995). The PFC stabilizes and protects representations through a net-
work including also the basal ganglia and sensory (e.g. visual) regions (Fallon et al, 2016; 
Frank et al, 2001; Hazy et al, 2006). The PFC strengthens top-down connections with poste-
rior regions that process task- relevant sensory input (such as visual stimuli) and increas-
es activation in these task-relevant posterior regions (Gazzaley et al, 2005a; Miller and 
Cohen, 2001). Hereby working memory representations are protected from distraction. 
Distracting information, especially when in the same domain as the to-be-remembered 
stimulus, weakens prefrontal top-down influence, task-relevant connectivity and thereby 
the robustness of a representation (Yoon et al, 2006). Updating of and selecting items into 
working memory is regulated through connections between PFC and basal ganglia (Baier et 
al, 2010; McNab and Klingberg, 2008; van Schouwenburg et al, 2012).  
Dopaminergic involvement in working memory
The neuromodulator dopamine is produced by the midbrain regions substantia nigra (SN) 
and ventral tegmental area (VTA) and diffused to frontal cortex, ventral striatum and dorsal 
striatum through mesocortical, mesolimbic and nigrostriatal pathways (Alexander et al, 
1986; Stahl, 2008) (Figure 1). Dopamine plays an important role in working memory, as 
evidenced by a broad range of animal and human work (Brozoski et al, 1979; Collins et al, 
2000; Diamond, 2007; Gibbs and D’Esposito, 2005; Luciana and Collins, 1992; Sawaguchi 
and Goldman-Rakic, 1991). Combined with electrophysiological work and computational 
models,  theoretical frameworks are formulated on the mechanism by which dopamine 
modulates working memory (Durstewitz et al, 2000a; Durstewitz and Seamans, 2008; 
Frank, 2005; Seamans and Yang, 2004). Empirical evidence for these models is accumu-
lating; in the PFC and the basal ganglia, dopamine has been proposed to modulate the 
stability and flexibility of representations in opposing ways (Frank et al, 2001)(Cools and 
D’Esposito, 2011; van Schouwenburg et al, 2010). This effect might be due to the relative 
abundance of D1 and D2 receptor families in the PFC and basal ganglia respectively (see 
also the dual state model of prefrontal dopamine, Durstewitz and Seamans 2008). 
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D1 receptor stimulation by dopamine increases the signal-to-noise ratio of neuronal firing 
in the PFC (Servan-Schreiber et al. 1990). Due to this increased neural signalling, the PFC 
reaches a ‘closed’ state that stabilizes representations of remembered information and 
that is difficult to be disturbed by new or distracting sensory inputs (Durstewitz and Sea-
mans, 2008). Although less abundantly present in the PFC, PFC D2 receptor stimulation is 
suggested to bring the PFC in an ‘open’ state. In an open state, neuronal firing in the PFC 
can be perturbed by new information coming from sensory areas and current representa-
tions can be updated. Thus, D1 and D2 modes of PFC are thought to correspond with 
enhanced and reduced distracter-resistance of working memory maintenance. However 
until recently there was no evidence for this in humans. In Chapter 2, I empirically tested 
the influence of D2 receptors on distractor-resistance of working memory maintenance 
using pharmacological imaging (see BOX 1). In the basal ganglia, D2 receptor families are 
more abundant than in the PFC, making this area more known for ‘gating in’ newly rele-
vant cognitive representations during working memory encoding, as necessary for working 
memory updating (Hazy et al, 2006). The PFC and striatum are thought to orchestrate 
working memory stability and flexibility respectively through dopaminergic D1 and D2 
receptor stimulation.
Figure 1. Dopamine pathways. Arias-Carrión O, Stamelou M, Murillo-Rodríguez E, 
Menéndez-González M, Pöppel E (2010). Dopaminergic reward system: a short integrative review. 
Int Arch Med 3: 24.
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Response inhibition 
Timely control over actions is vitally important for survival. Various laboratory tasks are 
used to measure control over actions, such as the stop-signal task (SST) (Lappin and 
Eriksen, 1966; Logan and Cowan, 1984), step tasks (Becker and Jürgens, 1979; Kenner et 
al, 2010) and Go/No-go tasks (Donders, 1969). The processes underlying these tasks differ 
slightly: SSTs measure the cancellation of an already initiated action, step tasks measure 
the switch from one to another action and the Go/No-go task taps into action restraint 
(rather than cancellation). Emergency response inhibition as needed e.g. in traffic, but also 
in sports or in house-hold activities such as cooking is measured using the SST. During the 
SST a simple action is executed (e.g. pressing a button) after the presentation of 
a Go-signal. When an infrequent stop-signal appears after the Go-signal was already 
presented, the initiated action needs to be cancelled. Typical observations are seen in 
stop-signal task performance: when the interval between to Go-signal and the 
Stop-signal is short (stop-signal delay (SSD)), there is a higher chance of successfully can-
celling the initiated response. When the SSD is long, response execution is closer to the 
point of no return and inhibition fails more often. The generic behavioural pattern 
observed in the stop task led to the development of the horse race model, stating that 
(un)successful inhibition depends on the outcome of a race between the Go and the Stop 
process (Logan and Cowan, 1984). The dependent measure of the SST is the duration 
of the Stop process, i.e. the time needed to cancel an initiated response. Based on the 
assumptions of the race model this covert response (namely a cancelled action) can be 
estimated, resulting in the Stop-Signal Reaction Time (SSRT) (Logan and Cowan, 1984; 
Verbruggen and Logan, 2009a). 
In the real world, an emergency break is relatively rare. More often, one knows that the 
need to inhibit may be upcoming, e.g. when traffic is congesting or surrounding cars may 
cross your lane at a lower speed in order to take a passing exit. In this situation, one 
prepares for a possible upcoming stop by reducing speed. Hereby the chance for successful 
(timely) inhibition, should a stop-signal appear, increases. Also in the SST this behaviour is 
commonly observed: with increasing stop-signal probability, subjects cautiously slow down 
their response times on the Go task (Chikazoe et al, 2009; Jahfari et al, 2010; Verbruggen 
and Logan, 2009b; Vink et al, 2005; Zandbelt and Vink, 2010) (Figure 2). By manipulating 
stop-signal probability in the SST, a dissociation can be made between reactive response 
inhibition (i.e. stopping after detecting the stop-signal, measured by SSRT) and proactive 
response inhibition (i.e. preparation for inhibition before the presentation of 
the stop-signal).
Introduction
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Neural architecture of response inhibition
The response inhibition network includes the right inferior frontal gyrus, medial frontal 
regions such as (pre-) supplementary motor area (SMA) and anterior cingulate cortex 
(ACC), basal ganglia regions such as the striatum and the sub-thalamic nucleus (STN), 
activity of which results in inhibition of the primary motor cortex in order to cancel a 
movement (Aron, 2011). Lots of what we know about the ‘lower level’ neural organization 
of response inhibition was obtained through electrophysiological recordings in monkeys 
performing an eye saccade version of the stop-signal task (the countermanding task). So 
called ‘fixation’ and ‘movement’ neurons collaborate reciprocally in the frontal eye fields 
(FEF), superior colliculi and substantia nigra when making and cancelling a saccade (Hanes 
et al, 1998; Hikosaka and Wurtz, 1983; Paré and Hanes, 2003). The timing of their activity 
patterns has been linked to successfully and unsuccessfully inhibited saccades. This work 
has led to updating of the race model into the physiologically plausible interactive race 
model, where a Go unit is inhibited by a Stop unit (Boucher et al, 2007). Medial frontal 
regions such as supplementary eye fields (SEF) have been found to influence activity of 
fixation and movement neurons e.g. in the FEF (Isoda and Hikosaka, 2007; Scangos and 
Stuphorn, 2010; Stuphorn et al, 2010; Stuphorn and Schall, 2006). Also human functional 
imaging studies that are more suitable to study network interactions between regions 
implicate the (pre-) SMA in response inhibition. Pre-SMA modulates motor cortex activity 
and monitors response conflict between motor plans (Chen et al, 2009, 2010; Sharp et 
al, 2010). Besides medial frontal regions, the right inferior frontal cortex (rIFC) has been 
shown to be crucially involved and is even said to be ‘the executive’ of response inhibition, 
signalling the need to inhibit and commanding response cancellation (Aron et al, 2003; 
Aron and Poldrack, 2006; Chambers et al, 2006, 2009a; Zandbelt et al, 2012a). The basal 
ganglia including striatum and STN are involved in the selection between multiple options 
such as action plans in case of response inhibition (Aron and Poldrack, 2006; Chambers et 
al, 2009b; Cohen and Frank, 2009; Vink et al, 2005; Zandbelt and Vink, 2010). 
Figure 2. Behavioural measure of proactive response inhibition: response slowing on the Go task 
as a function of stop-signal probability. Zandbelt BB, Vink M (2010). On the role of the striatum in 
response inhibition. PLoS One 5: e13848.
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Whether the brake command runs through the indirect pathway that connects the frontal 
cortex with the striatum or through the hyper-direct pathway via a frontal-STN connection 
(Jahanshahi et al, 2015) may depend on the type of inhibition being executed: 
the hyper-direct pathway seems suitable for fast and global stopping of all motor plans, 
whereas the indirect pathway could selectively stop one of multiple motor plans (Aron, 
2010, 2011; Smittenaar et al, 2013). 
Proactive response inhibition is supported by a fronto-striatal network partly overlapping 
with, but acting earlier than the reactive response inhibition network (Aron, 2011; van 
Belle et al, 2014; Chikazoe et al, 2009; Jahfari et al, 2010; Vink et al, 2005; Zandbelt et al, 
2012b; Zandbelt and Vink, 2010). Within the proactive response inhibition network, SMA, 
striatum and midbrain may modulate the degree of motor preparation in anticipation of 
a stop signal, and right inferior frontal and parietal activation may be related to expecta-
tion updating when a likely stop signal does not appear (Zandbelt et al, 2012b). Moreover, 
compared with reactive response inhibition, proactive response inhibition may rely more 
on internal goal setting and maintenance processes and associated prefrontal brain 
regions, rather than responding to external cues (Aron, 2011; Swann et al, 2012). 
Dopaminergic involvement in response inhibition
The role of dopamine in response inhibition is much less established than its role in work-
ing memory. Various neuro-modulators such as the catecholamines dopamine and 
noradrenaline, but also serotonin, have been shown to affect response inhibition, but 
there is controversy which sub-process is modulated by which modulator. Reactive 
response inhibition has been shown to be modulated by both noradrenaline (Chamberlain 
et al, 2007; Eagle et al, 2007, 2008) and dopamine (Albrecht et al, 2014; Bari et al, 2011; 
Congdon et al, 2009; Ghahremani et al, 2012). Pharmacological involvement in proactive 
response inhibition has so far not been explicitly dissociated from reactive response inhibi-
tion. However, I hypothesize that proactive response inhibition is modulated by dopamine. 
Animal work showed alteration of processes underlying proactive response inhibition 
(such as post-error slowing and go accuracy) after dopaminergic intervention (Bari et al, 
2009; Bari and Robbins, 2013) and neuroimaging studies demonstrate involvement of 
dopaminergic regions, such as frontal and midbrain areas, during proactive response inhi-
bition (Boehler et al, 2011; Zandbelt et al, 2011, 2012b). In Chapter 6 the role of dopamine 
in reactive and proactive response inhibition is studied using pharmacological neuroimag-
ing.  
Working memory and response inhibition in aging 
With aging, the brain suffers from reduced white matter integrity, cortical and sub-cortical 
shrinkage, decline of vascular quality and reduced signalling of neuro-modulators, among 
which dopamine, acetylcholine and serotonin (Peters, 2005). These brain changes are 
accompanied by decline of several cognitive functions, such as goal-directed behaviour, 
reward learning, response inhibition, working memory, episodic memory, attention and 
general processing speed (Braver et al, 2001; Eppinger et al, 2011; Kleerekooper et al, 
2016; Paxton et al, 2008; Rabbit, 1979; Turner and Spreng, 2012). Specifically frontal lobe 
deterioration in aging (Cabeza and Dennis, 2012; Nyberg et al, 2010) results in reduced 
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top-down suppression of irrelevant working memory items (Gazzaley et al, 2005b) and 
reduced delay dependent neuronal firing in the PFC (Wang et al, 2011). Frontal lobe 
deterioration also seems to contribute to impaired delay-dependent working memory 
maintenance, increased distractibility and reduced inhibitory abilities (Dunnett et al, 
1988b; Hasher and Zacks, 1988; Jost et al, 2011; Wang et al, 2011; West, 1996). Enhanced 
distractibility in older adults might have beneficial effects on performance, when working 
memory needs to be updated. Indeed, in some tasks greater benefits are observed for 
older than young adults by the presence of relevant, but to be ignored ‘distractors’ (for a 
review see, Weeks & Hasher, 2014). In Chapter 3 I aimed to dissociate working 
memory maintenance versus updating, assessing whether aging is accompanied by an 
age-related relative benefit in working memory updating compared with maintenance. 
Working memory load and task difficulty challenge the reduced capacity of the older 
frontal cortex (and other regions involved in cognitive control such as striatal and parietal 
regions), resulting in decreased performance and alterations in BOLD signal (Nagel et al, 
2011; Sebastian et al, 2013). This suggests that besides observed age impairments in re-
active response inhibition as measured with SSRT (Bedard et al, 2002; Coxon et al, 2012a, 
2014a; Kleerekooper et al, 2016; Kramer et al, 1994; van de Laar et al, 2011; Smittenaar et 
al, 2015), also impaired proactive response inhibition may be observed with age, especially 
depending on information load. So far, studies on proactive response inhibition without 
load modulation report no effect of age on RT slowing by stop-signal probability manipula-
tion (Kleerekooper et al, 2016; Smittenaar et al, 2015), but one reports excessive post-er-
ror slowing (van de Laar et al, 2011) (a form of proactive response inhibition). Frontal and 
parietal hyper-activation has been found for proactive response inhibition (Kleerekooper 
et al, 2016).  This may reflect a successful compensatory strategy, as BOLD signal in older 
versus young adults is said to increase in order to (attempt to) compensate for reduced 
capacity, and decrease along with performance when task demands exceed capacity 
(Reuter-Lorenz and Cappell, 2008; Reuter-Lorenz and Park, 2014; Schneider-Garces et al, 
2010) for a review see (Grady, 2012). How aging affects the reactive and proactive re-
sponse inhibition as a function of increased information load is investigated in Chapter 5.
Repleting dopamine in aging using the amino acid tyrosine?
Dopamine metabolism is altered in aging, more than noradrenaline and serotonin 
(Goldman-Rakic and Brown, 1981; Moretti et al, 1987). For example,  a loss of dopamine 
producing neurons in the SN (Fearnley and Lees, 1991) is reported, and receptor and trans-
porter numbers fall  (e.g. Frey et al, 1996; Kaasinen et al, 2000; Rinne et al, 1990; Volkow 
et al, 1994, 1998). Up-regulated striatal dopamine synthesis observed in older adults may 
compensate for these losses (Braskie et al, 2008), though also reduced frontal and striatal 
dopamine synthesis was found (Ota et al, 2006). Age-related reductions in frontal and 
striatal dopamine receptor and transporter binding have been linked to impairments in 
various cognitive functions such as attention, episodic and working memory (Backman et 
al, 2006; Bäckman et al, 2011). In contrast, up-regulated dopamine synthesis has also been 
observed in older adults, which was associated with detrimental performance on cognitive 
control tasks (in younger adults) (Braskie et al, 2008). working memory, episodic memory 
and reward learning deficits in healthy older humans and animals have been ameliorated 
by enhancing dopamine signalling pharmacologically 
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(Cai and Arnsten, 1997; Chowdhury et al, 2012, 2013; Mizoguchi et al, 2009). 
This may also be possible for age-related deficits in response inhibition, which implicates 
dopamine and altered signal in dopamine-rich fronto-striatal areas. 
In young adults, administration of the amino acid and dopamine precursor tyrosine 
(BOX 2) has been shown to improve cognitive control functions such as response inhibi-
tion, task switching, and working memory, especially in demanding task or environmental 
situations (for reviews see  (Deijen, 2005; Jongkees et al, 2015b; van de Rest et al, 2013)).  
Tyrosine administration might thus counteract reductions in dopamine signalling in the 
aging brain, thereby improving dopamine-dependent cognitive functioning. However, 
peripheral changes in tyrosine uptake such as first-pass clearance in the liver may occur 
with ageing (Mangoni and Jackson, 2004). These age-related changes may result in differ-
ent peripheral plasma concentrations and time course in older relative to young adults, 
possibly even when using the same dose. The altered amount of precursor subsequently 
passing through the blood-brain barrier likely has consequences for dopamine-dependent 
cognitive performance, such as working memory maintenance and updating. In Chapter 4 
plasma tyrosine levels after the same dose between young and older adults are compared. 
Moreover, the effect of three doses tyrosine on plasma levels and n-back performance 
in older adults was studied. Lastly, in Chapter 6, the effect of tyrosine administration on 
reactive and proactive response inhibition in older adults was studied in the MRI scanner. 
Hereby the role of dopamine in these two forms of response inhibition and associated 
brain regions was assessed. Moreover, the potential beneficial effect of tyrosine for 
dopamine-dependent cognition in aging is explored.
Outline of this thesis
The goal of this thesis is to assess the influence of cognitive load, age and dopamine on the 
neurocognitive mechanisms of two subcomponent cognitive control processes: working 
memory and response inhibition . To this end, I performed five experiments in healthy 
young and older adults using cognitive tasks, functional neuroimaging and dopaminergic 
interventions. 
D2 receptor stimulation is hypothesized to decrease the stability of working memory 
representations in the PFC, but has never been empirically proven in humans. 
Chapter 2 assessed the effect of dopamine D2 receptor stimulation on distractor-
resistance of working memory performance and associated BOLD signalling. The D2 recep-
tor agonist bromocriptine and dopamine precursor levodopa were administered to a group 
of young adults performing a distracted delay-match-to-sample task while undergoing 
fMRI.
Functional activation and connectivity during the delay phase of distracted working mem-
ory were analyzed. I predicted receptor-specific effects on working memory distractibility. 
Following bromocriptine administration, I expected a greater distractor cost, accompanied 
by altered delay-related PFC signal, possibly accompanied by connectivity changes with 
sensory posterior regions.
Given the literature showing increased distractibility by environmental cues in healthy 
aging, working memory maintenance in aging may be more impaired than working 
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memory updating. However, age effects on working memory maintenance and updating 
were never dissociated. In a behavioural study, Chapter 3 explored the effects of aging on 
distractibility of working memory maintenance and working memory updating. 
Using a task assessing both working memory maintenance after distraction as well as 
working memory updating I tested whether a selective, relative impairment of working 
memory maintenance versus updating can be observed in older versus young adults. 
After observing working memory deficits in older adults (Chapter 3), Chapter 4 aimed to 
assess a potential relation between working memory performance in older adults and 
increasing doses of the dopamine precursor tyrosine. I compared tyrosine plasma levels 
and time course of three doses of tyrosine with working memory performance measured 
with an n-back task. N-back performance was predicted to vary with dose-related changes 
in plasma tyrosine levels, possibly as a function of cognitive load, but this had never been 
tested in older adults. 
In Chapter 5, I explored age effects on another type of cognitive control: response 
inhibition. Reactive response inhibition is shown to be impaired with aging, but the effect 
of aging on proactive response inhibition was never explicitly disentangled. Given age-
related impairments in load-dependent working memory and prefrontal cortex function-
ing deficits, changes in proactive response inhibition may be observed. A variant of the 
stop-signal task was developed to test reactive response inhibition (outright stopping) 
and proactive response inhibition (cautious response slowing) as a function of information 
load, given evidence for age-related difficulties in information processing. Healthy young 
and older adults performed this task while being scanned using functional magnetic 
resonance imaging. Older adults were predicted to be impaired in proactive response 
inhibition, possibly as a function of information load, accompanied by altered load-
dependent prefrontal processing relative to young adults.
 
Age-related deficits in both reactive and proactive response inhibition as a function 
of information load were observed, accompanied by altered signal in (dopamine-rich) 
fronto-striatal regions. This suggests that the deficits might reflect changes in dopamine. 
However, the effects of dopamine on reactive and proactive response inhibition had never 
been directly compared. In Chapter 6 I aimed to assess the degree to which different types 
of response inhibition in older adults depend on dopamine. Older adults received tyrosine 
or placebo, after which they performed the stop-signal task in the MRI scanner. Based on 
studies showing dopaminergic involvement in proactive processes, I predicted that proac-
tive response inhibition (as a function of information load) is dopamine dependent. 
That is, response slowing and signal in fronto-striatal regions may be altered by tyrosine 
administration, possibly as a function of age. 
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BOX 1 Methods
Functional magnetic resonance imaging
Using functional magnetic resonance imaging (fMRI), active brain regions can be detected 
during a task condition of interest. When using the non-invasive technique fMRI, subjects 
perform a task while lying still in the MRI scanner. When subjects perform a task, oxygen 
rich blood flows to the areas involved in the execution of this task, for example to supply 
oxygen to PFC neurons during a working memory task. The oxygenated blood in e.g. the 
PFC has different magnetic properties than deoxygenated blood and this is measured by 
the MRI scanner. The 3D image of the brain that is computed based on the MR signal 
contains information on the location of oxygen-rich regions. The obtained blood-oxygen 
level dependent (BOLD) signal is an estimate of neuronal activity (Huettel et al, 2004). 
Events in a task can be dissociated up-to approximately 2 seconds distance. By averaging 
signal across equal events and participants, enough statistical power is reached. 
Corrections for differences in individual anatomy, brain read-out time and movement are 
needed to reduce variability in the signal that is not task-related. To detect brain regions 
exclusively active during a task condition (for example maintaining a face item after being 
distracted by a similar item), this signal is subtracted by signal of similar task phase within 
the same statistical general linear model (GLM), but yet differs on a critical aspect (main-
taining a face item after being distracted by a dissimilar item). This comparison is referred 
to as a contrast (of interest).
Functional MRI signal can also be used to compute connectivity between regions during a 
cognitive task, a technique called psychophysiological interaction (PPI) analysis. 
The interaction between the cognitive task time course and the BOLD time course from a 
seed region is added in a GLM as an explanatory variable in order to detect regions follow-
ing the same activation pattern over time (Friston et al, 1997). Signals in these regions are 
assumed to functionally connect during a task phase, for example the PFC with the fusi-
form face area when maintaining a face item after distraction by a similar item (Chapter 2).
Pharmacological intervention
By administering a pharmacological or nutritional compound, we can study its effect on 
cognitive performance and/or neural network. For valid results of the intervention, several 
factors are important (Honey and Bullmore, 2004). For example, the cognitive task must be 
performed during the therapeutic window of the compound. Also, a comparison must be 
made with performance on a placebo session, or a different dose in case of dose-response 
comparison (placebo or active controlled design). To reduce variance, all settings must be 
kept equal except administration of the compound or placebo. This way, the performance 
difference between the sessions can be ascribed to the effect of the compound. 
By testing the compound within the same group of people, between-subject variance 
is ruled out (within-subject design). Disadvantages of within-subject design – such as 
test-retest effects - can be counteracted by varying administration order (counterbalanced 
design). In the group data, between session variance influencing task performance, such 
as practice and how long the subject slept, is averaged out. Moreover, the intervention 
should take place during the same part of the day for all sessions, after equal amount of 
practice or instruction. To rule out a subject of experimenter bias based on expectation of 
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the effects, both subject and experimenter should not know when the active compound is 
administered (double-blind design). In Chapter 2 the effect of bromocriptine and 
levodopa on distractor-resistance of working memory was tested using pharmacological 
neuroimaging. Chapter 6 assessed the effect of a nutritional intervention, using tyrosine 
administration on reactive and proactive response inhibition in healthy older adults.
BOX 2 The amino acid tyrosine
Tyrosine is one of the large neutral amino acids (LNAAs), among e.g. phenylalanine, 
tryptophan, valine, leucine. As the other LNAAs, tyrosine is naturally present in pro-
tein-rich food such as such as cheese, milk, soy, meat, fish, eggs, seeds, nuts, lentils, and 
beans or in food supplements, readily available as over-the-counter product in 500 mg 
capsules. Tyrosine can also be synthesized from the essential amino acid phenylalanine 
(~15%), but this depends on sufficient availability of this precursor (Matthews, 2007). A 
daily required intake of phenylalanine and tyrosine for adults was estimated at 14 mg/kg 
bodyweight per day (World Health Organization, 1985) or 39 mg/kg/d in a more recent 
study (Basile-Filho et al, 1998). 
Tyrosine is absorbed from the gastrointestinal tract into the blood plasma together with 
other LNAAs. Some of the compound is metabolized in the liver and will not further enter 
the bloodstream. Tyrosine converts into protein and peptides in muscle and adipose cells, 
to thyroxin in the thyroid gland, to melanin in the skin and brain and to catecholamines 
(e.g. dopamine and noradrenaline) in the brain (Cansev and Wurtman, 2007). To enter the 
brain, tyrosine passes the blood brain barrier (BBB), facilitated by the LNAA transporter 
type 1 (LAT1) in the endothelial cells along brain capillaries (Pardridge, 1983). All LNAAs in 
the blood stream must enter through the transporter mechanism, meaning that they are 
in competition. Thus, brain levels of tyrosine correspond better to the ratio of tyrosine/
LNAAs than to plasma tyrosine in the blood plasma (Cansev and Wurtman, 2007). 
Finally tyrosine is converted to L-DOPA by the enzyme tyrosine hydroxylase (TH) and to 
dopamine by aromatic L-amino acid decarboxylase (AADC) in the substantia nigra and sub-
sequently to noradrenaline in the locus coerulus by the enzyme dopamine beta-hydrox-
ylase (DBH) (Carlsson and Lindqvist, 1978; Tam and Roth, 1997) (Figure 1). Dopaminergic 
rather than noradrenergic neurons appear to be modulated by tyrosine (under unstressed 
conditions), possibly due the high turnover rate of (frontal) dopaminergic neurons, 
making them more susceptible to their precursor (Hallman and Jonsson, 1984). McTavish 
et al. (1999a, 1999b) depleted tyrosine (and phenylalanine) and observed no effect on 
noradrenaline, but reduced dopamine synthesis. Rodent research shows that tyrosine 
reaches the brain proportional to the amount of protein in a meal (Glaeser et al, 1983) and 
that tyrosine administration increases dopamine metabolites in cerebrospinal fluid (CSF), 
like homovanillic acid (HVA) (Scally et al, 1977). This effect on CSF HVA levels was also 
observed in patients with Parkinson’s disease who took 100 mg/k tyrosine divided in three 
doses over 24 hours (Growdon et al, 1982).
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Figure 1 Left panel: The uptake of tyrosine in a central nervous cell and DA release in the 
synaptic cleft. Right panel: The conversion steps from tyrosine to dopamine and noradrenaline with 
its cofactors. Illustrations from Principles of Pharmacology, by David E. Golan, Armen H. Tashjian, Jr., 
Ehrin J. Armstrong, April W. Armstrong. Wolters Kluwer, 3rd edition.
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Abstract
Dopamine has long been implicated in the online maintenance of information across short 
delays. Specifically, dopamine has been proposed to modulate the strength of working 
memory representations in the face of intervening distracters. This hypothesis has not 
been tested in humans. We fill this gap, using pharmacological neuroimaging. Healthy 
young subjects were scanned after intake of the dopamine receptor agonist bromocrip-
tine or placebo (in a within-subject, counterbalanced and double blind design). During 
scanning, subjects performed a delayed match-to-sample task with face stimuli. A face or 
scene distracter was presented during the delay period (between the cue and the probe). 
Bromocriptine altered distracter-resistance, such that it impaired performance after face 
relative to scene distraction. Individual differences in the drug effect on distracter-
resistance correlated negatively with drug effects on delay period signal in the prefron-
tal cortex, as well as on functional connectivity between the prefrontal cortex and the 
fusiform face area. These results provide evidence for the hypothesis that dopaminergic 
modulation of the prefrontal cortex alters resistance of working memory representations 
to distraction. Moreover, we show that the effects of dopamine on the distracter-resist-
ance of these representations are accompanied by modulation of the functional strength 
of connections between the prefrontal cortex and stimulus-specific posterior cortex.
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Introduction 
We live in a demanding, highly distracting environment. The necessary increase in atten-
tional demands can be a particular problem for those who are already easily distracted. 
Indeed, several psychiatric disorders, including schizophrenia and ADHD, have been asso-
ciated with an inability to filter out distracting information. Recent theoretical frameworks 
have suggested that dopamine might play an important role in the resistance to distracters 
by stabilizing task-relevant representations in prefrontal cortex and by rendering them 
more resistant to new inputs (Durstewitz and Seamans, 2008). Here we aim to test this 
hypothesis in humans. 
Studies in non-human primates have long highlighted the importance of the prefrontal 
cortex (PFC) in working memory and distracter-resistance (Jacobsen, 1936; Malmo, 1942). 
These studies have focused primarily on cortex surrounding the principal sulcus, corre-
sponding to the dorsolateral PFC (DLPFC) in humans. Neurons in this PFC region show sus-
tained signal during the delay period of a working memory delayed response task (Fuster 
and Alexander, 1971; Miller et al, 1996). Moreover, DLPFC lesions in humans as well as 
ablation of analogue PFC regions in rhesus monkeys are accompanied by reduced 
distracter-resistance (Chao and Knight, 1995; Jacobsen, 1936). 
The PFC has been suggested to support working memory by selectively enhancing the 
processing of task-relevant information via excitatory top-down connections to the 
relevant sensory regions (Feredoes et al, 2011; Miller and Cohen, 2001). This hypothesis 
is corroborated by functional MRI studies in humans. For example, Gazzaley et al. (2004) 
have shown that the online maintenance of face stimuli was accompanied by significant 
connectivity between the DLPFC and the fusiform face area (FFA), a region involved in 
processing of faces (Kanwisher et al, 1997). Thus, DLPFC may support working memory by 
increasing connectivity with brain regions that process remembered information, thereby 
rendering this information resistant to distraction.
Distracter-resistance during delayed response tasks of working memory has been shown to 
depend on the similarity between encoding cues and intervening stimuli. 
Thus distracter-resistance is particularly vulnerable when distracters are very similar to the 
remembered information (Jha et al, 2004; Yoon et al, 2006). It was proposed that main-
tained information and distracting information are represented by independent patterns 
in the PFC and that the similarity between these patterns determines how well the PFC 
can dissociate between them (Durstewitz et al. 1999). Indeed, Yoon and colleagues (2006) 
showed that delayed match-to-sample performance with face memoranda was disrupted 
by (congruent) face distracter stimuli, but not (incongruent) scene distracter stimuli. More-
over, signal in DLPFC and connectivity between DLPFC and FFA were selectively perturbed 
after face distracters (Yoon et al, 2006).
In the current study we aimed to assess the role of dopamine in distracter-resistance, 
using an adapted version of the paradigm used by Yoon and colleagues. Pharmacological 
studies in both animals and humans have assigned an important role for dopamine in 
working memory (Brozoski et al, 1979; Collins et al, 2000; Diamond, 2007; Gibbs and 
D’Esposito, 2005; Luciana and Collins, 1992; Sawaguchi and Goldman-Rakic, 1991). 
However, the precise way in which dopamine alters working memory is still unclear. 
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Based on in vitro electrophysiological and computational modelling work it has been 
suggested that the effects of dopamine on working memory reflect dopamine-induced 
increases in the signal-to-noise ratio of neuronal firing in the PFC (Servan-Schreiber et al, 
1990), leading to increased stabilization of representations of remembered information, 
and importantly, increased robustness of these representations in the face of intervening 
distracters (Durstewitz et al, 2000b; Durstewitz and Seamans, 2008; Seamans and Yang, 
2004). Here we test this hypothesis by assessing the effects of dopaminergic drugs on 
working memory performance and neural working memory representations in the face of 
distraction. We predicted that dopaminergic drugs would alter distracter-resistance and, 
following Yoon et al. (2006) that these effects would be accompanied by modulation of 
delay period signal in the DLPFC as well as of delay period connectivity between DLPFC
and FFA. 
Empirical data (Sawaguchi and Goldman-Rakic, 1991; Wang et al, 2004) and current theo-
ries (Durstewitz and Seamans, 2008; Seamans and Yang, 2004) suggest that the effects of 
dopamine on working memory are receptor-specific, with D1 and D2 modes of PFC corre-
sponding with enhanced and reduced distracter-resistance respectively. To assess such 
receptor-specific effects we administered both the selective D2-receptor agonist 
bromocriptine (Kvernmo et al, 2006) as well as the (nonselective) dopamine precursor 
L-DOPA. 
Methods 
Subjects 
Data analysis was performed on 16 healthy subjects (8 men, mean age 19.8, SD 1.1). 
Twenty four subjects were recruited from the University of California Berkeley community 
and screened following a similar procedure used previously (Cools et al, 2007). All subjects 
gave written informed consent and were compensated for their participation. This study 
was approved by the Committee for the Protection of Human Subjects at the University 
of California Berkeley.
From the 24 subjects who participated in the study, 8 were excluded due to scanner prob-
lems, head movement or abnormal performance on the task, leading to our final sample of 
16 subjects, included in the analysis (Supplementary Material). 
Our original aim had been to assess dopaminergic drug effects as a function of trait 
impulsivity, to certify prior findings showing that dopaminergic drug effects are more 
pronounced in high-impulsive subjects (Cools et al, 2007). For that reason subjects on both 
ends of the Barratt Impulsiveness Scale (Patton et al, 1995) were selected; high impulsive 
subjects had a Barratt score between 77 and 87 and a mean score of 81, low impulsive 
subjects had a Barratt score between 44 and 54 and a mean score of 50. Unfortunately, the 
size of our final sample (9 low and 7 high impulsive subjects) did not allow us to assess im-
pulsivity-dependent effects. Accordingly, we report effects irrespective of trait impulsivity. 
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General procedure
Subjects were invited to visit the Helen Wills Neuroscience Institute on four sessions: 
on the first screening session they were interviewed for suitability, administered back-
ground neuropsychological tests, and explained the procedure. On the remaining sessions, 
subjects were scanned, after oral intake of a lactose placebo, the dopamine receptor 
agonist bromocriptine (1.25 mg), or the dopamine precursor L-DOPA (100 mg with 25 mg 
carbidopa), according to a double-blind, crossover design (Supplementary material). 
Experimental paradigm 
Subjects performed a modified version of a three-item delayed match-to-sample working 
memory task while being scanned (Figure 1). They were instructed to encode three face 
stimuli and make a match/nonmatch discrimination on the probe stimulus. The probe 
matched one of the cues 50% of the time. In the middle of the delay period, a distracter 
stimulus, either a face or scene was presented. Thus, the delay period was separated into 
two components, pre- and post-distraction. When a distracter stimulus was presented, 
subjects had to indicate whether the distracter stimulus was one of two pre-learned 
targets. This was the case on one out of three trials. 
The design included two trial types of interest: cue/distracter congruent (i.e. face 
distracter) and cue/distracter incongruent (i.e. scene distracter) trials. Furthermore the 
design included a trial type of no interest. In this trial type the images in the encoding, 
distracter and probe phase were scrambled images. Subjects had to press any button  
during the ‘distracter’ and the ‘probe’ phase to match conditions for motor demands.  
This trial type was inserted to provide an interpretable baseline condition. It was not in-
cluded in our contrasts of interest, which compared different working memory conditions 
with distinct levels of distraction. Subjects were presented with an equal number of trials 
for each of the three conditions. The task was scanned in six runs of 18 trials each. 
Localiser task
In addition to the delayed match-to-sample task, subjects performed a one-back task using 
alternating blocks of face, scene, objects and scrambled stimuli to localise the FFA (Kan-
wisher, McDermott, & Chun, 1997) (Supplementary Material). 
Behavioural data analysis 
Reaction times and error rates were calculated for the face distracter and scene distract-
er conditions separately. Subjects who had 1) a response count less than 80%, or 2) had 
error rates above 50% on one of the conditions on either the distracter or probe task were 
excluded from analysis (final sample n=16). For the reaction time analysis the first trial of 
each run was excluded as well as trials with an incorrect response on either the distracter 
or probe task. In addition, trials following an incorrect probe trial were excluded to avoid 
a potential bias across trial types in the reaction time data owing to differential rates of 
‘post-error slowing’ (Rabbit, 1966). A drug (3) x distracter (2) repeated measures ANOVA 
was performed on mean reaction times and error rates on the probe task. 
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The critical measure of interest, the distracter cost, was defined as error rates on face 
distracter trials minus error rates on scene distracter trials. Note that this measure reflects 
a ‘relative’ distracter cost that was chosen based on previous literature showing that con-
gruent distracters are more distracting than incongruent distracters (e.g. Yoon et al., 2006). 
Next, we calculated the drug effect on the distracter cost (distracter costdrug – distracter 
cost
placebo
) and used this measure for brain-behaviour correlations. 
MRI data acquisition and analysis
Whole-brain functional images and a T1-weighted anatomical scan were obtained on a 
Siemens 3-T MR scanner (for scanning parameters, see Supplementary Material). fMRI 
preprocessing was conducted using SPM8 (Statistical Parametric Mapping, Wellcome 
Trust Centre for Cognitive Neuroimaging, London, UK). Data was visually inspected for 
spikes and signal stability. Slice timing correction was performed using the first slice as a 
reference slice. Anatomical images were spatially coregistered to the mean of the func-
tional images and normalized using a unified segmentation approach. These normalization 
parameters were then applied to the functional images that were smoothed with an 8-mm 
FWHM Gaussian kernel.
Figure 1. Schematic diagram of the delayed match-to-sample working memory task. During the 
encoding phase (duration 2.9 seconds), subjects were presented with three face stimuli (sequential-
ly). After an 11.1 s delay period, they were shown a face or scene distracter (duration 0.9 seconds). 
Subjects pressed a right or left button to indicate whether this stimulus matched a pre-learned target 
face or scene. After another delay period of 11.1 s, the probe stimulus appeared and the subject 
made a left/right button press to indicate whether this probe stimulus matched one of the encoded 
stimuli. Thus, two responses were recorded per trial: one for the delayed response task at probe and 
one for the distracter target detection task.
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In a general linear model we included 15 regressors of interest, 5 for each of the 3 trial 
types: face distracter trials, scene distracter trials and scrambled trials. The 5 task phases 
were modelled at the onset of stimulus (encoding, distracter and probe) or in the middle 
of the delay period (pre-distraction and post-distraction delay periods). This approach 
minimizes the contamination of the delay period covariate by residual cue period signal 
and has been used to successfully model delay period signal in numerous published stud-
ies (Barde and Thompson-Schill, 2002; Curtis et al, 2004; Druzgal and D’Esposito, 2003; 
Pessoa et al, 2002; Postle et al, 2000; Ranganath et al, 2004). Thus to minimize collinearity 
between temporally adjacent regressors, the delay period was not modeled as a boxcar 
function beginning immediately after the offset of the cue stimulus and extending until the 
onset of the probe stimulus. Rather, care was taken to ensure that the onsets of temporal-
ly adjacent regressors were spaced at least 4 seconds apart (Zarahn et al, 1997). 
All regressors of interest were modelled as delta functions and convolved with a canonical 
hemodynamic response function. In addition, the six realignment parameters were mod-
elled as regressors of no interest. Time-series were high-pass filtered using 128 seconds 
cut-off. Parameter estimates for the regressors of interest, derived from the mean least-
squares fit of the model to the data, were estimated at the (subject-specific) first-level and 
were used in a second level random effects analysis. 
This study aimed to find a link between dopaminergic drug effects on behavioural 
distracter-resistance and concurrent effects on brain signal. We found no effect of L-DOPA 
on behaviour. Therefore, we decided to focus our fMRI analyses on the bromocriptine ver-
sus placebo contrast, which revealed a behavioural effect. Nevertheless, for completeness, 
we conducted supplementary analyses to compare the L-DOPA and placebo sessions, from 
which we report analogous contrasts.
The effect of bromocriptine on BOLD signal was assessed at the voxel-level, corrected for 
multiple comparisons in our search volumes (see below) (pFWE < 0.05). We predicted that 
bromocriptine would alter the effect of face versus scene distracters on delay period sig-
nal. Accordingly, we assessed drug x distracter interaction effects on post-distraction delay 
period signal. We assessed this interaction on a whole brain level as well as within those 
regions that exhibited signal during the pre-distraction delay. To select these regions, 
a volume of interest (VOI) was selected from the second-level contrast representing the 
pre-distraction delay period (averaged across face distracter and scene distracter con-
ditions and placebo and bromocriptine drug sessions). A lenient threshold was used to 
identify such delay period signal (height threshold p < .05 uncorrected for multiple com-
parisons, extent threshold 25 voxels), but it should be noted that this procedure did not 
bias our subsequent statistical test of interest (drug x distraction on post-distraction delay 
signal). Specifically, it should be noted that the VOI is independent because the selection 
is based on a main effect (face distracter and scene distracter conditions across drug 
sessions) and we test for an interaction effect (drug x distracter). In addition, the VOI was 
selected from a separate (independent) task phase. This selection procedure revealed 15 
clusters across the brain, which were combined into a single VOI (for a list of clusters and 
graphical overview of the pre-distracter VOI see Supplementary Material). In addition to 
assessing the drug x distracter interaction across all subjects, we also assessed a brain-
behaviour correlation for the same interaction.
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For illustration purposes, we display for each phase of the task the main effects of task 
(i.e. collapsed across face distracter and scene distracter conditions and placebo and 
bromocriptine drug sessions), at a threshold of p < 0.001 or p < 0.05 uncorrected. 
PPI analysis
Functional connectivity during the post-distraction delay period was assessed using 
psycho-physiological interaction (PPI) analysis. Individual DLPFC seed regions were based 
on coordinates of the DLPFC cluster that exhibited a significant brain-behaviour correlation 
(see Results and Supplementary Material). Timeseries were extracted from these individ-
ual seed regions and multiplied by a vector coding for the experimental conditions (face 
distracter condition minus scene distracter condition) to obtain the PPI. On the subject lev-
el, we included the PPI as a regressor of interest in a general linear model. The experimen-
tal condition and the extracted timeseries were modelled as additional  regressors of no 
interest, in order to assess the PPI estimates in the brain over and above shared functional 
activation and task-independent correlations in BOLD signal between the seed and other 
regions. This approach ensures that any obtained PPI results are independent of univariate 
results. The extracted timeseries (deconvolved in SPM) and experimental condition re-
gressors were convolved with a canonical hemodynamic response function and high-pass 
filtered (128 s). In addition, the six realignment parameters were modelled. 
The PPI analysis was performed for the drug sessions separately. 
As described in the introduction, we predicted that dopaminergic drug effects on 
distracter-resistance would be accompanied by drug effects on PFC-FFA connectivity.
Because of large individual variation in the anatomical location of the fusiform face area 
(FFA) it can be challenging to find whole brain effects at the group level. Therefore we 
defined VOI’s for the FFA individually using an independent localizer task conform prior 
studies (Gazzaley et al, 2004; Kanwisher et al, 1997; Yoon et al, 2006)(for details see Sup-
plementary Material). Beta values were extracted from these individual VOIs and tested 
for bromocriptine-induced changes in PFC-FFA connectivity using a paired t-test. 
This analysis effectively tests for a drug x distracter interaction, similar to the univariate 
analysis, because the contrast face minus scene distracter condition was already included 
in the PPI analysis. In addition to the VOI analysis we performed an exploratory whole-
brain PPI analysis, again using the DLPFC as a seed. 
Results
Behavioural results
An initial omnibus ANOVA of error rates with three drug levels (L-DOPA, bromocriptine 
and placebo) failed to reveal the predicted interaction effect between drug and distracter 
(F(2,30) = 1.52; p = 0.24). Subsequent ANOVA with two drug levels (bromocriptine and 
placebo), however, did reveal a significant interaction effect between drug and distracter 
(F(1,15) = 5.39 ; p = 0.04), which was due to bromocriptine significantly increasing the 
face (vs scene) distracter cost compared with the placebo condition (t(15) = 2.3, p = 0.04). 
There was also a main effect of distracter (F(1,15) =6.62; p = 0.02). Across drug conditions, 
more errors were made in the congruent (face) condition than in the incongruent (scene) 
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condition. Post hoc t-tests confirmed that the face (vs scene) distracter cost did not differ 
between placebo and L-DOPA (t(15)= 1.0, p = 0.35) or between L-DOPA and bromocriptine 
(t(15)= 0.64, p =0.53) (Figure 2, Table S1). 
An ANOVA of reaction times did not reveal any effects. 
fMRI results
Inspection of the main effects of task (averaged across face distracter and scene distracter 
conditions and across bromocriptine and placebo drug sessions) revealed the expected 
network during encoding, distraction and probe (Figure 3). As is often reported, our group 
analyses were somewhat less sensitive to detecting delay period signal, presumably be-
cause such delay period signal is more variable between individual subjects than is signal 
during task periods that are accompanied by visual input (e.g. Druzgal and D’Esposito, 
2003). As outlined above, we had anticipated that the degree to which post-distracter 
delay period signal is modulated after distraction would vary as a function of both the type 
of distraction (face versus scene) as well as drug. Testing this hypothesis by means of a 
drug x distracter ANOVA did not reveal any such effects when all subjects were collapsed 
into one group (whole brain pFWE < 0.05). Restricting our search volume to the VOI of the 
pre-distraction delay period also did not show such a drug x distracter interaction. The lack 
of a drug effect across the group as a whole concurs with many previous studies showing 
individual differences in dopaminergic drug effects (for review see Cools and D’Esposito, 
2011; Mehta and Riedel, 2006). In fact, regression analysis within the pre-distracter VOI 
revealed a significant brain-behaviour correlation in the left DLPFC (p
SVC
 = 0.04, T = 5.57, 
MNI coordinates x, y, z = -24 40 26) (Figure 4A, encircled region). In this region, a decrease 
in face (> scene) related delay period signal after administration of bromocriptine was
associated with a greater bromocriptine-induced distraction by faces > scenes (Figure 4B). 
Similar analyses for l-DOPA induced effects showed no results at the whole brain level or 
the VOI level. 
Figure 2. Distracter cost in error rate (face >scene distracters) for each drug condition. Error bars 
represent standard errors of the difference between face and scene distracter conditions.
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Connectivity results
Psycho-physiological interaction analyses revealed, similar to the univariate analyses, 
significant brain-behaviour associations. Specifically, there was a negative correlation 
between drug-related changes in the distracter cost and drug-related changes in post-
distraction delay-related connectivity between the DLPFC and the FFA (VOI analyses within 
the individually defined FFA: r = -0.62; p=0.01). In other words, a decrease in face- 
(> scene-) related DLPFC-FFA connectivity after administration of bromocriptine was 
Figure 4. Brain-behaviour correlation A) Whole brain results of a regression analysis between drug 
effects on behavioural distracter cost and drug effects on neural distracter cost. The bar indicates 
T-values and figures are thresholded for a T-value of 3.79, corresponding to a p-value of 0.001 uncor-
rected for multiple comparisons. B) Data were extracted and plotted from the peak voxel in the DLPFC 
cluster that was found in the whole-brain correlation analysis (encircled in panel A) for illustrative 
purposes. Only the DLPFC cluster revealed a significant brain behaviour correlation when correcting 
for multiple comparisons across the VOI (see Methods). 
Figure 3. Main effect of task for all task phases; encoding, pre-distraction delay, distracter (face and 
scene), post-distraction delay and probe. For all task phases, T-maps are thresholded at p=0.001 un-
corrected (smaller network in the red to yellow gradient, left bar in the legend) and p=.05 uncorrect-
ed (more widespread network in the orange gradient, right bar in the legend).
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accompanied by greater bromocriptine-induced increases in the face (> scene) distracter 
cost. Thus the effect on connectivity resembled the effect on DLPFC signal (Figure 5A, 
bottom). Similar to the univariate results, we found no main effect of drug on DLPFC – FFA 
connectivity (individual VOIs), and there was no significant DLPFC-FFA connectivity when 
the placebo or bromocriptine sessions were assessed separately. Therefore, we conducted 
exploratory whole brain analyses. These did reveal an effect of bromocriptine on connec-
tivity between the DLPFC and the visual association cortex (Brodmann area 17) across the 
group as a whole (Figure 5B, top, p = 0.001 uncorrected for multiple comparison). Thus, 
bromocripine increased face- (> scene-)related connectivity between the DLPFC and the 
visual association cortex. Simple effects analyses revealed that there was no significant 
connectivity between DLPFC and FFA under placebo or bromocriptine separately. 
Critically, as in the individually localized FFA ROIs, a negative correlation (r = -0.69 
p= 0.005) was seen between the drug effect on connectivity and the drug effect on beha-
viour (Figure 5, panel B, bottom).
Thus, both ROI and whole-brain analysis of brain-behaviour correlations confirmed that 
individual differences in the drug effect on behaviour were associated with individual 
differences in the drug effect on DLPFC-FFA connectivity. Bromocriptine increased face- 
(> scene-)related delay-period connectivity in subjects who were not affected by bro-
mocriptine behaviourally. Conversely, bromocriptine did not increase face- (> scene-)
related connectivity in subjects where bromocriptine increased distracter-vulnerability.
Figure 5. Panel A, top panel: Localiser-based individual FFA VOIs (see Supplementary Material). Bot-
tom panel: Correlation between drug effects on DLPFC and individual FFA VOI connectivity during the 
post-distraction delay phase as a function of distracter (face > scene) and drug effect on the behav-
ioural distracter cost (face > scene). Panel B, top panel: Effect of bromocriptine (> placebo) on connec-
tivity (whole-brain) with the DLPFC. Bottom panel:  Brain-behaviour correlation. Data extracted from 
the encircled region (visual association cortex).
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Discussion
The present study provides empirical evidence for an important role for dopamine in 
distracter-resistance in humans. The dopamine D2 receptor agonist bromocriptine modu-
lated behavioural distracter-resistance and this was accompanied by changes in prefrontal 
BOLD signal. This finding is in line with experimental animal and human work showing that 
dopamine acts on the PFC to modulate working memory (Brozoski et al, 1979; Cools et al, 
2002; Gibbs and D’Esposito, 2005; Mattay and Tessitore, 2002; Sawaguchi and 
Goldman-Rakic, 1991). Here we significantly extend this prior work by showing that 
distracter-resistance might be one mechanism by which dopamine alters working memory. 
Our finding concurs with theoretical models suggesting that dopamine in the PFC mod-
ulates the stability of online working memory representations by changing the signal-
to-noise ratio of neuronal firing (Durstewitz and Seamans, 2008; Seamans and Yang, 
2004). According to these models, PFC networks can be in one of two alternative states: 
a closed state with high neuronal firing in which representations are robust and resistant 
to distraction and an open state in which there is a low signal-to-noise ratio with unstable 
neuronal firing. In an open state new information can easily interfere with currently active 
representations, such that these active representations are vulnerable to distraction. 
The particular state of the PFC has been suggested to depend on the ratio by which dopa-
mine binds to prefrontal D1 versus D2 receptors. When D2 receptor stimulation dominates 
the PFC is in an open state, while a closed state is present when D1 receptor stimulation 
dominates (Durstewitz and Seamans, 2008). Our results are consistent with this model: 
administration of the D2 receptor agonist bromocriptine decreased distracter-resistance 
in our subjects. Thus, across subjects, bromocriptine presumably increased prefrontal D2 
receptor stimulation, thereby switching the PFC to an open state, in which representations 
are unstable and vulnerable to distraction. This model might also explain why we did not 
find effects of the dopamine precursor L-DOPA. An increase in dopamine levels might 
increase overall dopamine receptor stimulation, but not change the D1/D2 binding ratio, 
thereby leaving the PFC state unchanged. 
The effect of bromocriptine on distracter-resistance also correlated negatively with drug 
effects on functional PFC-FFA connectivity. Indeed, working memory representations are 
thought to be maintained through simultaneous activation of a network of regions, rather 
than activation of the PFC alone. For instance, neuroimaging studies in humans have 
shown delay period signal in parietal cortex, caudate nucleus, thalamus and visual cortex 
(Gazzaley et al, 2004; Jha and McCarthy, 2000). Here we focused analyses specifically on 
the visual association cortex following previous studies showing that connectivity between 
the PFC and this region predicts behavioural working memory performance (Clapp et al, 
2010; Yoon et al, 2006). Future studies might investigate how the network as a whole 
interacts during working memory maintenance and distraction using more advanced con-
nectivity analyses such as dynamic causal modelling. 
The effect of bromocriptine on the behavioural distracter cost, which was significant when 
analyzed across the whole group of subjects, was not accompanied by supra-
threshold neural effects across the group as a whole. Instead, a significant neural effect 
was revealed only when taking into account individual differences in the behavioural drug 
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effects. Indeed in some subjects bromocriptine did not increase but rather decreased the 
distracter cost (Figure 4 and 5). In these subjects, face- versus scene-distracter related 
DLPFC signal and connectivity was not decreased but rather enhanced by bromocriptine. 
The presence of individual differences is perhaps less surprising when considering accumu-
lating evidence that there is large individual variability in drug effects, which at least in part 
reflects individual variability in baseline levels of dopamine (Cools et al, 2007, 2009; Cools 
and D’Esposito, 2011; Floresco, 2013). Thus bromocriptine might have opposite effects in 
subjects with sub- versus supra-optimal baseline levels of dopamine, with bromocriptine 
acting predominantly at post- versus presynaptic D2 receptors, leading to a net increase 
versus decrease in receptor stimulation respectively. As such bromocriptine might push 
performance towards versus away from an optimal D2 state in subjects with sub- versus 
supra-optimal baseline levels of dopamine. 
Exploratory whole-brain connectivity analyses strengthened our observation from the 
connectivity analyses within the individually defined localizer FFAs that the correlation 
between drug effects on connectivity and drug effects on behavioural distractibility was 
negative. However, it also highlighted that in most subjects bromocriptine in fact increased 
connectivity. Bromocriptine increased face-related connectivity to a greater extent in 
subjects who were less affected by bromocriptine behaviourally. Conversely, bromocrip-
tine did not increase face-related connectivity in subjects where bromocriptine increased 
distracter-vulnerability. Together, these findings suggest that drug-induced increases in 
face-related BOLD signal in the DLPFC and in face-related connectivity between the DLPFC 
and the FFA (more generally visual association cortex) protected against drug-induced 
distraction by faces. 
We had hypothesized that bromocriptine would increase distracter vulnerability of work-
ing memory representations by reducing the robustness of (and thus disrupting) delay-
period activity in prefrontal cortex. Our observation that bromocriptine increased rather 
than decreased connectivity across the group as a whole does not seem consistent with 
this hypothesis. However, one possibility is that our univariate analysis approach with its 
focus on persistent delay-period activity was not appropriate for measuring neural pat-
terns in prefrontal cortex that encode stable working memory representations. 
Indeed, recent work indicates that the neural patterns of stable working memory 
representations might well be spatially distributed and varying across time, thus detecta-
ble only using multivariate pattern classification techniques (Sreenivasan et al, 2014). 
Accordingly, any disruptive effect of bromocriptine on prefrontal representations might 
have gone unnoticed. Instead, our approach might have been more optimized for measur-
ing (effects of bromocriptine on) cognitive control processes in prefrontal cortex that are 
key for protecting against distraction. In future work multivariate analysis techniques might 
be employed to assess whether the observed effects of bromocriptine on 
protective prefrontal control processes are accompanied by disruptive effects on 
(multivariate) prefrontal working memory representations. 
A number of caveats should be noted. First, bromocriptine increased the behavioural 
distracter cost by decreasing error rate in the incongruent (scene) condition rather than 
by increasing error rate in the congruent (face) condition (Table S1). Here we would like to 
point out that task-specific drug effects are best interpretable in terms of difference scores 
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rather than absolute scores. Thus it is well possible that the drug also had non-specific 
effects, for example on vigilance or motivation, leading to an overall global performance 
improvement. Such a global improvement could be superimposed on a more task-selective 
(i.e. distracter-dependent) impairment, which would then surface as a selective improve-
ment on the control trial type rather than a selective impairment on the experimental trial 
type. For this reason, and following many other studies, we here focused on drug effects 
on the relative measure (i.e. face versus scene, referred to as distracter cost) which con-
trols for such non-specific effects.  
 
A second caveat of the present study is that we failed to replicate previous research 
showing that dopaminergic drug effects were most pronounced in high-impulsive subjects 
(Cools et al, 2007). We were not able to replicate this finding here, probably because our 
sample sizes for the low and high-impulsive groups were too small. In fact, supplementary
analyses revealed that the results presented in this paper were mostly driven by subjects 
in the high-impulsive group, although the full interaction did not reach significance. 
In addition, in contrast to previous findings (Jha et al, 2004; Yoon et al, 2006), we did not 
find a significant face (vs scene) distracter cost in the placebo condition. Thus, after place-
bo subjects showed no differences in performance between the face and scene condition. 
Although we do not have a good account of this lack of sensitivity in some of our subjects, 
we speculate that this might reflect individual variability in the existence of compensatory/
complementary systems that can help protect against distractibility.
Finally, we also note that we cannot make definitive claims about the D2 receptor selec-
tivity of the observed effect. Although bromocriptine is a D2 receptor agonist, it also has 
low affinity for D1, D3, D4, noradrenalin and serotonin receptors (Kvernmo et al, 2006). 
This means that bromocriptine might have also exerted its effects via other receptor types. 
Nevertheless, bromocriptine has the highest affinity for D2 receptors (Seeman and van Tol, 
1994) and as such our results concur with theoretical predictions as described above. 
To conclusively assess receptor specificity, future work might assess whether D2 antago-
nists e.g. sulpiride or haloperidol show opposite effects on distracter-resistance. A design 
in which subjects are pre-treated with a D1 or D2 receptor antagonist can also be used to 
assess effects of D2 receptors specifically. 
In conclusion, the present study supports the hypothesis that dopamine-induced changes 
in working memory performance reflect changes in distracter-resistance of working mem-
ory representations. In addition, it establishes an important role for the prefrontal cortex 
and its connectivity with stimulus-specific visual regions in posterior cortex in this effect of 
dopamine on distracter-resistance. Bromocriptine modulated delay period PFC signal and 
connectivity with visual areas possibly reflecting a compensatory and/or protective effect 
on prefrontal regions that are key for protection against distraction.
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Supplementary methods
Subject inclusion
Subjects were selected based on their total score on the Barratt Impulsiveness Scale 
(Patton et al, 1995); only volunteers with high or low scores were invited (see Cools et 
al, 2007). During an intake session participants were screened according to the following 
exclusion criteria: claustrophobia, neurological and cardiovascular diseases, metal parts in 
the body, regular use of medication, soft or hard drugs, heavy smoking, excessive alcohol 
consumption or moderate to severe depression (Beck depression inventory (Beck, 1996), 
BDI > 20). All subjects had normal or corrected to normal vision and were right handed.  
From the 24 subjects who participated in the study, datasets from two subjects were 
incomplete due to scanner problems. Three more subjects were excluded from the group 
level analysis due to excessive head movement in the scanner in one or more sessions; 
we imposed a maximal movement threshold of 4 mm in any one direction for inclusion. 
Finally, three subjects were excluded because of abnormal performance on the task in one 
or more sessions, leading to our final sample of 16 subjects, included in the analyses. 
General Procedure
Subjects entered the scanner at 90 min after drug intake; at a time when plasma levels of 
bromocriptine and levodopa are high (Deleu et al, 2002; Luciana and Collins, 1992). Behav-
ioural data were collected while subjects were scanned. Subjects were instructed to avoid 
eating large meals on the day of testing, as well as on the day prior to their visit, but to 
have a light meal 1 h before arrival. They were asked to refrain from caffeine and cigarettes 
on the days of testing. Light snacks were provided after drug intake and after scanning. 
Task details
The distracter stimulus was presented as a panel with 4 identical pictures, to help distin-
guish the distracter stimulus from the cue and probe stimuli. Trials were grouped into 
6 blocks with each block consisting of 18 trials, with a total of 108 trials for each subject. 
The order of trials within each block was pseudo-randomized. The same order of trials was 
used between and within subjects. The intertrial interval was 3100 ms. 
Stimulus presentation and response recordings were conducted with E-Prime (Psychology 
Software Tools, Inc., Pittsburgh, PA; http://www.pstnet.com).
Localiser task
Subjects were presented with 16 s blocks of face, scene, object and scrambled stimuli 
(20 stimuli per block, each presented for 300 ms, inter-stimulus interval of 500 ms), and 
rest periods (four blocks of each type) and were instructed to press buttons with their left 
and right index finger whenever they noticed an immediate (one-back) repeat of a stimu-
lus. Acquisition and preprocessing of fMRI data was performed as for the main experiment 
(see below), and the statistical analysis was conducted using the normalized and smoothed 
images. In a general linear model, we included five regressors of interest (face, scene, 
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Supplementary Table S1. Regions in the pre-distracter VOI based on the contrast bromocriptine and 
placebo, faces and scenes averaged, thresholded at p=.05 uncorrected, extent threshold 25, sorted anterior 
to posterior. 
MNI coordinates X Y 
Z 
Region nr of voxels 
-18  54   4 Left Superior Frontal Gyrus, medial 523 
-22  38  26  Left Middle Frontal Gyrus - DLPFC 
cluster 
62 
 -2  28   4  Anterior Cingulate Cortex 321 
 36  28   6  Right Insula 30 
-36  14  12  Left Insula 83 
-48   0 -26  Left Middle Temporal Gyrus 35 
 54  -2 -22  Right Middle Temporal Gyrus 104 
 -8  -6  54  Area 6 - Left Supplementary Motor 
Area 
742 
 18 -18  48  Right Area 6 (close to medial 
cingulate) 
44 
  2 -20 -12  Thalamus 1232 
-36 -26  58  Area 4 - Left Precentral Gyrus 597 
 24 -38  20  Ventricle 137 
-22 -40  18  Ventricle 25 
 32 -50 -10  Right fusiform Gyrus 61 
 -28 -52 -12 Left Fusiform Gyrus 32 
 
object, scrambled and rest blocks), and the six realignment parameters as regressors of no 
interest. The blocks were modelled at the onset of the first stimulus presentation, with a 
duration of 16 s and convolved with a canonical hemodynamic response.
MRI acquisition
Images were acquired on a Siemens 3T Tim MAGNETOM Trio system, equipped with 
a standard 12-channel head coil using gradient echo-planar pulse sequences, using an 
oblique orientation to minimize signal loss in orbitofrontal cortex (TR = 2 s, TE = 32 ms, 
flip angle = 90; 27 oblique slices, matrix = 128 x 128, FOV = 230 x 230 mm, slice thickness 
= 3mm, voxel size 1.8 x 1.8 x 3.45 mm, 412 volume acquisitions per run). High-resolution 
T1-weighted anatomical images were acquired using magnetization-prepared rapid acqui-
sition with gradient echo (MP-RAGE) protocol (TR = 2.3 s, TE = 2.98 ms, FOV = 256 mm, 
matrix size = 256 x 256, voxel size: 1 x 1 x 1 mm). Head motion was minimized by inserting 
foam pads around the head. The experimental task was projected on a screen mounted 
within the scanner bore. 
Overview of the pre-distracter VOI
Selection of the pre-distracter VOI resulted in 15 clusters that are summarised below in 
Table S1 and Figure S1. 
Supplementary Table S1. Regions in the pre-distracter VOI based on the contrast bromocriptine and 
placebo, faces and scenes averaged, thre holded t p=.05 uncorrected, extent threshold 25, sorted 
anterior to posterior.
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Supplementary figure S1. Graphical overview of the pre-distracter VOI based on the contrast bromocriptine and placebo, faces and 
scenes averaged, thresholded at p=.05 uncorrected, extent threshold 25. (See Figure 4 in main text for the DLPFC cluster within this 
VOI that showed a significant brain-behaviour correlation). 
 
Psycho-Physiological Interaction analysis  
 
Timeseries were extracted from a seed region in the DLPFC. The selection of this seed was performed based 
on the brain-behaviour correlation observed during the post-distractor delay. Because the exact locations 
of activation maxima varied across subjects, we determined individual peak voxels, under the constraints 
that it 1) exceeded a threshold of p<0.05 (uncorrected) during the post-distraction delay (averaged across 
the face distracter and scene distracter condition) and 2) was within 12 mm of the peak voxel in the DLPFC 
across the group (MNI coordinates of the peak for post-distractor brain-behaviour correlation x, y, z = -24 
40 26). Ten subjects did not show activity at the p<0.05 uncorrected threshold, which was therefore 
lowered to p=0.5 uncorrected. Peak voxels were found at this threshold for nine subjects, the remaining 
subject was excluded from analysis, leaving 15 subjects for the PPI analysis. To summarize the regional time 
series, we computed the first eigenvector across all supra-threshold voxels (< 0.05 or <0.5 uncorrected) 
within a 3 mm sphere around each individual’s peak voxel.  
To define the FFA VOIs, we used a combination of functional and anatomical constraints to select the FFA 
region individually. Within the anatomical masks of the fusiform face area (FFA) (defined using the AAL 
interface (Tzourio-Mazoyer et al, 2002), the voxel with the highest value was determined in the faces 
versus scenes contrast for every subject separately. Voxels that 1) were within the anatomical masks, 2) 
were within a sphere (radius of 3 mm) around the peak voxel, and 3) exceeded a statistical threshold of < 
0.05 (uncorrected) were included in the subject’s FFA VOIs. 
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determined individual peak voxels, under the constraints that it 1) exceeded a threshold of 
p<0.05 (uncorrected) during the post-distraction delay (averaged across the face distracter 
and scene distracter condition) and 2) was within 12 mm of the peak voxel in the DLPFC 
across the group (MNI coordinates of the peak for post-distractor brain-behaviour cor-
relation x, y, z = -24 40 26). Ten subjects did not show activity at the p<0.05 uncorrected 
threshold, which was therefore lowered to p=0.5 uncorrected. Peak voxels were found at 
this threshold for nine subjects, the remaining subject was excluded from analysis, leaving 
15 subj cts for the PPI analysis. To summariz  the regional time series, w  computed th  
first eigenvector across all supra-threshold voxels (< 0.05 or <0.5 uncorrected) within a 
3 mm sphere around each individual’s peak voxel. 
To define the FFA VOIs, we used a combination of functional and anatomical constraints to 
select the FFA region individually. Wit in the anatomical masks of the fusiform face area 
(FFA) (defined using the AAL interface (Tzourio-Mazoyer et al, 2002), the voxel with the 
highest value was determined in the faces versus scenes contrast for every subject 
separately. Voxels that 1) were within the anatomical masks, 2) were within a sphere 
(radius of 3 mm) around the peak voxel, and 3) exceeded a statistical threshold of < 0.05 
(uncorrect d) were included in the subject’s FFA VOIs.
Supplementary figure S1. Graphical overview of the pre-distracter VOI based on the contrast 
bromocriptine and placebo, faces and scenes averaged, thresholded at p=.05 uncorrected, extent 
threshold 25. (See Figure 4 in main text for the DLPFC cluster within this VOI that showed a significant 
brain-behaviour correlation).
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Supplementary Table S2. Behavioural data for different drug conditions. Reported are the error rates and 
reaction times on the probe task. 
  Placebo Levodopa Bromocriptine 
  face scene face scene face scene 
Mean percentage 
error rate (SEM) 23.4 (2.2) 21.8 (2.5) 25.8 (2.3) 21.0 (2.7) 25.9 (1.5) 18.5 (2.3) 
Mean RT in ms 
(SEM) 1059.0 (66.4) 1088.2 (70.9) 1033.5 (55.1) 1023.6 (59.3) 1030.1 (52.3) 1049.7 (61.9) 
 
On the distracter task, accuracy was higher across sessions for face distracters; F(1,15)= 4.87, p= .04.  RT 
was slower across sessions; F(1,15)=15,51, p=.001. There was no main effect of drug or no drug x distracter 
interaction on accuracy or RT measures. 
Supplementary Table S3. Behavioural data for different drug conditions on the distracter task. Reported 
are accuracy and reaction times. 
  Placebo Levodopa Bromocriptine 
  face scene face scene face scene 
Mean percentage 
accuracy (SEM) 96.2(4.7) 93.9(4.3) 95.1(7.1) 93.2(5.4) 96.2(3.2) 93.8 (6.5)  
Mean RT in ms 
(SEM) 920.9 (219.6) 837.9(151.2) 895.3(191.0) 841.7 (161.9) 868.1(158.8) 819.0 (149.8)  
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Abstract
Resistance to irrelevant information is key for successful working memory maintenance. 
However, for successful updating of working memory, new information actually has to be 
processed rather than resisted. In healthy aging, working memory maintenance is im-
paired. Age-related impairments in working memory maintenance may result from the 
relatively larger influence of prefrontal than striatal dopamine loss, involved in distractor 
resistance and working memory updating respectively. Therefore, we tested the hypoth-
esis that older adults simultaneously display impaired working memory maintenance 
(stability) but relatively spared working memory updating (flexibility). Twenty-one older 
adults and 24 young adults performed a working memory task designed to dissociate 
maintenance from updating. No conclusive evidence was found for differential age effects 
on working memory maintenance versus updating. Instead, we found that - independent 
of maintenance or updating - older adults were slower when remembering items after a 
longer delay (i.e., 11 sec). For more recent items (i.e., 5 sec delay), older adults performed 
equally well as young adults. Moreover, older adults were slower to reject novel probes. 
Instead of an age-related dissociation in working memory maintenance versus updating 
performance, these findings suggest that aging is accompanied by a delay-dependent 
working memory deficit and impaired working memory retrieval when novel items are 
presented. Depleted prefrontal cortex-guided attentional resources in older adults may 
result in both observed effects.
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Introduction
Our busy, crowded environment requires us to resist irrelevant information. Preventing 
distraction is key to successfully maintaining task-relevant representations for a period 
of time (Baddeley and Hitch, 1974b; Logie et al, 1990). Animal and human studies have 
shown the importance of the prefrontal cortex for distractor resistance; e.g. damage to 
prefrontal cortex increases distractibility (Chao and Knight, 1995; Malmo, 1942) and pre-
frontal activity as well as its connectivity with posterior sensory areas is perturbed during 
distraction (Yoon et al, 2006). Dopamine modulates the stability of working memory rep-
resentations, with dopamine D1 and D2 receptor states of the prefrontal cortex putatively 
corresponding with enhanced and reduced distracter-resistance, respectively (Durstewitz 
and Seamans, 2008). Previously, we demonstrated the modulating role of dopamine in dis-
tractor resistance in humans by showing that D2 receptor stimulation decreased distractor 
resistance, which was accompanied by reduced prefrontal signal as well as diminished con-
nectivity with stimulus-specific posterior cortex (Bloemendaal et al, 2013). On the other 
hand, dopamine in the striatum is suggested to be involved in ‘gating in’ of newly relevant 
cognitive representations, as necessary for working memory updating (Hazy et al, 2006). 
Aging is accompanied by impairments in working memory maintenance, especially when 
keeping items online over a longer period of time (Dunnett et al, 1988b; Wang et al, 2011).  
Dopamine reduction in prefrontal cortex of healthy older adults has been associated with 
reduced working memory performance (Backman et al, 2006; Bäckman et al, 2011; 
Goldman-Rakic and Brown, 1981; Landau et al, 2009; MacDonald et al, 2012). In aged 
animals, the causal relationship between prefrontal cortex dopamine and working mem-
ory has been empirically proven: repleting prefrontal cortex dopamine with a D1 receptor 
agonist improved performance on working memory tasks (Cai and Arnsten, 1997; 
Mizoguchi et al, 2009). Although dopamine availability is reduced both in frontal as well as 
striatal areas in aging, reduced dopamine availability in the frontal cortex seems to have a 
larger impact due to the higher dopamine turnover in this region relative to the striatum 
(Bradberry, 1989; Tam and Roth, 1997). For this reason, reduced dopamine availability in 
healthy aging may impact working memory maintenance (i.e. stability), associated primar-
ily with prefrontal cortex dopamine, to a greater degree than working memory updating 
(i.e. flexibility), associated primarily with striatal dopamine. 
It has been argued that maintenance deficits in older adults are due to impaired inter-
nally guided, top-down suppression of irrelevant working memory items (Gazzaley et al, 
2005b; Jost et al, 2011) as well as greater reliance on (distracting) environmental cues (for 
a review, see Lindenberger & Mayr, 2014). However, enhanced influence of environmental 
stimuli can also lead to performance benefits. In fact, using different tasks, a greater ben-
efit was shown for older than young adults for relevant, but to be ignored ‘distractors’ (for 
a review see, Weeks & Hasher, 2014). For example, such age-related performance benefits 
were observed when an auditory tone improved response times in a visual detection task 
(Peiffer et al, 2007) or when a common theme had to be detected among three target 
words, and this theme was congruently primed by a to-be ignored distractor (May, 1999). 
Given that older adults seem to benefit from ‘congruent distraction’, i.e. unintentionally 
processing new items, working memory updating may similarly benefit from reduced 
distractor resistance. However, no previous published study has attempted to dissociate 
working memory maintenance versus updating in aging.  
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In this study, we tested the hypothesis that working memory updating in aging is relatively 
intact in comparison with working memory maintenance by using an adapted version of 
a delayed-match-to-sample task that dissociates maintenance and updating of working 
memory (Fallon and Cools, 2013). During working memory maintenance, items needed to 
be remembered despite distracting items in the delay period (Ignore trials). During work-
ing memory updating, items maintained had to be updated by new items (Update trials). 
Moreover, the task allowed the dissociation between correctly recognizing a probe item, 
rejecting a distracting probe item, or rejecting a novel probe item during retrieval. We 
predicted to find impaired working memory maintenance, i.e. slower and worse perfor-
mance on Ignore trials, and relatively intact or even enhanced working memory updating 
(on Update trials) in older relative to young adults. Moreover, by disentangling the results 
per probe type (Target, Distractor and Novel Probes), we tested whether subjects pro-
cessed new information (i.e. salient environmental stimuli) to such an extent that it would 
interfere with retrieving the correct information, i.e. leading to impaired rejection of those 
novel probes. 
Methods
Participants
Forty-five subjects were included in the analyses: 24 young (mean age: 22.7, range 18-29, 
14 men) and 21 older adults (mean Age: 67.3, range 61-75, 13 men). Participants met the 
following inclusion criteria: normal or corrected-to-normal vision, right handed, function-
ing within normal limits of general cognitive function with the Mini-Mental State Exam-
ination (MMSE) (Folstein et al, 1975) (cut-off > 27 of 30), no neurological or psychiatric 
disorders, estimated verbal IQ >85 based on the Dutch version of the North American 
Adult Reading Test (Schmand et al, 1991). Fifty-two participants performed the task: seven 
subjects (one young and six old) were outliers on either Ignore, Update or No-Interference 
accuracy determined by Tukey’s test (Tukey, 1977). This also ensured inclusion of subjects 
performing above chance. The experiment was approved by the local ethics committee 
(CMO 2001/095), and all participants gave written, informed consent. We aimed to match 
participants on verbal IQ, Hospital Anxiety and Depression Scale (HADS, (Bjelland et al, 
2002)) and gender. Participants were further tested on impulsivity (Barratt Impulsiveness 
Scale, BIS-11 (Patton, Stanford, & Barratt, 1995)), immediate and delayed story recall 
(Wilson et al, 1985a), digit span forward and backward (Wechsler, 1997), Stroop cards 
(Stroop, 1935) and verbal fluency (using the begin letters D, A and T) (Tombaugh et al, 
1999).
The working memory task was the last task assessed in a session of about 4.5 hours. 
Subjects had practised and performed a response-inhibition and n-back working memory 
task in the MRI scanner and completed a neuropsychological test battery. Participants 
received standardized task instructions and completed two practice blocks of 18 trials, 
taking 8 minutes in total. Older and young adults were trained equally long on the task 
before the actual experiment.
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Task Procedure
Participants performed a delayed-match-to-sample task, which was modified to include 
an extra component during the delay period (Figure 1). In its standard form, the delayed-
match-to-sample task involves presenting participants with a series of items that have to 
be remembered (referred to as the target). After a variable delay period, a probe stimulus 
is displayed. Participants have to indicate whether the item presented at probe was a 
member of the item set they had to encode, i.e., whether the probe was one of the target 
stimuli.
In the current version of the delayed-match-to-sample task, an interference phase was 
added in which different items were presented. Task instructions determined whether 
to ignore or to encode the items presented in the interference phase. In total, each trial 
consisted of 3 distinct phases separated by two delay periods. Delay periods consisted of a 
blank screen and took 4 seconds. 
Figure 1. Schematic illustration of each trial type of the delayed-match-to-sample task. The task 
consisted of three phases, an encoding phase, an interference phase and a probe phase with two 
delay periods in between. The last column reflects the delay between the presentation of a stimulus 
during the recognition (probe) phase relative to the encoding/interference phase of the experiment 
(i.e. novel, short, or long).
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Encoding Phase: 
Firstly, participants were presented with the letter “T” in the middle of the screen flanked 
by two computer-generated “spirographs” of different colours 
(Figure 1). These stimuli remained on the screen for 2000ms. Participants were instructed 
that the presence of a “T” in the centre of the screen indicated that the stimuli had to be 
remembered as the “Target” stimuli and that those stimuli remained the target stimuli 
until they saw a new set of stimuli with a “T” in the centre of the screen. 
Interference phase: 
Working memory updating was manipulated by varying whether participants had to ignore 
or encode (i.e. update) new stimuli into working memory during the delay period. In the 
Ignore condition, participants were presented with two novel stimuli which they had to 
ignore. These were accompanied by the letter ‘N’ in the middle of the screen. Conversely, 
in the Update condition participants were presented with two novel stimuli with the letter 
‘T’ in the middle, signalling the need to update these items into their working memory 
(thus displacing the previous set of target stimuli). There was also a control, No-interfer-
ence, condition in which only a fixation cross appeared on the screen. Items in the interfer-
ence phase were presented for 1000 ms. 
Probe phase: 
In this phase, participants were presented with a single stimulus in the centre of the 
screen. Participants had to respond according to whether this probe was a target (match) 
or non-target stimulus (non-match) with their right index or middle finger respectively. 
There was an equal probability of the probe being a target or non-target stimulus. Half of 
the non-target stimuli were novel stimuli, the other half were stimuli that featured, in the 
case of ignore blocks, as distracters or, in the case of update blocks, as stimuli that were 
initially encoded as target stimuli but which were displaced by targets in the intervening 
period. 
Thus, the task consisted of three Condition trial types: Ignore, Update, and No-
Interference. The probe types of these condition trials were further divided into: Novel, 
Distractor, and Target. This resulted in eight Probe trial types: Ignore Novel, Ignore Dis-
tractor, Ignore Target, Update Novel, Update Distractor, Update Target, No-Interference 
Novel, and No-Interference Target (Figure 1). An Ignore Target is one of the items from the 
Encoding phase; an Update Target is one of the items presented in the Interference phase. 
Conversely, an Ignore Distractor item is one of the items presented as interfering informa-
tion in the Interference phase. An Update Distractor is one of the items presented during 
the Encoding phase that needed to be updated in the Interference phase. Novel targets 
are items not previously presented in the task.
Subjects were instructed to respond as soon as they knew the answer, but otherwise 
within 3000 ms. Each trial was separated by an ITI of 4000 ms and at the end of each block 
participants were presented with a screen that informed them of their accuracy during 
the previous block. Participants completed 96 trials, which were divided into 2 runs. 
Trials were blocked (i.e. 2 update and 2 ignore blocks) rather than randomized to reduce 
‘task-switching’ effects. Each block contained 12 trials of which 8 ignore or update trials 
and 4 no-interference trials. In total, the task took almost 29 minutes. 
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Analysis
Our main indices of behaviour were accuracy and reaction times recorded during the 
probe phase. Incorrect RTs and RTs below 200 ms were excluded from analysis. 
Outlier subjects on Ignore, Update or No-Interference accuracy, determined by Tukey’s test 
(Tukey, 1977), were excluded. Levene’s test revealed that log transformation of RTs and 
arcsin transformation (2 arcsin√x) of accuracy rates was successful in equalizing variances 
between the age groups. 
First, an ANOVA on RT and accuracy of no-interference trials only, using the within-
subjects factor Block (ignore, update) and between-subjects factor Age (young, old), 
assessed whether the no-interference trial types in both blocks (each 16) could be grouped 
together. Thereby, the No-interference trial type yielded 32 trials, similar to the other 
interference types Ignore and Update. This analysis also checked whether the no interfer-
ence trials were influenced by the ‘ignore’ or ‘update’ context they were placed in. Speci-
fically, if subjects strategically refused to encode the stimuli in the first phase of the update 
trials due to realizing that most items need to be updated in most trials anyway, this would 
be reflected in differential performance between Update and Ignore No-interference trials. 
Second, the effect of interference was assessed by means of an ANOVA on accuracy and 
RT values using the within-subjects factor Condition (Ignore, Update, No-Interference com-
bined) and the between-subjects factor Age (young, old). Third, the effect of interference 
on accuracy and RT was also assessed per Probe type, by means of an ANOVA using within 
factors Condition (Ignore, Update), Probe (Novel, Target, Distractor) and the between 
factor Age (young, old). 
The design of the task is such that the time between the presentation of the probe and its 
first occurrence in the trial can be 11 seconds or 5 seconds. Specifically, the delay between 
the target item (‘match’) (presented in the Interference phase) and the probe in the Up-
date condition is 6 seconds shorter than the delay between the target item (presented in 
the encoding phase) and the probe in the Ignore condition (Figure 1). In contrast, the delay 
between the distractor item (‘non-match’) (presented in the Interference phase) in the 
Ignore condition is 6 seconds shorter than the delay between the distractor item (present-
ed in the encoding phase) and the probe in the Update condition . As a result, Probe types 
can be categorized into Long delay, Short delay or No delay in the case of Novel Probes. 
To assess the effect of the delay between the target or distracter and the probe , a control 
analysis was performed, i.e. a fourth ANOVA using within-subjects factors Condition (Up-
date, Ignore) and Delay (Novel, Short, Long) and between-subjects factor Age (young, old). 
Upon significant main or interaction effects, simple effects were determined using ANO-
VA’s and paired t-tests. Age differences between older and young adults on neuropsycho-
logical assessment (MMSE, HADS, verbal IQ, BIS-11, Story recall, digit span, Stroop cards 
and verbal fluency) were determined using two-sampled t-tests. Categorical measures 
were tested using chi-square tests.  
Upon significant age effects in any of the neuropsychological tests, modulation of the task 
results by this measure was tested by including it as a covariate in a control ANOVA.
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Table 1. Demographics and Neuropsychological tests 
Variable Young (n=24) Old (n=21) p-value 
Age (years) 22.8 (0.6) 67.4 (0.8)      <.001 
Gender  (Female/Male) F: 10 M:14  F: 9 M: 12 .94 
Verbal IQ 106.3 (1.4) 115.6 (2.3) <.001 
Education (points) 6.8 (.1) 5.8 (.1) <.001 
HADS 5.7 (0.8) 4.4 (0.6) 0.2 
MMSE 29.4 (0.1) 29.3 (0.1) .3 
BIS-11 motor 21.9 (0.8) 19.6 (0.7) .03 
BIS- 11cognitive 15.1 (0.8) 13.8 (0.5) .1 
BIS- 11nonplanning 22.8 (0.8) 21.4 (0.9) .3 
BIS-11 total 60.0 (2.2) 53.2 (1.5) .02 
Story immediate recall 11.5 (0.8) 9.5 (0.6) .13 
Story delayed recall 10.5 (0.7) 8.3 (0.6) .02 
Digit span forward 10.0 (0.4) 8.9 (0.5) .08 
Digit span backward 9.8 (0.4) 8.3 (0.3) .01 
Stroop effect (secs) 21.6 (1.3) 39.6 ( 6.9)      <.001 
Stroop effect (errors)  0.3 (0.1) 0.2 (0.2) .6 
Verbal Fluency  49.9 (2.8) 48.9 (3.3) .4 
Note: All data in Young and Old columns represent mean (standard error of the mean) except for the variable Gender, for which 
data reflect frequencies. Verbal IQ is defined by scores on the Dutch Reading Test; Education level points according to (Verhage, 
1964); MMSE = Mini-Mental State Examination; BIS-11 = Barratt Impulsiveness Scale; Stroop effect = colour naming: incongruent 
minus neutral cards). Significant p-values are in bold. 
 
Working memory updating versus maintenance in aging 
 
First, we determined whether we could pool the No-Interference trials across Update and Ignore blocks to 
obtain equal trial numbers per Interference condition (Ignore, Update, No-interference). Indeed, No-
Interference RTs and accuracy were not different between Update and Ignore blocks across age groups (RT: 
F(1,43)=1.36, p=.25; accuracy: F(1,43)=.06, p=.81), between age groups (RT: F(1,43)=.22, p=.64; accuracy: 
F(1,43)=.19, p=.17), or within age groups (RT young: t(23)= .56, p=.59; accuracy young: t(23)= .89, p=.39; RT 
old: t(20)= 1.0, p=.31; accuracy old: t(20)= -1.1, p=.31). This also suggests that the different block contexts 
(i.e. update versus ignore) did not evoke a different strategy in encoding the stimuli. 
Second, we performed an ANOVA using the within-subject factor Condition (Ignore, Update, No-
Interference) and between-subject factor Age (young, old) to address our main hypothesis that working 
memory maintenance (i.e. ignoring distractors) in aging is relatively more affected than working memory 
updating .  However, we did not observe an Condition x Age interaction on RTs (F(2,86)=.9, p=.41) or 
accuracy (F(2,86)=1.3, p=.29) (Figure 2 and Table 2 for raw RT and accuracy scores). Thus, compared with 
young adults, the performance of older adults was not differentially affected by the Condition trial types 
Ignore, Update and No-Interference.  
 
Main effects of Condition across age groups were found on both accuracy (F(2,86)= 6.4, p=.003) and RT 
(F(2,86)= 17.4, p<.001) (see Figure 2, split by Age group). Update RTs were faster than No-Interference RTs 
(t(44)= -4.0, p<.001) and Ignore RTs (t(44)= 6.8, p<.001). Accuracy was lower for Ignore trials, relative to 
Results
Seven subjects (one young, six old) were outliers on Ignore, Update or No-Interference 
performance as determined by Tukey’s test. The outliers’ accuracy was 59% or lower, 
whereas all included subjects had an accuracy of 60% or more. Demographics and 
neuropsychological test scores of both age groups are mentioned in Table 1. After subject 
exclusion, age groups were no longer matched on verbal IQ and education level. These 
age effects were in different directions: verbal IQ was higher in older adults, but education 
level was higher in the young adults. Older adults were less impulsive than young adults, 
specifically on motor impulsivity. In terms of neuropsychological task performance, older 
adults recalled fewer items and were slower than young adults on delayed story recall and 
digit span backward. Moreover, older adults needed more time on the Stroop cards than 
young adults.
Note: All data in Young and Old columns represent mean (standard error of the mean) except for the 
variable Gender, for which data reflect frequencies. Verbal IQ is defined by scores on the Dutch Read-
ing Test; Education level points according to (Verhage, 1964); MMSE = Mini-Mental State Examina-
tion; BIS-11 = Barratt Impulsiveness Scale; Stroop effect = colour naming: incongruent minus neutral 
cards). Significa t p-values are in bold.
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Working memory updating versus maintenance in aging
First, we determined whether we could pool the No-Interference trials across Update 
and Ignore blocks to obtain equal trial numbers per Interference condition (Ignore, 
Update, No-interference). Indeed, No-Interference RTs and accuracy were not different 
between Update and Ignore blocks across age groups (RT: F(1,43)=1.36, p=.25; accuracy: 
F(1,43)=.06, p=.81), between age groups (RT: F(1,43)=.22, p=.64; accuracy: F(1,43)=.19, 
p=.17), or within age groups (RT young: t(23)= .56, p=.59; accuracy young: t(23)= .89, 
p=.39; RT old: t(20)= 1.0, p=.31; accuracy old: t(20)= -1.1, p=.31). 
This also suggests that the different block contexts (i.e. update versus ignore) did not 
evoke a different strategy in encoding the stimuli.
Second, we performed an ANOVA using the within-subject factor Condition (Ignore, 
Update, No-Interference) and between-subject factor Age (young, old) to address our 
main hypothesis that working memory maintenance (i.e. ignoring distractors) in aging is 
relatively more affected than working memory updating. However, we did not observe 
an Condition x Age interaction on RTs (F(2,86)=.9, p=.41) or accuracy (F(2,86)=1.3, p=.29) 
(Figure 2 and Table 2 for raw RT and accuracy scores). Thus, compared with young adults, 
the performance of older adults was not differentially affected by the Condition trial types 
Ignore, Update and No-Interference. 
Main effects of Condition across age groups were found on both accuracy (F(2,86)= 6.4, 
p=.003) and RT (F(2,86)= 17.4, p<.001) (see Figure 2, split by Age group). Update RTs were 
faster than No-Interference RTs (t(44)= -4.0, p<.001) and Ignore RTs (t(44)= 6.8, p<.001). 
Accuracy was lower for Ignore trials, relative to Update trials (t(44)= -2.1, p=.044) and to 
No-Interference trials (t(44)= -3.86, p<.001). As expected, a main effect of age was found 
on accuracy (F(1,43)= 25.6, p<.001) and RT (F(1,44)= 9.3, p=.004), with older adults being 
both slower as well as less accurate than young adults.
Figure 2. Main effects of condition on transformed accuracy and RT. Error bars represent SEM.
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In sum, older adults were slower and performed less accurate than young adults on the 
working memory task. However, the performance of older relative to young adults was not
affected by the type of interference, i.e. we did not find evidence for disproportionally 
impaired maintenance relative to updating.
Probe type-dependent effects of working memory interference in aging
To test for an age effect on the salient novel probes relative to target probes (‘match’) or  
distractor probes (‘non-match’), we ran a third ANOVA (without No-Interference as this 
condition had no distractor trials) with the factors Condition (Ignore, Update) x Probe type 
(Novel, Target, Distractor probe) x Age (young, old). This analysis revealed a three-way in-
teraction between Condition x Probe x Age in RTs (F(2,86)=5.3, p=.007) (Figure 3A). Break-
ing down this interaction showed that it was driven by a Probe x Age interaction in Update 
trials (F(2,86)=4.61, p=.013), not Ignore trials (F(2,86)=1.22, p=.3). Within the Update trials, 
older adults were less impaired on one probe type relative to young adults: i.e., whereas 
they were significantly slower than young adults when rejecting Update 
Novel probes (t(1)=14.1, p=<.001) and when rejecting Update Distractor probes (t(1)=11.29 
p=.002), they were not significantly slower in recognizing an Update Target probe (t(1)=3.0, 
p=.093). When comparing the different Update probe types within age groups, we found 
that older adults’ RTs were faster for Update Target than Distractor probes (t(20)=2.66, 
p=.015), whereas young adults RTs did not show a significant difference between these 
probes (t(23)=-.97 p=.34) (Probe (Update Distractor, Update Target) x Age (young, old): 
F(1,43)=6.17, p=.02). In contrast, young adults’ RTs were faster on Update Novel than 
Target probes (t(23)=2.96 p=.007), whereas older adults RTs did not show a significant dif-
ference between these probes (t(20)=-7.55, p=.46) (Probe (Update Novel, Update Target) 
x Age (young, old): F(1,43)=7.31, p=.01). No such interaction with Age was observed for 
Update Distractors and Novel probes (F(1,43)=.001, p=.97).  
The Probe by Age interaction in RTs was not significant in Ignore trials. However, post-hoc 
testing revealed that within the Ignore trials, older adults were also less impaired on one 
probe type relative to young adults: i.e., whereas they were significantly slower than young 
adults on Ignore novel and Ignore target probes (F(1,43)=10.3, p=.002 and F(1,43)=8.66, 
p=.005 respectively), they were not slower on Ignore distractor probes (F(1,43)=2.38, 
p=.13))  (Figure 3A). 
No interaction effects with Age were observed on accuracy scores. 
Besides main effects of Condition (RT: F(1,43)=27.2, p<.001; accuracy: F(1,43)=4.2, p=.047) 
and Age (F(1,43)=15.1, p=.003; accuracy: F(1,43)=11.9, p=.001) (also reported in the 
ANOVA without the extra factor Probe), a main effect of probe type was observed (RT: 
F(2,86)=7.0, p=.001; accuracy: F(2,86)=31.9, p<.001). Novel probes were responded to fast-
er and more accurately than Distractor and Target probes (Novel versus Distractor probes, 
RT: t(44)= -3.5, p=.001; accuracy: t(44)= 4.26, p<.001; and Novel versus Target probes, RT: 
t(44)= -3.18, p=.003; accuracy: t(44)= 7.38, p<.001). Accuracy was also higher on Distractor 
probes than on Target probes (t(44)= 3.55, p<.001). Thus, across age groups, Novel trials 
were responded to fastest as well as most often correctly rejected. Target probes seemed 
hardest to correctly recognize, evidenced by the lowest accuracy scores. 
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(F(1,43)=10.3, p=.002 and F(1,43)=8.66, p=.005 respectively), they were not slower on Ignore distractor 
probes (F(1,43)=2.38, p=.13))  (Figure 3A).  
 
No interaction effects with Age were observed on accuracy scores.  
 
Besides main effects of Condition (RT: F(1,43)=27.2, p<.001; accuracy: F(1,43)=4.2, p=.047) and Age 
(F(1,43)=15.1, p=.003; accuracy: F(1,43)=11.9, p=.001) (also reported in the ANOVA without the extra factor 
Probe), a main effect of probe type was observed (RT: F(2,86)=7.0, p=.001; accuracy: F(2,86)=31.9, p<.001). 
Novel probes were responded to faster and more accurately than Distractor and Target probes (Novel 
versus Distractor probes, RT: t(44)= -3.5, p=.001; accuracy: t(44)= 4.26, p<.001; and Novel versus Target 
probes, RT: t(44)= -3.18, p=.003; accuracy: t(44)= 7.38, p<.001). Accuracy was also higher on Distractor 
probes than on Target probes (t(44)= 3.55, p<.001). Thus, across age groups, Novel trials were responded to 
fastest as well as most often correctly rejected. Target probes seemed hardest to correctly recognize, 
evidenced by the lowest accuracy scores.  
 
A control analysis tested whether subjects adhered to the task instructions. In the Ignore condition the 
distractors were indeed processed, suggested by lower accuracy (t(44)=-3.38, p=.001) and slower RTs 
(t(44)=2.01, p=.05) on Ignore Distractor versus Ignore Novel probes across age.  
In sum, older adults responded more slowly on the task than young adults (i.e. main effect of age). 
However, this slowing was not uniformly divided across the different probe types. Specifically, age-related 
slowing was not seen when correctly recognizing Update target trials and when correctly rejecting Ignore 
distractor probes. Thus, older adults responded relatively faster on these probes in comparison with other 
probe types. This suggests that intact response times in aging were independent of updating or ignoring 
and independent of a match or non-match response. Instead, what both Update target and Ignore 
distractor probes have in common is that the probe was presented after only a short delay following the to-
be-recognized (Update target) or to-be-rejected (Ignore distractor) stimulus. Hence, we performed a fourth 
ANOVA, described below, which modeled the duration of the delay between the familiar stimulus and the 
probe instead of Probe type (target or distractor).  
 
Table 2. Mean (Standard error of the mean) RTs (in seconds) and accuracy (in percentages) per trial type for older and young adults 
as well as across age groups. 
Condition type Probe type Old  Young  Total  
  RT Accuracy RT Accuracy RT Accuracy 
Ignore   Novel 1.24 (.06) 94.8 (2.2) 1.01 (.04) 94.4 (2.0) 1.12 (.04) 94.5 (1.5) 
 Target 1.36 (.05) 73.9 (3.1) 1.14 (.06) 87.4 (1.0) 1.24 (.04) 81.1 (2.1) 
 Distractor 1.26 (.06)  83.0 (2.9) 1.14 (.06) 90.3 (3.1) 1.20 (.04) 86.9 (2.2) 
Update Novel 1.19 (.05) 96.0 (1.5) .95 (.05) 97.5 (1.0) 1.06 (.04) 96.8 (.9) 
 Target 1.17 (.05) 78.8 (3.4) 1.06 (.05) 89.2 (1.9) 1.11 (.03) 84.3 (2.0) 
A c ntrol alysis tested whether subjects ad ered t  the task instruction . In th  Ignore
condition the distractors we  ind ed processed, sugg ste by lower accuracy (t(44)=
-3.38, p=.001) and slower RTs (t(44)=2.01, p=.05) on Ignore Distractor versus Ignore Novel 
probes across age. 
In sum, older adults responded more slowly on the task than young adults (i.e. main effect 
of age). However, this slowing was not uniformly divided across the different probe types. 
Specifically, age-related slowing was not seen when correctly recognizing Update target 
trials and when co rectly rejecting Ignore distractor probes. Thus, older adults responded 
relatively faster on the e probes in comparison with oth r e types. This suggests that
intact respo se times in aging were independent of updating or ig oring and independent 
of a match or non-match esponse. I stead, what both Updat  target and Ignore distractor 
probes have in common is that th  robe was presented after o ly a short delay foll wing 
the to-be-recognized (Update target) or to-be-rejected (Ignore distractor) stimulus. Hence, 
we performed a fourth ANOVA, described below, which modeled the duration of the delay 
between the familiar stimulus and the probe instead of Probe type (target or distractor).
Age effects depend on the delay
To explain the above mentioned RT effects on probe type, we ran a fourth ANOVA on RTs 
using factors Condition, Delay and Age in which probe types were grouped by Novel, Short 
and Long delays rather than Distractor, Target and Novel probes. This yielded a Delay x Age 
interaction (F(2,86)=4.9, p=.01), but no Condition x Delay x Age interaction (F(2,86)=.4, 
p=.7) (Figure 3B). This interaction effect was driven by an age effect on Long delay trials 
(F(1,43)=11.3, p=.002) and Novel trials (F(1,43)=13.2, p=.001), but not on Short delay trials 
(F(1,43)=3.0, p=.091). Age-related differences were larger on Long delays than on Short de-
lays (F(1,43)=8.34, p=.006), and larger on  Novel versus Short delays (F(1,43)=5.46, p=.024), 
but not on Long versus Novel delays (F(1,43)<1). 
Table 2. Mean (Standard error of the mean) RTs (in seconds) and accuracy (in percentages) per trial 
type for older and young adults as well as across age groups.
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The older group responded more slowly on Long versus Short delay probes (t(20)= -5.15, 
p<.001) and versus Novel delay probes (t(20)=4.56, p<.001), but responded equally fast 
on Short and Novel probes (t(20)=-.29, p=.78). The young age group responded faster 
on Novel versus Short delay probes (t(23)=-2.86, p=.01) and versus Long delay probes 
(t(23)=-4.13, p<.001), whereas responding to Short versus Long delay probes did not differ 
(t(23)=.016, p=.99) (Figure 3B). 
In sum, when we categorized the probe types in terms of it being familiar on a short or 
long delay (independent of being a target or distractor, ignored or updated) or being unfa-
miliar (novel), we found that older adults were especially impaired on Long delay probes as 
well as on Novel probes. In contrast, older adults showed intact responding to Short delay 
probes, while being slower on both other probe types relative to young adults. 
Besides main effects of age, scores on BIS-11 motor, BIS-11 total, verbal IQ, education, 
digit span backward or Stroop did not co-vary with the Condition x Probe x Age interaction 
or the Delay x Age interaction.
Discussion
In this study we assessed whether age-induced performance impairments on working 
memory stability (i.e. ignoring distractors) were larger than on working memory flexibility 
(i.e. updating). When disentangling the effects per probe type, we seemed to have found 
partial evidence for this hypothesis: i.e. a relative benefit for working memory updating in 
older relative to young adults, only when correctly recognizing an updated target. How-
ever, a control analysis in which probe items were sorted into novel, short and long delay 
probe relative to its first presentation revealed that all items retained during a short delay 
were spared of age-related slowing compared with long delay items. Notably, this delay 
effect was found to be independent of type of interference (factor Condition), i.e. a short 
delay between presentation and test facilitated correct updating as well as correct 
Figure 3. RT on Condition trials (Ignore, Update and No-Interference) as a function of Probe type 
(Novel, Distractor, Target) (A) and as a function of Delay (Novel, Short, Long) (B). A: A two-way 
interaction between Probe type and Age on Update trials (purple lines) was observed. B: Two-way 
interactions between Probe type and Age: longer RTs for Novel and Short, but not Long delay trials.
Dopaminergic modulation of distracter-resistance and prefrontal delay period signal
3.
59
maintenance (ignoring distractors) in older adults relative to a long delay. In young adults, 
a short or a long delay between the presented stimulus and the probe did not affect 
response times. Thus, the relatively intact performance for working memory updating 
(targets) in older compared with young adults seems to be (at least partially) caused by the 
beneficial effect of a short versus long retention time. Indeed, working memory perfor-
mance is known to depend on the time that an item needs to be kept online (Pasternak 
and Greenlee, 2005). Here, we show – with a delay of 11 versus 5 seconds - that older 
adults are more sensitive to this effect of delay on working memory performance than 
young adults, at least in terms of RTs. A differential effect of delay on working memo-
ry performance with age is not unexpected: dopamine D1 receptor modulation affects 
delay-dependent working memory performance (Chudasama and Robbins, 2004) and 
dopamine availability declines in healthy aging (Backman et al, 2006; Bäckman et al, 2011; 
Goldman-Rakic and Brown, 1981). Animal work has demonstrated that working memory 
processes are associated with delay-dependent neuronal activity in prefrontal cortex, in 
connection with thalamus and temporal cortex (Fuster et al, 1985; Fuster and Alexander, 
1971). Critically, delay-dependent neuronal activity is shown to be attenuated in aged 
monkeys (Wang et al, 2011).
It has been proposed that aging might be associated with a compensatory benefit in 
recognizing through familiarity. This is grounded in the observation that aging is accom-
panied by relatively larger hippocampal shrinkage than entorhinal decline (Daselaar et al, 
2005; Raz et al, 2005), as well as the observation that familiarity depends on regions of the 
medial temporal lobe other than the hippocampus, such as perirhinal or entorhinal cortex 
(Davidson and Glisky, 2002; Zarahn et al, 2005). However, enhanced reliance on familiarity 
cannot account for the current results. We observed age-related impairments on to-be-
rejected novel probes, whereas reliance on familiarity would, if anything, have resulted 
in better performance at novel probes. Moreover, enhanced reliance on familiarity would 
also predict ‘exclusion errors’ or false positives (Davidson and Glisky, 2002). We did not 
observe such false positives, as older adults showed relatively intact responding to both 
Update targets that needed to be recognized and Ignore distractors that needed to be 
rejected. When older adults would rely on familiarity, we would have expected slower and 
more erroneous responses to the Ignore distractors that were familiar, yet should not be 
recognized as a target. Instead, we argue that the short delay between a first and second 
presentation of a stimulus was driving the intact performance seen currently on these 
trials in older adults. Older adults were able to successfully maintain an item and protect it 
from distraction during a short, but not during a longer time span. 
We hypothesized a selective deficit on the Ignore condition, based on the observation that 
aging is accompanied by disproportionate dopamine depletion in the prefrontal cortex. 
Possibly, the reduction in dopamine in healthy aging is not selective to the prefrontal cor-
tex and, hence, its associated cognitive functions. Indeed, evidence exists for age-
related decline of substantia nigra dopamine neurons projecting to striatum and reduced 
amounts of dopamine receptor types most abundant in the striatum in aging (e.g. Fearnley 
& Lees, 1991; Ota et al., 2006; Volkow et al., 1998). Subsequent cognitive effects of striatal 
dopamine decline (i.e. on working memory updating) might have equal impact in com-
parison with prefrontal cortex dopamine decline (i.e. on working memory maintenance). 
Moreover, dopaminergic neuron loss in the ventral tegmental area (VTA), projecting to the 
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prefrontal cortex, also results in a reduction of dopamine projections to the hippocampus 
with advancing age (Bunzeck et al, 2007; Düzel et al, 2010). Hippocampal function is linked 
to working memory processes (Fallon et al, 2016; Ranganath et al, 2004), thus, might have 
affected our results as well. Future studies should relate regional-specific dopamine chang-
es in the aging brain to working memory updating versus maintenance performance, for 
example using positron emission tomography in combination with cognitive testing. Last 
but not least, other mechanisms than dopamine might play a role. For example, changes 
in the noradrenergic system influenced performance on delayed-match-to-sample tasks in 
young and older monkeys (Arnsten and Goldman-Rakic, 1985; Li et al, 1999). In addition, 
cholinergic manipulations have improved delay-dependent working memory performance 
in monkeys (Dunnett et al, 1988a; Sood et al, 2007). 
We also found age-related slowing in responding to novel probe items. Slower RTs for the 
rejection of novel probes may be a reflection of the tendency of older adults to rely on 
environmental cues, specifically salient ‘oddball’ events (Lindenberger and Mayr, 2014). 
Our finding concurs generally with the observation that novel or oddball items are pro-
cessed differently by older relative to young adults, related to an increase or shift of the P3 
event-related potential (ERP) over fronto-parietal regions that have been associated with 
attention switches towards new items (Daffner et al, 2006; Pato and Czigler, 2011; West et 
al, 2010). Moreover, another ERP over fronto-parietal regions (i.e. the N450), associated 
with better performance in an auditory detection task with salient distractors, was not ob-
served in older adults who also performed worse than young adults on the task (Passow et 
al, 2012). These data suggest that our older participants may have (involuntary) processed 
the salient novel probes to a larger extent than the young adults, which takes more time 
rather than quickly rejecting these novel items. Nevertheless, this age-related saliency-
induced attention deficit, presumably underlying slower responses for rejecting novel 
items, did not result in relative worse performance for ignoring versus updating (salient) 
distractors. The age effects during the delay period were seemingly more dependent on 
the length of the working memory delay; such delay-dependent working memory process-
es are also dependent on the prefrontal cortex (see above).
A limitation in the current design is the differential delay between Condition trial types, 
in which different probe types were also associated with different delays between the 
presentation of a same stimulus. Future studies should control for the effects of delay, for 
example, by using a No-Interference trial type with a short delay and an Updating trial type 
with a long delay. Furthermore, the reported results require replication in future longitudi-
nal studies, to control for cohort effects that may have influenced the current cross-
sectional design. General effects of aging such as behavioural slowing are unlikely to 
explain our results, because we observed differential age effects on RTs depending on 
trial type. Also, the differences between estimated verbal IQ and education level between 
young and old (Table 1) did not influence the current results. In fact, estimated verbal IQ 
was higher for older than young, whereas the reverse pattern was seen for education level. 
These measures seem to be influenced by cultural cohort differences rather than reflecting 
actual differences in IQ. 
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Concluding, the hypothesized relatively greater impairment of working memory mainte-
nance versus updating in older adults was not observed. Instead, recency seems to abate 
age-related impairments in working memory performance. Slower responses on (appar-
ently distracting) novel probes in older relative to young adults may be interpreted as 
enhanced reliance on novel, environmental stimuli, thus resulting in longer RTs to reject 
those novel items. The common cause for these effects may be reduced prefrontal  
cortex-based attentional resources in older adults, resulting in impaired maintenance dur-
ing working memory delay periods as well as decreased inhibition of salient, novel stimuli 
during responding.
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Abstract
Tyrosine is a precursor of the neurotransmitter dopamine. Tyrosine supplementation has 
been shown to improve cognitive performance in young adults. However, tyrosine effects 
on cognitive functioning in older adults have not been investigated, although aging is 
accompanied by a decline in dopamine signaling. 
We aimed to assess a dose-dependent response to tyrosine administration in older adults 
in both plasma tyrosine concentrations and working memory performance. We employed 
a double blind randomized cross-over design in which 17 older adults (aged 60-75 years) 
received a single administration of 100, 150 or 200 mg/kg body weight of tyrosine mixed 
with banana-flavoured yoghurt. For comparison, 17 young adults (aged 18-35 years) 
received a dose of 150 mg/kg body weight of tyrosine. Tyrosine plasma concentrations 
were determined at seven time points, i.e. before and 90, 120, 150, 180, 210 and 240 
minutes after tyrosine intake. Working memory was assessed using the N-back task at 90 
minutes after tyrosine administration. Older adults showed a dose-dependent increase in 
plasma tyrosine concentrations (p<.001). Load-dependent working memory performance 
decreased with higher doses of tyrosine (p=.048), especially in those older adults with 
greater dose-dependent plasma tyrosine responses (p=.035).  We show that while result-
ing in elevated plasma levels, higher tyrosine doses lead to declined cognitive functioning 
in older adults.
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Introduction
Tyrosine is one of the conditionally essential amino acids and is particularly found in 
protein-rich foods such as dairy, meat, fish, eggs, seeds, nuts, and beans. It can also be syn-
thesized from the essential amino acid phenylalanine, but this is dependent on sufficient 
availability of this precursor (Matthews, 2007). Tyrosine is the precursor of the neuromod-
ulatory catecholamines dopamine and noradrenaline (Carlsson and Lindqvist, 1978; Tam 
and Roth, 1997). In animal models, concentrations of brain tyrosine were shown to be 
modifiable by dietary intake. For instance, in rats, brain tyrosine levels increased propor-
tional to the amount of protein in a meal (Glaeser et al, 1983) and tyrosine administration 
enhanced central catecholamine synthesis (Fernstrom, 1983; Gibson and Wurtman, 1978; 
Scally et al, 1977; Sved et al, 1979). Furthermore, tyrosine depletion in rats led to reduced 
dopamine but not noradrenaline synthesis and release in particularly the striatum and nu-
cleus accumbens (McTavish et al, 1999). The dopamine metabolite homovanillic acid (HVA) 
was found to increase in the cerebrospinal fluid (CSF) of patients with Parkinson’s disease 
after tyrosine ingestion, also suggesting effects of tyrosine manipulations on dopamine 
synthesis in humans. 
Dopamine is important for working memory (Cools and D’Esposito, 2011; Durstewitz and 
Seamans, 2008). Several studies have shown that tyrosine administration can reverse 
working memory impairments in young adults under stressful conditions (for reviews, see 
(Jongkees et al, 2015; van de Rest et al, 2013)), during which cognitive functioning  
decreases as a function of changes in dopamine (and noradrenaline) (Arnsten and  
Goldman-Rakic, 1998; Bliss et al, 1968). More recent studies by Colzato and colleagues also 
observed beneficial effects of tyrosine supplementation on cognition, including working 
memory, in regular environmental conditions in young adults (Colzato et al, 2013; Colzato 
et al, 2014; Steenbergen et al, 2015).
Aging is characterized by a decline in brain dopamine signaling (Backman et al, 2006), 
which is accompanied by impairments in working memory (Cai and Arnsten, 1997; Gaz-
zaley et al, 2005; Turner and Spreng, 2012). Therefore, older adults may also cognitively 
benefit from tyrosine supplementation. However, to date, no studies have investigated the 
effects of tyrosine administration on cognition in older adults.
Studies of tyrosine supplementation in young adults showed that peak plasma concentra-
tions of the compound were reached approximately two hours after ingestion of doses of 
100 mg/kg body weight and 150 mg/kg body weight. The increase in plasma tyrosine con-
centrations was more pronounced and longer persisting after the 150 mg/kg body weight 
dose than after the 100 mg/kg body weight dose (Glaeser et al, 1979). With aging, changes 
in, for example, absorption and metabolism may occur and consequently the same dose 
of tyrosine may lead to a different response in plasma (i.e. peripheral) tyrosine concen-
trations in older relative to young adults. We investigated this in older adults with three 
tyrosine doses using a randomized cross-over design (100 mg/kg, 150 mg/kg and 200 mg/
kg body weight of tyrosine) and a 150 mg/kg body weight dose of tyrosine in young adults 
for comparison with previous studies using this dose (Jongkees et al, 2015). Moreover, it is 
unknown how different peripheral effects would affect central (i.e. cognitive) functioning, 
which we assessed using working memory performance as a proxy, applying the same 
three doses in older adults.
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Methods
Participants
We included 17 young (17-35 years of age) and 17 older adults (60-75 years of age) with 
a Body Mass Index (BMI) between 18.5 and 27 kg/m2, who were Dutch-speaking and had 
a normal or corrected-to-normal vision. Participants were recruited through an existing 
database of volunteers with interest in participating in studies at Wageningen University. 
Exclusion criteria were: [1] smoking; [2] thyroid problems; [3] use of tyrosine supplements 
or medication that can interfere with tyrosine’s action; [4] following a low-protein diet 
as prescribed by a dietician or physician; [5] alcohol consumption >14 (women) or >21 
(men) units per week; [6] Mini-Mental State Examination (MMSE) score <24 (only for 
older adults) (Folstein et al, 1975); [7] IQ <85 as estimated by the Dutch version of the 
National Adult Reading Test (NART) (Schmand et al, 1991); [8] intestinal problems that 
affect nutrient absorption; [9] Parkinson’s Disease, history of depression or other clinically 
significant psychiatric or neurological disorder; [10] under treatment for cardiac or vascular 
diseases and use of medication for these conditions; [11] being allergic or having a dislike 
for the product carrier (banana-flavored yoghurt), [12] bad venous access as judged by the 
research nurse, and [13] general medical conditions affecting test performance, such as 
repetitive strain injury (RSI) or sensorimotor handicaps, as judged by the investigator. 
In addition, performance on the N-back task during the screening test session (15 min-
session without feedback) needed to be >60% on levels 0-, 1 and 2-back to assure partici-
pants performed according to the instructions. If performance after two practice sessions 
with feedback and a 15-min test session without feedback was <60%, participants per-
formed one more practice session with feedback and 15-min-session without feedback. 
If performance was still <60%, participants were excluded. The performance score was 
calculated by hits /(hits + misses + incorrect rejections + false alarms) * 100% for each 
level. The Wageningen University Medical Ethical Committee approved the study; partici-
pants gave written informed consent and were compensated for participation. 
Study design
Participants were screened between October 2014 and November 2014, and intervention 
took place between November and December 2014. We used a double-blind, randomized, 
cross-over design to investigate the response in plasma tyrosine concentrations follow-
ing administration of a single dose of 100, 150 or 200 mg/kg body weight of tyrosine 
to healthy older adults (Figure 1). There was at least 1 week between the different test 
conditions (i.e. doses). A reference group of young adults received a dose of 150 mg/kg 
body weight tyrosine, as this dose has been often used in this age group. Test sessions took 
place in the morning after an overnight fast (10-12 hr). An independent researcher rand-
omized the older adults over the three different doses of tyrosine by means of 
a computer-generated order.
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Figure 1. Schematic overview of the study design. Older adults (n=17) ingested 100, 150 or 200 mg/kg body weight of tyrosine in a 
random order with one week in between. Young participants (n=17) received only a dose of 150 mg/kg body weight of tyrosine. 
Plasma tyrosine was determined before and 90, 120, 150, 180, 210 and 240 minutes after consuming the tyrosine dose. Working 
memory was assessed 90 minutes after the tyrosine consumption. 
 
Study design 
Participants were screened between October 2014 and November 2014, and intervention took place 
between November and December 2014. We used a double-blind, randomized, cross-over design to 
investigate the response in plasma tyrosine concentrations following administration of a single dose of 100, 
150 or 200 mg/kg body weight of tyrosine to healthy older adults (Figure 1). There was at least 1 week 
between the different test conditions (i.e. doses). A reference group of young adults received a dose of 150 
mg/kg body weight tyrosine, as this dose has been often used in this age group. Test sessions took place in 
the morning after an overnight fast (10-12 hr). An independent researcher randomized the older adults 
over the three different doses of tyrosine by means of a computer-generated order. 
A pre-screening comprising an initial check on eligibility criteria was performed by phone. When potential 
participants fulfilled to the criteria, they were invited for a screening visit during which they were informed 
about study details and signed the informed consent after which possible inclusion based on in- and 
exclusion criteria (see Participants) was further determined. Furthermore, participants were weighted and 
familiarized with the N-back task, which was repeated during the test visits. 
 
Tyrosine 
The doses of L-tyrosine powder (Bulkpowders™, Sports Supplements Ltd.) were mixed with banana-
flavored yoghurt (Arla® Food Nederland) in a 1:20 ratio to ensure comfortable ingestion of the product. 
Weighing of the doses and preparing and coding the samples was performed by a staff member not 
involved in the study. Participants had to consume the whole portion within 10 minutes, together with one 
glass of water (150 ml). 
 
 
Tyrosine 
dose 1 
1 week 
wash-out 
Tyrosine 
dose 2 
1 week 
wash-out 
 
Tyrosine 
dose 3 
150 mg 
tyrosine 
Older 
adults 
Young 
adults 
A pre-screening comprising an initial check on eligibility criteria was performed by phone. 
When potential participants fulfilled to the criteria, they were invited for a screening visit 
during which they were informed about study details and signed the informed consent 
after which possible inclusion based on in- and exclusion criteria (see Participants) was 
further determined. Furthermore, participants were weighted and familiarized with the 
N-back task, which was repeated during the test visits.
Tyrosine
The doses o  L-tyrosine powder (Bulkpowd rs™, Sports Suppleme ts Ltd.) were mixed with 
b nana-flavored yoghurt (Arla® Food Nederland) in a 1:20 ratio to ensure comfortable 
ingestion of the product. Weighing of the doses and preparing and coding the samples was 
performed by a staff member not involved in the study. Participants had to consume the 
whole portion within 10 minutes, together with one glass of water (150 ml).
Cognitive performance: N-back working memory task
Participants performed four conditions of a numerical (digits 0-9) N-back task on the 
computer (previously described in (Henckens et al, 2011; Jonides et al, 1997) (Figure 2)): 
a control condition, where a single digit  is specified as the target (0-back) and conditions 
with increasing cognitive load, where the target is any digit identical to the digit presented 
n trials prior (1-back, 2-back and 3-back). The digits were presented in white in the center 
of a black screen using a blocked design with 32 blocks (eight blocks for each condition). 
At the start of the task and in between blocks, a fixation cross was presented for 2400 ms. 
Each block started with the presentation of an instruction cue for 2000 ms, followed by 12 
trials of single digits. During the trials the instruction cue was constantly displayed on the 
screen. Each digit was presented for 400 ms and followed by an inter-stimulus interval of 
1400 ms. Total duration of one block was 26000 ms. Blocks were presented in a mirrored 
design. Each block contained a pseudorandom sequence with either two or three tar-
gets and no more than two consecutive targets, making a total of 20 targets within each 
condition. A different sequence was used for each test session. The total task duration 
was 14 minutes. Participants pressed the left mouse button using the right-index finger 
Figure 1. Schematic overview of the study design. Older adults (n=17) ingested 100, 150 or 200 mg/
kg body weight of tyrosine in a random order with one week in between. Young participants (n=17) 
received only a dose of 150 mg/kg body weight of tyrosine. Plasma tyrosine was determined before 
and 90, 120, 150, 180, 210 and 240 minutes after consuming the tyrosine dose. Working memory 
was assessed 90 minutes after the tyrosine consumption.
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Figure 2. Schematic overview of the numerical N-back task. At the start of the task, and in between blocks, a fixation cross was 
presented for 2400 ms. Each block started with a presentation of the IC for 2000 ms, followed by 12 trials of single digits. SP was 
400 ms, ISI 1400 ms. Total duration of one block was 26000 ms. FC, fixation cross; IC, instruction cue; SP, stimulus presentation; ISO, 
inter-stimulus interval. 
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Shurtleff et al, 1994). The task was presented on a laptop using Presentation 17.1 software 
(Neurobehavioural Systems, Inc. San Francisco, USA). A standard protocol was used, and all tests were 
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for targets. The task was explained and practiced twice with feedback and once without 
feedback during the screening visit. During the test visit, the task was practiced once more 
with and without feedback, right after consuming the study product. The actual N-back 
task was performed 90 minutes after tyrosine consumption, the moment that we expect-
ed the tyrosine levels to begin peaking, as based on previous studies (Glaeser et al, 1979; 
Shurtleff et al, 1994). The task was presented on a laptop using Presentation 17.1 software 
(Neurobehavioural Systems, Inc. San Francisco, USA). A standard protocol was used, and all 
tests were performed in the same quiet room. 
Plasma tyrosine concentrations
Plasma tyr sine concentrations were assessed at seven time points, i.e. before tyrosine 
consumption (T0), and 90, 120, 150, 180, 210 and 240 minutes after tyrosine consump-
tion. A perip eral venous catheter as u ed to collect the blood samples into 10 ml ED-
TA-vacutai ers. The catheter was fl sh d with a soluti n of 0.9% f NaCl to keep it open. 
Directly after collection, blood samples were centrifuge  during 10 minutes at 1200 g and 
a temperature of 4°C, and plasma was transferred to 1 mL microvial tubes and stored at 
-80°C until laboratory analyses. Plasma tyrosine concentrations were quantified by hydro-
philic interaction liquid chromatography (HILIC) coupled with tandem mass-spectrometry 
as described by Prinsen and collegues (Prinsen et al, 2016).
Figure 2. Schematic overview of the numerical N-back task. At the s art of the task, and in between 
blocks, a fixation cross was presented for 2400 ms. Each block started with a presentation of the IC 
for 2000 ms, followed by 12 trials of single digits. SP was 400 ms, ISI 1400 ms. Total duration of one 
block was 26000 ms. FC, fixation cross; IC, instruction cue; SP, stimulus presentation; ISO, inter-
stimulus interval.
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Other measurements
We obtained information on educational level and by questionnaire and education was 
categorized according to Statistics Netherlands (CBS). Body height was measured at base-
line with a wall-mounted stadiometer to the nearest 0.1 cm. Body weight was measured 
to the nearest 0.1 kg with a calibrated digital scale at the screening visit, with participants 
dressed in underwear. There was a maximum of four weeks between the screening visit 
and the first test session and we instructed participants not to change their diet, activity 
pattern and lifestyle during the study, so that the weight measured during the screening 
visit was a reliable measure of someone’s weight at the test session. At the start of each 
test session adherence to this instruction was checked with the participant.
Statistical analysis
Data analysis was performed using IBM SPSS Statistics 22. Differences between older 
and young adults on demographic values (age, sex, education, estimated verbal IQ, body 
weight, BMI, MMSE) were determined using two-sample t-tests or chi-square tests. 
Plasma tyrosine concentrations following tyrosine administration are visualized over time 
using mean and standard error of the mean (SEM) per dose and age group. Outliers were 
determined based on Grubbs test (Grubbs, 1969). Baseline differences in plasma tyrosine 
concentrations between young and older adults were determined using a one-way ANOVA 
on tyrosine levels after 150 mg/kg body weight at T0, with Age group (Young, Older adults) 
as grouping variable. Baseline differences between the three dosages within the older 
adult group were assessed using paired t-tests (T0 tyrosine levels between 100  and 150 
mg/kg, 150 and 200 mg/kg and 100 and 200 mg/kg body weight). The effect of age on 
plasma tyrosine concentrations after 150 mg/kg body weight tyrosine administration, 
at baseline corrected time points, was assessed using an ANOVA with within-subjects 
factor Time (T90minT0, T120minT0, T150minT0, T180minT0, T210minT0,T240minT0) and 
between-subjects factor Age (Young, Older adults). Differential effects of the three dosages 
on plasma tyrosine concentrations within older adults were determined using an ANOVA 
with within-subjects factors Dose and Time.
Tyrosine effects on working memory (i.e. N-back) performance was only assessed for the 
older adults, as their performance could be compared between three doses. We also com-
pared N-back performance between the two age groups at the same dose (i.e. 150 mg/
kg body weight) to replicate the well-known age-related impairments in working mem-
ory (see Introduction). Percentage hits, misses, correct rejections and false alarms were 
calculated as well as reaction times (RT) for hits and false alarms. Within-subject repeated 
measures ANOVAs using factors Dose (100, 150, 200 mg/kg body weight) and Cognitive 
load (0-back, 1-back, 2-back, 3-back) were used to compare percentages of hits and false 
alarms as well as RT of hits on the N-back task between the three tyrosine doses. Further-
more, we tested for an effect of individual differences in dose-related plasma level increase 
on N-back performance (percentage of hits and false alarms and RTs). For this purpose, the 
slope of plasma level increase as a function of dose was calculated per subject. This was 
done by subtracting the baseline (T0) from the peak measurement (T90) per dose and cal-
culating the slope as a function of the three increasing doses, resulting in one bèta value 
per subject. Subsequently, ANOVAs were performed using the within-subject factors 
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TABLE 1. Characteristics at screening of 17 young and 17 older adults assigned into the study 
 Young  
(n=17) 
Older adults  
(n=17) 
p-value 
Age (years) 21.5 ± 2.81 
(18-30) 
69.6 ± 2.9 
(65-74) 
<.001 
Sex, Male (%) 47 47 1 
Education Low/ Middle/ High (%) 0/ 6/ 942 0/ 29/ 71 0.076 
Body weight (kg) 68.3 ± 9.8 73.0 ± 13.2 .25 
BMI (kg/m2) 21.5 ± 1.6 25.2 ± 2.7 <.001 
MMSE score N.A. 28 (27-29) 3 - 
Adjusted NART score 94.8 ± 4.6 103.6 ± 5.5 <.001 
1 Mean ± SD (all such values) 
2 Dutch Education system: 1, Primary education; 2, Vocational or secondary education; 3, Senior vocational/ 
academic or tertiary education 
3 Median (IQR) 
Abbreviations: MMSE, Mini-Mental State Examination; NART, Dutch version of the National Adult Reading 
Test 
 
Age- and dose-dependent tyrosine effects on plasma tyrosine 
Age and Time course comparison at 150 mg/kg body weight dose 
At baseline, tyrosine levels were higher for older compared with young adults (main effect of Age group: 
F(1,30)=23.35, p<.001) (Figure 4, Table 2). When corrected for baseline differences, older adults displayed a 
higher increase in plasma tyrosine concentrations than young adults across time points (main effect of Age 
group F(1,30)=55.17, p<.001), driven by all baseline-corrected time points (T90minT0: F(1,30)=53.15; 
T120minT0: F(1,30)=45.51; T150minT0: F(1,30)=51.20; T180minT0: F(1,30)=40.10; T210minT0: 
F(1,30)=33.45; T240minT0: F(1,30)=35.25; all p<.001) (Figure 4, Table 2). Moreover, tyrosine levels followed 
a different time course in older compared with young adults (Time by Age group interaction: F(5,150)=4.11, 
p=.002). Young adults did not show a significant decrease with time (F(1,15)=2.02, p=.086), but plasma 
levels decreased in the older adults group after T150 onwards (main effect of Time: F(1,15)=11.70, p<.00).  
In sum, we observed higher baseline plasma tyrosine concentrations in older compared with young adults. 
Moreover, after receiving the same dose of a 150 mg/kg body weight, older adults displayed a higher 
(baseline-corrected) plasma level increase than young adults. 
Dose (100, 150, 200 mg/kg body weight) and Cognitive load (0-back, 1-back, 2-back, 
3-back) and between-subject factor Plasma level increase (median split of slope (beta) 
values into low and high tyrosine-induced plasma level increase). Upon significant results, 
simple effects were assessed. We considered a two-sided p-value <0.05 as significant. 
Results
The flowchart of participants through the study is shown in Figure 3. For data analysis of 
plasma tyrosine concentrations, one young adult was excluded based on extremely high 
plasma tyrosine concentrations at T90, T180 and T240 and one older adult because of 
extremely low plasma tyrosine concentrations at all time points after 100 mg/kg body 
weight, T150, T210 and T240 after 150 mg/kg body weight and all time points but T0 after 
200 mg/kg body weight. N-back data after the 150 mg/kg body weight dose was missing 
for one older adult, who was excluded from the analyses including this dose. Therefore, 
those data analyses are based on 16 individuals instead of 17. For baseline characteristics 
of the older and young adults, see Table 1. Age groups were not different in sex and body 
weight; the latter implicates that the absolute tyrosine dose also did not differ between 
the age groups. Older adults received less education, but displayed a higher estimated IQ 
(adjusted Dutch NART score) relative to young adults. BMI was higher for older than for 
young adults, but did not interact with our plasma outcome measures when added as 
covariate in the analyses (all p’s >0.43). Tyrosine administrations were well tolerated; no 
adverse events were reported.
TABLE 1. Charact i ti  t scr e ing of 17 young and 17 ol er adults assigned into the study
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Age- and dose-dependent tyrosine effects on plasma tyrosine
Age and Time course comparison at 150 mg/kg body weight dose
At baseline, tyrosine levels were higher for older compared with young adults (main effect 
of Age group: F(1,30)=23.35, p<.001) (Figure 4, Table 2). When corrected for baseline dif-
ferences, older adults displayed a higher increase in plasma tyrosine concentrations than 
young adults across time points (main effect of Age group F(1,30)=55.17, p<.001), driven 
by all baseline-corrected time points (T90minT0: F(1,30)=53.15; T120minT0: F(1,30)=45.51; 
T150minT0: F(1,30)=51.20; T180minT0: F(1,30)=40.10; T210minT0: F(1,30)=33.45; 
T240minT0: F(1,30)=35.25; all p<.001) (Figure 4, Table 2). Moreover, tyrosine levels 
followed a different time course in older compared with young adults (Time by Age group 
interaction: F(5,150)=4.11, p=.002). Young adults did not show a significant decrease with 
time (F(1,15)=2.02, p=.086), but plasma levels decreased in the older adults group after 
T150 onwards (main effect of Time: F(1,15)=11.70, p<.00). 
In sum, we observed higher baseline plasma tyrosine concentrations in older compared 
with young adults. Moreover, after receiving the same dose of a 150 mg/kg body weight, 
older adults displayed a higher (baseline-corrected) plasma level increase than young 
adults.
Dose comparisons within older adults
Among the older adults, baseline tyrosine levels at T0 did not differ between dosages.  
We observed a clear dose-dependent response after administration of 100, 150 or 200 
mg/kg body weight of tyrosine in the older adults (Figure 4, Table 2). Specifically, a higher 
dose resulted in higher tyrosine plasma levels relative to a lower dose (main effect of 
Dose on baseline corrected tyrosine levels: F(2,30)=151.18, p<.001), significant between 
Figure 4. Plasma tyrosine concentrations after tyrosine administration, by tyrosine dose and age 
group. Plasma tyrosine concentrations are given as μmol/L (mean ± SEM) 0, 90, 120, 150, 180, 210 
and 240 minutes after tyrosine administration (left: raw values; right: baseline-corrected values).
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all three doses (100 vs. 150 mg/kg body weight: F(2,30)=48.35 p<.001; 100 vs. 200 mg/
kg body weight: F(1,15)=361.32, p<.001; 150 vs. 200 mg/kg body weight: F(2,30)=121.32, 
p<.001).  Moreover, the time course of plasma levels was different between doses 200 mg/
kg and 100 mg/kg and 150 mg/kg body weight (Time (6)* Dose (100, 150, 200) interaction: 
F(10,150)=3.30, p=.001, driven by a Time (6)* Dose (100, 200) interaction: F(5, 75)=4.80, 
p=.001 and a Time (6)* Dose (150, 200) interaction: F(5,75)=4.30, p=.002 instead of a 
Time (6)* Dose (100,150) interaction: F(5,75)<1). After the 200 mg/kg body weight dose, 
plasma levels increased further after T90 peaking at T120 compared with the 100 mg/kg 
body weight (Time (T90, T120) * Dose (100,200) interaction: F(1,15)=9.32, p=.008) and 
compared with the 150 mg/kg body weight (Time (T90, T120) * Dose (150,200) interac-
tion: F(1,15)=9.09, p=.009). Furthermore, across doses, baseline-corrected tyrosine levels 
changed as a function of time (main effect of Time: F(5,75)=13.80, p<.001), with plasma 
levels decreasing after T150 onwards (Figure 4). 
In sum, tyrosine plasma levels in older adults increased with increasing dose. The peak was 
reached half an hour later after the highest compared with the lower doses: plasma levels 
peaked at 90 minutes after the 100 mg/kg and 150 mg/kg body weight dose, but at 120 
minutes after the 200 mg/kg dose in older adults. After all doses, tyrosine levels decreased 
from 2.5 hours after ingestion, not returning to baseline levels within four hours.
Dose-dependent tyrosine effects on working memory performance
For accuracy scores and RTs, see Table 3. Total percentage of hits (across levels) was great-
er than 60%, i.e. above chance. 
As expected, RT slowed down, hits decreased and false alarms increased as a function of 
N-back level difficulty across age groups (main effect of Cognitive load, hits: F(3,45)=70.28, 
p<.001; false alarms: F(3,45)=25.58, p<.001; RT: F(3,45)=72.33, p<.001), and older adults 
performed worse on the N-back task than young adults on the same dose of tyrosine (i.e. 
150 mg/kg body weight; hits: F(3,93)=83.83, p<.001; false alarms: F(3,93)=29.82, p<.001; 
RT: F(3,93)=57.04, p<.001). 
Next, we assessed the effect of different doses of tyrosine on working memory perfor-
mance (i.e. percentage of hits) in older adults. We found a dose-dependent tyrosine 
effect on working memory in older adults (Dose * Cognitive load (F(6,90)=2.23, p=.048) 
(Figure 5). This dose-dependent effect was driven by performance on the highest working 
memory load, i.e. on the 3-back level (main effect of Dose: F(2,30)= 3.38, p=.047). Spe-
cifically, relative to the 100 mg/kg body weight dose, 3-back performance decreased on 
the 150 and 200 mg/kg dose (150 vs. 100 mg/kg: F(1,15)=4.98, p=.041; 200 vs. 100 mg/
kg: F(1,16)=6.89, p=.018). We did not observe performance differences on the 3-back level 
between 150 and 200 mg/kg body weight. On the other working memory loads (i.e. 0-, 1- 
and 2-back), no main effect of dose was observed. No main effect of Dose or interactions 
with Cognitive load were observed on percentage of false alarms or RTs.
To relate plasma increase of tyrosine to working memory performance, we calculated 
individual bèta (i.e. slope) values of tyrosine plasma increase (T90-T0) as a function of 
increasing oral dose. 
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Participants with a lower versus higher dose-dependent plasma level increase were sepa-
rated by a median split on their plasma increase beta values (range plasma level increase: 
50.85 – 182.8, median split on beta of 105.5, low increase group n= 8, high increase group 
n= 7). We used an ANOVA with factors Dose (100, 150, 200 mg/kg body weight) x Cognitive 
load (0-back, 1-back, 2-back, 3-back) x Plasma level increase groups (low versus high beta 
values of dose-dependent plasma level increase) to assess the effect of individual differ-
ences in plasma level increase on N-back performance. 
We observed that the above-mentioned dose-dependent tyrosine effects on N-back per-
formance were indeed dependent on whether the older adult had a low or high dose-
dependent increase in tyrosine plasma values (Dose x Cognitive load x Plasma increase 
group: F(6,78)=2.40, p=.035) (Figure 6). This effect was driven by the high plasma increase 
group, showing a Dose x Cognitive load interaction (F(6,36)=2.85, p=.023), not the low 
plasma increase group (F(6,42)=1.78, p=.123). Specifically, within the high plasma increase 
group, percentage of hits decreased with increasing Cognitive load in the 200 mg/kg body 
weight dose compared with 100 mg/kg body weight (Dose x Cognitive load interaction: 
(F(3,21)=5.32, p=.01). Percentage of hits as a function of Cognitive Load was not differ-
ent between 150 and 100 or 200 mg/kg body weight doses (F(3,18)=1.88, p=.168 and 
F(3,18)=1.51, p=.245, respectively).
Percentage of hits was also differentially modulated by Dose and Plasma increase group 
independent of Cognitive Load (Dose x Plasma increase group interaction: (F(2,26)= 6.25, 
p=.006). In the high plasma increase group, we observed a trend towards lower accuracy 
overall as a function of dose, whereas in the low plasma increase group we observed a 
trend in the other direction (main Dose: F(2,14)=3.54, p=.057 and F(2,12)=3.61, p=.059, 
respectively). No interactions between Dose or Cognitive Load with Plasma increase group 
were observed on percentage false alarms or RTs.
In sum, relative to the lowest dose, higher tyrosine doses resulted in a lower percentage 
of hits on the highest working memory load (i.e. 3-back level) in older adults. This adverse 
dose-dependent tyrosine effect on working memory performance was particularly evident
in older adults who also had higher dose-dependent increases in plasma tyrosine concen-
trations, providing a link between our psychological and physiological findings.
Discussion
To the best of our knowledge this is the first study investigating the effects of tyrosine 
administration on its plasma concentrations and cognitive effects in older adults. Using a 
cross-over design, our findings showed a clear dose-related increase in plasma tyrosine 
concentrations after administration of 100, 150 or 200 mg/kg body weight of tyrosine, 
using a cross-over design. Importantly, we observed that older adults had a higher tyrosine 
plasma levels than a comparison group of young participants after the same dose of 150 
mg/kg body weight tyrosine. Furthermore, this study demonstrates unfavourable effects of 
higher doses (i.e. 150 and 200 mg/kg body weight) of tyrosine relative to a lower dose (i.e. 
100 mg/kg body weight) on working memory performance in older adults. This dose-
dependent decline in terms of N-back hits was especially seen in older adults with higher 
dose-dependent increases in plasma tyrosine concentrations. 
Oral tyrosine administration decreases working memory of older adults in a dose-dependent manner
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TABLE 3. Hits, misses, correct rejections, false alarms, and reaction times on the N-back task for the different tyrosine doses per age group 
  Young adults Older adults  
  150 mg/kg (n=17) 100 mg/kg (n=17) 150 mg/kg (n=16) 200 mg/kg (n=17) 
Hits (%) 0-back 100 ± 0.01 98.2 ± 0.9 99.1 ± 0.5 99.2 ± 0.8 
 1-back 98.6 ± 0.6 96.7 ± 1.0 97.2 ± 0.9 94.7 ± 3.0 
 2-back 90.0 ± 1.7 85.9 ± 2.5 87.1 ± 2.7 85.1 ± 3.0 
 3-back 78.3 ± 3.1 75.2 ± 2.9 68.1 ± 3.3 66.6 ± 4.0 
Misses (%) 0-back 0.0 ± 0.0 1.8 ± 0.8 0.9 ± 0.5 0.8 ± 0.8 
 1-back 1.4 ± 0.5 3.3 ± 1.0 2.8 ± 0.9 5.7 ± 3.0 
 2-back 10.0 ± 1.7 14.1 ± 2.5 12.9 ± 2.7 14.9 ± 3.0 
 3-back 45.0 ± 21.8 24.8 ± 2.9 31.9 ± 3.3 33.4 ± 4.0 
Correct rejections (%) 0-back 99.7 ± 0.1 98.8 ± 0.3 97.8 ± 1.9 97.4 ± 2.1 
 1-back 99.1 ± 0.2 98.1 ± 0.6 96.5 ± 2.2 97.1 ± 1.2 
 2-back 98.1 ± 0.3 94.8 ± 1.0 94.7 ± 1.4 95.6 ± 1.0 
 3-back 96.3 ± 0.8 91.8 ± 1.1 91.4 ± 1.6 90.1 ± 1.3 
False alarms (%) 0-back 0.3 ± 0.1 1.2 ± 0.3 2.2 ± 1.9 2.6 ± 2.0 
 1-back 0.9 ± 0.2 1.9 ± 0.6 3.5 ± 2.2 2.8 ± 1.2 
 2-back 1.9 ± 0.3 5.2 ± 1.0 5.3 ± 1.4 4.4 ± 1.0 59 
 
59 
 
 3-back 3.7 ± 0.8 8.2 ± 1.1 8.6 ± 1.6 9.91 ± 1.3 
Reaction time target (ms) 0-back 457.6 ± 21.4 474.3 ± 24.3 481.7 ± 23.8 483.7 ± 23.9 
 1-back 545.0 ± 26.4 546.5 ± 26.1 549.0 ± 23.2 548.2 ± 22.7 
 2-back 629.8 ± 29.9 658.2 ± 32.4 645.1 ± 30.6 620.2 ± 27.8 
 3-back 729.3 ± 45.3 738.1 ± 32.6 706.8 ± 35.1 713.5 ± 33.4 
1 Values are mean ± SEM 
 
Baseline plasma tyrosine concentrations of the young adults were significantly lower com-
pared with those of the older adults, as observed previously in women (Caballero et al, 
1991). Therefore, we adjusted the dose-response analyses for baseline tyrosine levels. 
Our time courses for tyrosine were similar to those in the previous studies using a 150 
mg/kg body weight dose (Glaeser et al, 1979; Shurtleff et al, 1994). However, where the 
increase in tyrosine levels was two- to threefold in those studies, the increase in our study 
was five- to sevenfold in both young and older adults after the same doses of tyrosine. 
The larger increase in our study might be caused by the type of carrier used for oral inges-
tion. The previous studies mixed the tyrosine either in water (Glaeser et al, 1979) or apple 
sauce (Shurtleff et al, 1994), whereas we used banana-flavored yoghurt to ensure comfort-
able ingestion (see also (Neri et al, 1995)). Yoghurt, however, contains amino acids by itself 
as well, among which tyrosine and other LNAAs. However, since our tyrosine doses were 
multiple times higher and thus prevailing, we do not expect this has affected our results 
in comparison with other studies. Moreover, although other LNAAs compete for transport 
across the blood-brain barrier (Fernstrom, 2012), we still observed clear dose-dependent 
tyrosine effects on (dopamine instead of e.g. serotonin-related) cognitive functioning, 
TABLE 3. Hits, misses, correct rejections, false alarms, and reaction times on the N-back task for the 
different tyrosine doses per age group
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Figure 5. Effect of tyrosine dose on hits in the N-back task as a function of working memory load in 
older adults. Accuracy in terms of percentage hits with SEM.
Figure 6. Effect of tyrosine dose and cognitive load on accuracy in older adults who had either a low 
or high dose-dependent plasma tyrosine increase (based on a median split).
indicating a successful intervention. Nevertheless, future studies should also take blood 
plasma concentrations of the other LNAAs into account.
In addition to increased baseline tyrosine levels, we observed higher (baseline-corrected) 
tyrosine plasma levels after the same dose in older versus young adults. This effect might 
be due to an age-related reduced first pass effect in the liver (Klotz, 2009), such that higher 
amounts of tyrosine enter the blood stream in older adults. Moreover, age-related insulin 
resistance (Caballero et al, 1991) or other kinetic effects (Condino et al, 2013) may contrib-
ute to reduced peripheral amino acid uptake from the blood. 
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On a cognitive level, relative to the lowest dose, higher doses of tyrosine were accompa-
nied by negative effects on working memory performance in older adults, especially in the 
most difficult N-back level. This adverse effect of tyrosine was linked to the peripheral plas-
ma tyrosine responses, as greater dose-dependent increases in plasma tyrosine concen-
trations predicted greater cognitive detriments with increasing dose. Other studies using 
the same 150 mg/kg body weight tyrosine dose, which gave adverse effects versus the 
100 mg/kg body weight dose in our older adults, have shown beneficial effects of tyrosine 
on working memory performance in young adults (e.g. (Shurtleff et al, 1994; Thomas et 
al, 1999)). We did not have a placebo-controlled design and, hence, cannot infer whether 
tyrosine improved or diminished working memory performance in older adults relative to 
placebo. Future placebo-controlled designs should further test the beneficial or unfavora-
ble effects of tyrosine administration on cognitive functioning in older adults.
The currently observed decrements in working memory performance with increasing 
tyrosine dose in older adults might be surprising in the light of previous theories suggest-
ing against dose-dependent effects in young adults (Deijen, 2005; Jongkees et al, 2015). 
However, the older adults showed markedly increased plasma tyrosine levels compared 
with the same dose in young adults, and this increase was associated with apparently par-
adoxical cognitive effects. This suggests that much more tyrosine has reached, and prob-
ably crossed, the blood-brain barrier in older adults. With this high precursor availability, 
subsequently increased catecholamine synthesis could have inhibited tyrosine hydroxylase 
(TH), the enzyme that converts tyrosine to L-dopa (i.e. the final precursor of dopamine) 
(Nagatsu et al, 1964). In rats, for example, 250 mg/kg of phenylalanine, the precursor of 
tyrosine, increased dopamine release, 500 mg/kg had no effect, and 1000 mg/kg reduced 
dopamine release, suggesting a TH inhibitory mechanism (During et al, 1988). Reduction 
of dopamine synthesis by inhibiting TH may also occur further in the dopamine signaling 
cascade, when an excess of dopamine increases dopamine D2 autoreceptor binding (Lind-
gren et al, 2001). The aging brain might be more sensitive to overshoots in auto-regulation, 
for example due to increased inflammatory markers, such as cytokines, which increase 
with age (Michaud et al, 2013) and can alter TH availability and autoregulatory dopamine 
transporter expression (Felger and Miller, 2012). 
However, one might argue that tyrosine availability should have no effects on dopamine 
synthesis and release, and thus on cognitive functioning, under normal circumstances (see 
also (Lieberman et al, 1985)) as TH is the rate-limiting enzyme in catecholamine synthesis 
(Nagatsu et al, 1964). Nevertheless, tyrosine administration does affect catecholamine 
synthesis when the neuron’s firing rate is sufficiently high (for a review, see (Cansev and 
Wurtman, 2007)), such as during stress (Kvetnansky et al, 1992). This might explain why 
our adverse cognitive effects only became apparent in the most difficult N-back condi-
tion, i.e. 3-back, when neuronal firing was presumably highest. Whereas in young adults, 
tyrosine only showed beneficial effects in such demanding task situations (Colzato et al, 
2013; Thomas et al, 1999), in older adults, higher tyrosine doses in this high firing condi-
tion could have momentarily increased dopamine synthesis to such an extent that those 
dopamine levels inhibited TH or stimulated autoreceptors, leading to a net reduction in 
post-synaptic dopamine signaling.
Oral tyrosine administration decreases working memory of older adults in a dose-dependent manner
4.
79
Although we did not have a placebo comparison in older adults, the present dose-
dependent effects in cognition question the cognitive enhancing potential of tyrosine in 
healthy aging, at least with the currently used doses. Perhaps, a longer duration of tyrosine 
supplementation with lower doses would normalize TH inhibitory mechanisms. In young 
adults, five daily doses of 2 grams tyrosine resulted in beneficial cognitive effects (Deijen 
et al, 1999). Future studies should use such longer supplementation designs to study the 
effects on cognition in older adults.
In conclusion, in this double-blind, randomized cross-over trial, we observed a clear 
dose-response in plasma tyrosine after three different doses of tyrosine in older adults. 
Moreover, our data demonstrated that plasma tyrosine concentrations were markedly in-
creased in older compared with young adults. Importantly, a high dose-dependent plasma 
tyrosine response was related to decrements in working memory performance in older 
adults with higher tyrosine doses. Using an older population, this is the first demonstration 
of adverse effects with tyrosine, the precursor of dopamine.
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Abstract
Two distinct forms of response inhibition may underlie observed deficits in response inhi-
bition in aging. We assessed whether age-related neurocognitive impairments in response 
inhibition reflect deficient reactive inhibition (outright stopping) or also deficient proactive 
inhibition (anticipatory response slowing), which might be particularly evident with high 
information load. We used fMRI in young (n=25, age range 18-32) and older adults (n=23, 
61-74) with a stop-signal task. Relative to young adults, older adults exhibited impaired 
reactive inhibition (i.e. longer stop-signal reaction time) and increased BOLD signal for 
successful versus unsuccessful inhibition in the left frontal cortex and cerebellum. Fur-
thermore, older adults also exhibited impaired proactive slowing, but only as a function of 
information load. This load-dependent behavioural deficit was accompanied by a failure 
to increase BOLD signal under high information load in lateral frontal cortex, pre-supple-
mentary motor area and striatum. Our findings suggest that inhibitory deficits in older 
adults compared with young adults are caused both by reduced stopping abilities despite 
increased BOLD signal and by diminished preparation capacity during information over-
load, indicated by decreased BOLD signal under high information load.
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Introduction
Older adults can have trouble stopping an action. Indeed, relative to young adults, old-
er adults have been shown to exhibit impaired response inhibition in classic stop-signal 
paradigms; i.e. they need more time to stop a response when presented with a stop 
signal (Bedard et al., 2002; Kramer et al., 1994; van de Laar et al., 2011). At the neural 
level, older adults are known to exhibit attenuated BOLD signal as well as reduced tract 
strength between brain regions involved in response inhibition (Coxon et al., 2014; Coxon 
et al., 2012). However, the processes underlying these age-related behavioural and neural 
deficits in response inhibition are unclear. Two forms of response inhibition have been 
distinguished: reactive response inhibition is the process of cancelling an ongoing response 
at the moment this is needed (i.e. outright stopping), whereas proactive response inhibi-
tion entails the preparation for stopping when this may become necessary. Experimental 
designs in previous studies on aging did not enable the separate investigation of reactive 
and proactive response inhibition. Thus, it remains unclear whether the effects of aging 
on response inhibition, both neurally and behaviourally, reflect deficient reactive or also 
altered proactive processing. This issue is particularly pertinent given recent proposals that 
an understanding of cognitive control deficits in aging requires taking into account dual – 
reactive  and proactive – mechanisms of control (Braver et al., 2007) and evidence indicat-
ing deficient proactive, but intact reactive control with age (Bugg, 2014; Jimura & Braver, 
2010; Paxton et al., 2008). 
Cautious response slowing in preparation for the possible upcoming need to stop increas-
es the probability of successful stopping. Older adults might lack the cognitive capacity 
to process preparatory cues during information overload. Indeed, there is clear evidence 
for (load-dependent) reductions in working memory capacity due to deficits in prefrontal 
cortex functioning (Gazzaley et al., 2005; Nagel et al., 2009; Nyberg et al., 2010). 
By analogy, work with patients with schizophrenia has demonstrated an association 
between poor proactive response inhibition and low working memory capacity as well as 
reduced BOLD responses in frontal cortex (Zandbelt et al., 2011). Here, we investigated 
whether diminished response inhibition in older adults is accompanied by altered behav-
ioural and neural preparation for inhibition, and whether this is particularly evident in 
situations of information overload. 
To address these questions, young and older adults were scanned using event-related 
functional magnetic resonance imaging (fMRI) during the performance of an adapted 
version of a stop-signal task that allowed us to disentangle proactive and reactive response 
inhibition (Zandbelt & Vink (2010). To assess whether response inhibition in aging varies 
as a function of information load, we manipulated the information processing demands 
required for interpreting the stop-signal probability cues.  
A simple go task required a button press on every trial, unless a stop signal appeared indi-
cating that the initiated button-press had to be cancelled. A measure of reactive response 
inhibition was obtained based on the race model (Logan and Cowan, 1984) by calculating 
the time needed to cancel an initiated response (i.e. the stop-signal reaction time, SSRT). 
In addition, proactive slowing was indexed by the degree of preparatory response slowing 
of reaction times in response to cues signalling stop-signal probability 
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(Chikazoe et al., 2009; Jahfari et al., 2010; Verbruggen & Logan, 2009c; Vink et al., 2005; 
Zandbelt & Vink, 2010). This stop-signal probability was manipulated parametrically, so 
that higher stop-signal likelihood would elicit greater proactive slowing. Critically, we 
also manipulated the information processing demands for interpreting these stop-signal 
probability cues, thus allowing us to assess our key hypothesis that besides behaviour-
al and neural impairments during reactive response inhibition (discussed above), aging 
is accompanied also by deficits in proactive inhibition and associated prefrontal cortex 
signalling. Specifically, the effect of aging on proactive inhibition may vary as a function of 
information load, because increased information load places greater weight on prefrontal 
resources that are vulnerable to aging. 
Methods
Participants
Forty-eight participants were included in the analyses: 25 young (mean age: 22.7 years, 
range 18-29, 14 men) and 23 older adults (mean age: 67.6 years, range 61-74, 14 men). 
Participants met the following inclusion criteria: normal or corrected-to-normal vision, 
right handed, functioning within normal limits of general cognitive function with the Mi-
ni-Mental State Examination (MMSE) (Folstein et al., 1975) (cut-off > 27 of 30), estimated 
verbal IQ >85 (Schmand et al., 1991), no neurological or psychiatric disorders, 
no contraindications for MRI and no use of psychotropic medication or medication influ-
encing the BOLD signal, such as blood pressure normalizing medication. Fifty-six partici-
pants were initially tested; eight participants were excluded, of which 4 young and 4 older 
adults. Five participants were excluded before statistical data analysis: 2 due to technical 
problems (one young and one older) and three participants (two young and one older) 
were excluded due to excessive head movement (>4 mm translation). Upon data analysis 
of the behavioural effects, three participants were excluded due to task non-compliance 
(see below) (one young, two older). The experiment was approved by the local ethics 
committee (CMO 2001/095), and all participants gave written informed consent. Partici-
pants were matched on verbal IQ, Hospital Anxiety and Depression Scale (HADS, (Bjelland 
et al., 2002)) and gender (Table 2). Participants also completed the Barratt Impulsiveness 
Scale (BIS-11; Patton et al., 1995), immediate and delayed story recall (Wilson et al., 1985), 
digit span forward and backward (Wechsler, 1997), Stroop cards (Stroop, 1935), and verbal 
fluency (Tombaugh et al., 1999). 
Experimental Design: Load-Dependent Stop-Signal Anticipation Task 
Participants performed a stop-signal anticipation task with blocks differing in information 
load. The paradigm was based on the stop-signal anticipation task (Zandbelt and Vink, 
2010), which involved a modification of the classic stop-signal task (Verbruggen and Logan, 
2008). 
The paradigm consisted of Go trials and Stop trials. On every trial, a bar moved at a con-
stant speed from a lower horizontal line towards an upper horizontal line, reaching a mid-
dle line (flanked by two vertical lines) in 800 milliseconds (ms). The horizontal and vertical 
lines were continuously present throughout the task (Figure 1). 
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The main Go task was to bring the bar to a halt as close to the middle line as possible, by 
pressing a button with the right thumb. A minority of trials were Stop trials. On these trials 
a stop signal appeared: the bar stopped moving automatically before reaching the middle 
line. This stop signal instructed the participants to withhold the planned Go response. 
The middle horizontal line and the two vertical lines represented cues that indicated 
stop-signal probability context by varying in colour (caption Figure 1). To manipulate infor-
mation load, the task consisted of three levels that alternated in short blocks (see below). 
Between levels, stop-signal probability cues varied in amount as well as in complexity. 
The stop-signal probability could be anticipated based on the colour of the cues (i.e. hori-
zontal and vertical lines). Level A was the level with the least information load, with only 
white cues (stop probability of 26%) and green cues (stop probability of 0%). In Level B, 
there were 5 types of Go trials with varying stop-signal probability, using an intuitive colour 
range for the cues (Zandbelt and Vink, 2010): green, 0%; yellow, 17%; amber, 22%; orange, 
28%; and red, 35%, with a mean of 26% stop probability (caption Figure 1). The non-green 
trials are collectively called >0% trials. Level C consisted of the same types and numbers 
of stop-signal probability cues as Level B. However, in level C only one of the vertical lines 
signalled the correct stop-signal probability context. The correct side could be identified by 
the colour of the middle line: a blue middle line indicated that the left vertical line colour 
was valid, whereas a purple middle line indicated that the right vertical line colour was 
valid.
We instructed participants that going and stopping were equally important and that it 
would not always be possible to suppress a response when a stop signal occurred. Partici-
pants were not informed about the exact stop-signal probabilities, but they were told that 
stop signals in all levels would not occur on trials with a green cue, and that stop signals in 
level B and C were least likely in the context of a yellow cue and most likely in the context 
of a red cue, with the amber and orange cues coding intermediate, and respectively de-
creasing, stop-signal probabilities.
Figure 1. Load-Dependent Stop-Signal Anticipation Task. Information load increased with level. 
Percentages reflect the probability a trial will be a Stop trial rather than a Go trial. For level B and C, 
stop-signal probability increased as a function of cue colour. Every level contained 70 trials with 0% 
(green) and 270 trials with >0% (white) stop-signal probability. Of these 270 >0% trials, 70 were Stop 
trials, with a mean stop-signal probability of 26%. For Level B and C, each >0% trial type contained 50 
Go trials, plus a varying amount of Stop trials per colour resulting in varying stop-signal probabilities 
(in between brackets): 10 yellow (17%), 14 amber (22%), 19 orange (28%) and 27 red (35%).
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The stop-signal probability cues (i.e. coloured horizontal middle line and vertical lines) 
were presented for 500 ms at the beginning of each trial before the bar started to move 
upwards (relative to 0 ms in the original paradigm of Zandbelt & Vink (2010), thereby pro-
viding more time to process the stop-signal probability cues). On Stop trials, a stop signal 
was presented after some delay (stop-signal delay, SSD). SSD was initially set to 
550 ms relative to moving bar onset (i.e. 250 ms before the target response time), equally 
for all stop-signal probability levels. During the experiment, SSD was adjusted depending 
on stopping performance, i.e. 25 ms decrease after a failed stop (StopFailure trial) and 
25 ms increase after a successful stop (StopSuccess trial), for each level and stop-signal 
probability separately. This ensured roughly equal numbers of successful and unsuccess-
ful Stop trials. In total, all trials had a fixed duration of 1500 ms. Levels were presented in 
34 blocks, each lasting 27 seconds and consisting of 10 trials, with an inter-trial interval 
of 1000 ms. Each block began with an instruction cue, displaying for 2000 ms which level 
would be presented in the coming block. The sequence of trials and blocks were pseudo 
randomized (ensuring that the first three blocks of the task were always in order of levels 
A-B-C). 
In each level, 70 Go trials with 0% stop-probability, 200 Go trials with >0% stop-probability 
and 70 Stop trials were presented (caption Figure 1). Two rest blocks of 20 s each were 
implemented at one-third and two-thirds of the task, respectively. The total task duration 
was approximately 45 minutes. 
Procedure
Older and young adults were trained for an equal number of practice trials on the stop-
signal anticipation task before the actual fMRI experiment. Each level was explained and 
practiced separately for 48 trials (Level A) and 72 trials (Levels B and C). Participants were 
asked to repeat task instructions to ensure sufficient understanding. Then they practiced 
the task (levels were presented in alternating blocks) for 10 minutes. After the fMRI ex-
periment, an exit questionnaire assessed the participants’ strategy and understanding of 
the task instructions.
Behavioural data analysis 
Data were tested for compliance with the main assumptions of the race model (Logan 
and Cowan, 1984). Inhibition functions were calculated, i.e. the probability of successfully 
inhibiting a response for every stop-signal delay, where the probability to inhibit decreases 
as the stop-signal is presented more closely to the moment that the response is made 
(Logan and Cowan, 1984). Specifically, for each level and age group separately, we as-
sessed whether 1) mean RTs were faster on StopFailure versus >0% trials (paired t-test), 
2) mean RTs were faster for StopFailure RTs for short versus long SSDs (paired t-test), 
3) individual inhibition functions represented the increasing probability of failed inhibition 
as a function of normalized SSD (as measured with a Weibull function fitted to the data). 
Reactive response inhibition was measured by calculating the stop-signal reaction time 
(SSRT), according to the integration method (Verbruggen and Logan, 2009c). 
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In short, >0% Go trials are sorted in ascending order. The Go RT corresponding to the per-
centage unsuccessful inhibitions is taken from this ranked list. Subsequently, the mean SSD 
is subtracted from this value. Hereby, SSRT represents the time needed to cancel an 
already initiated response (Logan and Cowan, 1984). An ANOVA of SSRTs was used with 
the within-participants factor Level (A, B, C) and the between-participants factor Age 
(young, older). 
Previous studies have shown that participants slow down their responses in advance of a 
stop signal (Logan and Burkell, 1986; Verbruggen and Logan, 2009d; Vink et al, 2005; Zand-
belt and Vink, 2010). RT slowing as a function of increasing stop-signal probability, indicat-
ed by the coloured cues, indexed proactive response inhibition. For each level, the slope 
of RTs was calculated as a function of stop-signal probability using a general linear model, 
resulting in a beta value for the slowing slope. Hence, for level A, the slowing slope was 
calculated on the two proactive trial types (0% (green cues) and 26% (white)). For level B 
and C, the five proactive trial types were included in the slowing slope (0% (green cues), 
17% (yellow), 22% (orange), 28% (amber) and 35% (red)). Level A consists of fewer cells 
than Levels B and C and was therefore not compared with the other levels. An ANOVA was 
performed using the within-participants factor Level (Level B, C) and the between-partici-
pants factor Age (young, older). The effect of Age on Level A was assessed using a separate 
one-way ANOVA. 
To assess the separate contributions of the information load manipulation on 0% and >0% 
stop-signal probability trials (present in all three levels), two ANOVA’s were performed 
(using the factors Level (A, B and C) and Age (Young, Older) on the median RTs of 0% and 
>0% trials separately. Task instructions implied differential processing of 0% and >0% 
stop-signal probability trials, resulting in more slowing on >0% than 0% trials 
(i.e. a positive difference between these trial types). Task non-compliance was determined 
by a negative difference on median RTs between 0% (green) and >0% (white) trials during 
the lowest cognitive load (Level A). Three participants were excluded from analysis due to 
task non-compliance: negative slowing on Level A (one young subject), not following the 
task instruction of timing the moving bar on the middle line (1 older subject) or failing to 
stop on every Stop trial (one older subject).
Age differences between older and young adults on neuropsychological assessment 
(MMSE, HADS, verbal IQ, BIS-11, Story recall, digit span, Stroop cards and verbal fluency) 
were determined using two-sampled t-tests. Categorical measures were tested using chi-
square tests. 
MRI data acquisition and pre-processing
Whole-brain imaging was performed on a 3 Tesla MR scanner (Magnetrom Skyra Tim, 
Siemens Medical Systems, Erlangen, Germany). Functional data were obtained using a 
multi-echo gradient T2*-weighted echo-planar scanning sequence (Poser et al., 2006) with 
blood oxygen level-dependent (BOLD) contrast (34 axial-oblique slices, repetition time, 
2070 ms; echo-times, 9.0, 19.3, 30.0 and 40.0 ms; in plane resolution, 3.5x3.5 mm; slice 
thickness, 3 mm; distance factor, 0.17; field of view, 224 mm; flip angle, 90º). Visual stimuli 
were projected on a screen and were viewed through a mirror attached to the head coil. In 
addition, a high-resolution T1-weighted magnetization-prepared rapid-acquisition gradient 
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echo anatomical scan was obtained from each subject (192 sagittal slices; repetition time, 
2.3 s; echo time, 3.03 ms; voxel size 1.0 x 1.0 x 1.0 mm; field of view 256 mm). 
Pre-processing and mass-univariate data analysis were performed using SPM8 software 
(Statistical Parametric Mapping; Wellcome Trust Centre for Cognitive Neuroimaging, 
London, UK). Realignment parameters were estimated for the images acquired at the first 
echo-time and subsequently applied to images resulting from the three other echoes. 
The echo-images were combined by weighting with a PAID algorithm, assessing the signal-
to-noise ratio as described by Poser and colleagues (2006). Thirty volumes, acquired 
before the task, were used as input for this algorithm. After data quality check (i.e. for 
signal intensity spikes), the echo combined and realigned images were slice time corrected 
to the middle slice. The functional images were co-registered to the T1 scan. A sample-
specific template was created by segmenting each individual T1 and using diffeomor-
phic anatomical registration to place each subject’s grey and white matter images in a 
study-specific space (Ashburner, 2007). Deformation parameters were stored in a sub-
ject-specific flow field. The co-registered fMRI images and anatomical T1 scan were non-
linearly normalized to the sample-specific anatomical template (using the subject-
specific flow field), affine-aligned into a Montreal Neurological Institute template, and 
finally smoothed using an 8.0-mm full width at half maximum Gaussian filter. 
fMRI task analysis
Twelve regressors of interest were included in a general linear model. For each Level, we 
included a regressor modelling all Go trials (i.e. containing 0% and >0% stop-signal prob-
ability trials) and a corresponding parametric regressor modelling stop-signal probability 
matching the behavioural slowing slope (6 regressors: Go Level A, Proactive Level A, Go 
Level B, Proactive Level B, Go Level C, Proactive Level C). In Level A, the parametric regres-
sor consisted of 2 trial types (0% (green cues) and >0% (white cues)). In Level B and C, 
the parametric regressors consisted of 5 trial types (0% (green cues), Go 17% (yellow), 
Go 22% (orange), Go 28% (amber) and Go 35% (red)).  An actual stop-signal appeared on 
a proportion of >0% trials. These Stop trials were separately modelled as StopSuccess trials 
and StopFailure trials, based on whether or not the behavioural response was inhibited 
(6 regressors: StopSuccess level A, StopFailure level A, StopSuccess level B, StopFailure 
level B, StopSuccess level C, StopFailure level C). As regressors of non-interest, we included 
a regressor for missed trials across all levels (i.e. no button box response on a Go trial), 
as well as a regressor modelling task instructions at the beginning of each mini-block. 
Moreover, twenty four realignment parameters were modelled as regressors of no interest 
(6 rigid-body movement parameters, plus Volterra expansion of these: first derivatives and 
quadratic derivatives of the original as well as first derivatives (Lund et al, 2005). 
Finally, to prevent contribution of global signal changes, we included signal from segment-
ed out-of-brain voxels in the model as regressor of non-interest. All regressors of interest 
were modelled as delta functions at the onset of the trial and were convolved with a 
canonical hemodynamic response function. Time series were high-pass filtered (128s 
cut-off) and serial correlations were corrected using an autoregressive (AR)1 model during 
classical (ReML) parameter estimation. Parameter estimates for the regressors of interest, 
derived from the mean least-squares fit of the model to the data, were used to estimate 
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contrasts on the first level. 
At the subject-specific, first level we specified the reactive and proactive contrasts with-
in, across and between levels. The first level contrast images were subsequently used in 
a second level random effects analysis to assess consistent effects across participants as 
well as the effects of age. Reactive response inhibition can be assessed using two differ-
ent contrasts: StopSuccess > StopFailure or StopSuccess > Go. The contrast StopSuccess 
> StopFailure provides optimal control for stimulus-driven processing (i.e. presentation 
of the stop signal). The contrast StopSuccess > Go provides optimal control for the timing 
of the Go responses (i.e. Go and StopSuccess RTs are both slower than Stop Failure) and 
the outcome of the trial (i.e. both successful in Go and StopSuccess). In the main text, we 
focus on the StopSuccess > StopFailure contrast, because we prioritized optimal control for 
stimulus-driven processing and because it is orthogonal by design to the proactive inhibi-
tion contrast (which also involves the Go trials). For completeness, we report the results of 
the contrast StopSuccess > Go in the Supplementary Materials. 
At the group level, the main task effect of proactive response inhibition was assessed using 
a one sampled t-test of the parametric proactive regressors across Levels and Age. 
Task effects for reactive and proactive response inhibition were also tested using a one 
sampled t-test per Age group and per Level separately and are reported in the Supplemen-
tary Materials. In addition to the main task effects, Level x Age interactions were assessed 
using independent t-tests, comparing young and older age groups. For reactive response 
inhibition, this resulted in contrasts assessing Level x Age interactions for StopSuccess > 
StopFailure Level A versus Level B, Level C versus Level B, Level A versus Level C. 
For proactive response inhibition, a Level x Age interaction was assessed, comparing Level 
C versus Level B only, similar to the behavioural data analysis. This was done because the 
slope of Level A consists of an unequal number of cells compared with Levels B and C. 
Upon significant Level x Age interactions, we calculated simple effects of Level per age 
group or effects of Age per level. 
To establish a relation between behaviour and regions involved in the different types of 
response inhibition, whole brain- behaviour correlations were assessed within age groups 
for the main reactive and proactive task contrasts across levels with mean SSRT and mean 
proactive slowing. Upon significant effects, we assessed the brain-behaviour correlations 
per level.Statistical inference (pFWE <.05) was performed at the cluster level, correcting for 
multiple comparisons over the whole brain. The intensity threshold necessary to deter-
mine the cluster-level threshold was set at p<.001, uncorrected. 
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Table 1. Demographics and Neuropsychological tests 
Variable Young (n=25) Older (n=23) p-value 
Age (years) 22.7 (0.6) 67.6 (0.7)  <.001 
Sex (women/men) W: 11 M:14  W: 9 M: 14 .9 
Verbal IQ (points) 107.4 (1.26) 112.4 (2.5) 0.1 
HADS (points) 5.32 (0.9) 5.6 (0.8) 0.8 
MMSE (points) 29.4 (0.1) 29.3 (0.16) 0.5 
BIS-11 motor (points) 22.9 (0.8) 19.3 (0.6) 0.01 
BIS- 11cognitive (points) 14.9 (0.6) 14 (0.4) 0.2 
BIS- 11nonplanning (points) 22.5 (0.8) 22.2 (0.8) 0.8 
BIS-11 total (points) 58.9 (2.2) 55.5 (1.2) 0.2 
Story immediate recall (points) 11.3 (0.8) 8.8 (0.8) 0.02 
Story delayed recall (points) 10.5 (0.7) 7.7 (0.7) 0.01 
Digit span forward (points) 9.8 (0.4) 8.7 (0.5) 0.05 
Digit span backward (points) 9.5 (0.4) 8.6 (0.3) 0.06 
Stroop effect (secs) 20.9 (1.3) 31.4 ( 2.7)  <0.001 
Stroop effect (errors)  0.3 (0.1) 0.2 (0.2) 0.6 
Verbal Fluency DAT (items) 50.1 (2.9) 48.4 (2.7) 0.7 
Note. All data in Young and Older columns represent mean (standard error of the mean) except for the variable Sex, for which 
data reflect frequencies. Verbal IQ is defined by scores on the Dutch Reading Test, MMSE = Mini-Mental State Examination, BIS-
11 = Barratt Impulsiveness Scale subscales and total score. Immediate and delayed story recall, digit span forward and 
backward, Stroop cards (colour naming: incongruent minus neutral cards), verbal fluency. Significant p-values are in bold. 
 
Figure 2. Effects of Age and Level on reactive response inhibition, SSRT (ms). Error bars represent SEM.
Results
Behavioural results 
Demographics and neuropsychological test scores from both age groups are presented in 
Table 1; an overview of task performance is given in Table 2. Response times of the par-
ticipants followed the assumptions of the independent race model (Supplementary Mate-
rials, Table S1, and Figure S1). 
Reactive response inhibition
SSRTs are presented in Figure 2 and Table 2 as a function of Level and Age. There was a 
main effect of Level on SSRT across Age groups (F(2, 92)=5.30,p=.007), indicating that reac-
tive inhibition became more efficient with increasing information load (Figure 2). 
SSRTs in Level C were shorter compared with SSRTs in Level B (t(47)=2.39, p=.021) and 
compared with SSRTs in Level A (t(47)=2.90, p=.006). SSRTs did not differ between level A 
and B (t(47)=1.32, p=.19). There was no Age x Level interaction (F(2,92)=1.94, p=.83). 
However, critically, there was a main effect of Age: Older adults were on average 15 ms 
less efficient in stopping their initiated response than younger adults, irrespective of 
Level (F(1,46)=23.18, p<.001) (Figure 2).
Note. All data in Young and Older column  r present m an (standard error of he mean) excep  
for the variable Sex, for which data reflect frequencies. Ve bal IQ is defined b  scores on the Dutch 
Reading Test, MMSE = Mini-Mental State Examinatio , BIS-11 = B rratt Impulsiv ess Scale subscal s 
and total score. Immediate and delayed story recall, digit span forward and backward, Stroop cards 
(colour naming: incongruent minus neutral cards), verbal fluency. Significant p-values are in bold.
Table 1. Demographics and Neuropsychological tests
Contrasting neural effects of aging on proactive and reactive response inhibition
5.
91
Proactive response inhibition
The degree of proactive slowing (i.e. RT) with increasing stop-signal probability is present-
ed as a function of Age and Level in Figure 3 and Table 2. As shown in Figure 3A (see also 
last column of Table 2), both older and young adults showed a significant decrease in the 
slowing slope from Level B to C (older adults: Level C<B, t(22)=4.1, p<.001; young adults: 
Level C<B, t(24)=4.5, p<.001). Thus, the degree to which proactive slowing increased with 
increasing stop-signal probability was reduced under high versus low information load. 
Critically, this decline in proactive slowing with increasing information load (i.e. Level) was 
greater in older than in young adults (Figure 3). This observation was substantiated by 
a Level (B, C) x Age (Young, Older) interaction (F(1,46)=5.76, p=.02). There was no main 
effect of Age across Levels B and C (F(1,46)=.12, p=.73), and no simple main effects of 
Age per Level, although older adults tended to show more proactive slowing during level 
A than young adults (Level A (F(1,46)=3.57, p=.065), Level B (F(1,46)=1.69, p=.2), Level C 
(F(1,46)=1.27, p=.27)). 
To investigate whether the effects of Age were driven by effects on the baseline 0% 
stop-signal probability condition or by the >0% conditions (Figure 3B), we assessed simple 
interaction effects separately for the 0% stop-signal probability and >0% (grouped togeth-
er) trial types. Level x Age interactions were found on 0% trials (F(2,92)=3.86, p=.025) as 
well as on >0% trials (F(2,92)=3.14,p=.048). Thus older adults exhibited a steeper Lev-
el-dependent increase of RTs for the 0% trial type, as well as a steeper Level-dependent 
decrease of RTs on the >0% trial types. Thus, the age-related decrease in slowing slope 
as a function of Level is driven by opposing effects on both trial types: relatively slower 
responding with increasing information load on the 0% trial type, but relatively faster 
responding with increasing information load on the >0% trial type. 
Figure 2. Effects of Age and Level on reactive response inhibition, SSRT (ms). Error bars represent 
SEM. 
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Table 2. RTs (in milliseconds) per trial type per Level. Median RTs for Go trails. 
Median 
RTs 
(ms)(SEM) 
 0% 
Green 
>0%  
Other 
colours 
17% 
Yellow 
22% 
Amber 
28% 
Orange 
35% 
Red 
Proactive 
slowing 
slope 
(beta) 
SSRT (over 
levels)  
Level A         
Young  811.5 
(4.8) 
834.2 
(5.7) 
    .96 (.62) 248.0 (2.6) 
Older 838.4 
(6.8) 
878.1 
(7.7) 
    1.38 (.90) 264.2 (3.0) 
All 824.4 
(4.5) 
855.2 
(5.7) 
    1.16 (.79) 255.8 (2.3) 
Level B         
Young 812.0 
(4.3) 
833.9 
(5.8) 
830.2 (5.5) 832.0 
(6.0) 
834.5 
(6.1) 
842.0 
(6.8) 
.85 (.62) 246.6 (2.2) 
Older 838.3 
(6.2) 
871.7 
(7.9) 
864.7 (8.4) 868.6 
(7.7) 
873.4 
(8.2) 
878.6 
(7.8) 
1.11 (.76) 260.5 (3.2) 
All 824.6 
(4.2) 
852.2 
(5.5) 
846.7 (2.5) 849.5 
(2.4) 
853.2 
(2.6) 
859.5 
(2.6) 
.98 (.70) 253.2 (2.2) 
Level C         
Young 824.0 
(4.7) 
834.0 
(5.4) 
829.9 (5.2) 832.0 
(5.2) 
834.0 
(5.8) 
844.5 
(6.3) 
.58 (.47) 242.6 (2.0) 
 Older 861.9 
(8.1) 
871.0 
(8.1) 
869.8 (7.4) 872.3 
(8.0) 
870.2 
(8.3) 
874.9 
(7.8) 
.42 (.49) 257.6 (3.0) 
 All 842.1(5.3) 851.7 
(5.4) 
849.0 (5.3) 851.3 
(2.5) 
851.3 
(5.6) 
859.1 
(2.4) 
.50 (.48) 250.0 (2.0) 
 
Reactive response inhibition 
SSRTs are presented in Figure 2 and Table 2 as a function of Level and Age. There was a main effect of 
Level on SSRT across Age groups (F(2, 92)=5.30,p=.007), indicating that reactive inhibition became more 
efficient with increasing information load (Figure 2). SSRTs in Level C were shorter compared with SSRTs 
in Level B (t(47)=2.39, p=.021) and compared with SSRTs in Level A (t(47)=2.90, p=.006). SSRTs did not 
As expected, older adults were slower in responding n all Go trial types compared with 
young adults (main effect f ge on 0% trial ty es: F(1,46)=14.89, p<.001; and on >0% trial 
types: F(1,46)=17.72, p<.001).
In sum, relative to young adults, older adults showed decreased reactive response inhi-
bition (i.e. longer SSRTs), as previously observed (Bedard et al, 2002; Kramer et al, 1994; 
van de Laar et al, 2011), across all load levels. In addition, as hypothesized, the degree of 
proactive slowing depended on information load and age: relative to young adults, older 
adults exhibited relatively decreased proactive slowing under high versus low information 
load.
fMRI results 
Reactive and proactive inhibition activate frontoparietal networks and basal ganglia 
At our whole-brain corrected threshold of pFWE<.05 (cluster-level), main task effects 
revealed responses in a frontoparietal and striatal task network for reactive and proactive 
Table 2. RTs (in milliseconds) per trial type per Level. Median RTs for Go trails.
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response inhibition (Figure 4, Table S2, Table S3), and deactivation of e.g. motor cortex in 
the reactive response inhibition network, as shown previously (Aron, 2011; Chikazoe et al, 
2009; Jahfari et al, 2010; Swann et al, 2012; Zandbelt and Vink, 2010). Task effects of the 
StopSuccess > Go reactive response inhibition contrast are presented in the Supplementa-
ry Materials, Figure S2, Table S4), as are simple task effects per Level and per Age group
(Figure S3, S4 and S5).
Effect of Age during reactive response inhibition (StopSuccess > StopFailure)
During reactive inhibition, BOLD signal was increased in older relative to younger adults 
in the right middle cingulate gyrus, the right cuneus, left middle frontal gyrus orbital part, 
and left cerebellum (Figure 5 and Table S5). Concurring with the behavioural pattern, 
these Age effects did not differ between levels: there were no Level x Age interactions 
during reactive response inhibition. 
Upon further inspection, some of the age-related effects showed remarkable overlap with 
the deactivations observed for the StopSuccess > StopFailure contrast, 
Figure 3. A: Slowing slope, i.e. the degree to which participants slowed their responses with increas-
ing stop-signal probability, plotted as a function of age and level. B: Proactive slowing per level as 
a function of proactive cues for young and older adults in median RTs (ms). The slopes of the lines 
plotted in panel B are presented on the y-axis in panel A. Error bars represent SEM.
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(as plotted in Figure 4A). Indeed, in middle and anterior cingulate gyrus, the age effect 
on reactive inhibition was driven by more activation of the reverse contrast StopFailure > 
StopSuccess for young than older adults. However, in left middle frontal gyrus and bilateral 
cerebellum, the age effect represented over-recruitment during reactive stopping (Stop-
Success > StopFailure) by older versus young adults (encircled regions in Figure 5, further 
visualized in Figure S6).
No whole brain-behaviour correlations were observed within older or young adults be-
tween BOLD responses during reactive response inhibition and SSRT. For completeness, 
we report the effects of reactive response inhibition as defined by the StopSuccess > Go 
contrast (see Methods) in the Supplementary Materials, Figure S7 and text.
Figure 4. A: Main task effects for reactive response inhibition (StopSuccess > StopFailure). Images are 
thresholded at p<.001 uncorrected, and cluster-level significant clusters (pFWE<.05) are presented in 
Table S2. B: Main task effects for proactive response inhibition (Parametric regressors of Go) plotted 
across levels and age groups. Images are thresholded at p<.001 uncorrected, and cluster-level signifi-
cant clusters (pFWE<.05) are presented in Table S3.
The position of the slices is labelled with the Z coordinates of the MNI atlas. Task activation is plotted 
in hot colours, deactivation in cold colours.
Figure 5. Increased BOLD signal for older versus young adults during reactive response inhibition 
(StopSuccess > StopFailure). Cluster-level significant regions in which the age effect was driven by an 
over-recruitment of StopSuccess > StopFailure for older > young adults are encircled. Other regions 
are driven by the reverse effect: more activation by young > older adults for the reverse contrast 
StopFailure > StopSuccess. The reverse contrast young > older adults, did not yield any significant 
clusters. The position of the slices is labelled with the Z coordinates of the MNI atlas. Images thresh-
olded at p<.001 uncorrected, cluster-level (pFWE<.05) significant clusters are listed in Table S5.
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Effect of information load during reactive response inhibition (StopSuccess > StopFailure)
Similar to the behavioural results, Level effects irrespective of age were observed on reac-
tive response inhibition (StopSuccess > StopFailure), Figure 6. Specifically, BOLD signal for 
StopSuccess > StopFailure in the left superior frontal gyrus (encircled) was increased during 
level B relative to level C, (MNI coordinates [-9 66 18], p=.003, k =359).
Effects of Age for high versus low information load during proactive response inhibition 
As predicted and in accordance with the behavioural results, effects of Age during proac-
tive response inhibition varied as a function of information load, as evidenced by 
Age x Level interaction effects in terms of the parametric proactive regressors. These were 
observed in frontal, temporal and occipital areas: left inferior frontal gyrus extending into 
middle frontal gyrus and insula, right superior frontal gyrus extending into right anterior 
cingulate gyrus, vermis and bilateral calcarine gyri, left thalamus and right middle tempo-
ral gyrus (Figure 7A). When breaking down this interaction into simple effects, increased 
signal was revealed for older adults relative to young adults during Level B in occipital and 
frontal regions (Figure 7B in green). In contrast, decreased signal was found for older com-
pared with young adults during Level C (Figure 7B in violet) in medial and lateral frontal 
regions as well as a region extending into the right caudate nucleus. No cluster-
level significant regions were observed when comparing level C with level B per age group. 
Cluster-level (pFWE<.05) significant clusters are listed in Table S6. When assessing an age 
effect in Level A separately, we observed increased right pre- and post-central gyrus in 
older compared to young adults (Figure 7C in green).
Within older adults, we found a whole brain negative correlation between proactive BOLD 
signal across levels in the right middle occipital gyrus extending into angular gyrus (MNI 
coordinates [40 -72 28] and [42 -73 39], p=.008, k=318) and behavioural slowing across 
levels (Figure 8A). This correlation was driven by the low and intermediate information 
load levels (level A: r=-.520, p=.011; level B: r=-.49, p=.017) and not by the high load level 
(level C: r=.088, p=.69) (Figure 8B). Within young adults, no whole brain correlation during 
proactive response inhibition with behavioural slowing was observed. 
Figure 6. Level effects for reactive inhibition (StopSuccess > StopFailure), Level B > Level C across age 
groups, thresholded at p<.001 uncorrected. Left superior frontal gyrus is cluster level significant (MNI 
coordinates [-9 66 18], p=.003).
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Figure 7. A: Level x Age interaction for Level C>B, Young> Older adults during proactive response 
inhibition (parametric Proactive regressor). B: Significant simple effects, signal for Older > Young 
adults Level B in green, for Young> Older adults Level C in violet. C: Age effect for Older > Young 
adults during Level A in green. The position of the slices is labeled with the Z coordinates of the MNI 
atlas. Images are thresholded at p<.001 uncorrected. Cluster-level (pFWE<.05) significant clusters are 
listed in Table S6.
Figure 8. A: Whole-brain negative correlation within older adults between proactive response inhi-
bition signal in right occipital gyrus and behavioural response slowing across levels (scatter plot for 
illustration purposes). B: the correlation is driven by BOLD signal and slowing slopes in the low (Level 
A) and intermediate (Level B) information load levels, not the high (Level C) load level. 
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Discussion
We investigated how aging and information load impact inhibitory control. To this end, 
older and young individuals performed a stop-signal task designed to measure reactive 
inhibition (outright stopping) and proactive inhibition (anticipatory response slowing) 
across low, intermediate, and high levels of information load while being scanned with 
functional magnetic resonance imaging. We report three main findings.
First, reactive stopping was slower in older than young adults and was accompanied by 
more age-related activation of left middle frontal gyrus and bilateral cerebellum. 
We replicate the long-standing finding that aging is associated with slowing of the stop-
signal reaction time (Coxon et al., 2014; Kramer et al., 1994; Smittenaar et al., 2015; van de 
Laar et al., 2011; Williams et al., 1999) as well as differences in the neural correlate of this 
effect (Coxon et al., 2014). At first glance, our finding of more activation of left prefrontal 
and bilateral cerebellar cortex seems at odds with a previous study of response inhibition 
in aging (Coxon et al., 2014), reporting that slower reactive stopping in older adults was 
accompanied by less activation of regions more commonly associated with reactive stop-
ping, including bilateral anterior insula, supramarginal gyrus, right inferior frontal cortex, 
and pre-SMA. Closer inspection reveals that this discrepancy is likely due to a difference in 
the way reactive inhibition was measured: we contrasted successful stop trials with failed 
stop trials, whereas these authors contrasted successful stop trials with go trials. Indeed, 
when we assessed reactive stopping by contrasting successful stop trials with go trials, 
we found similar activation patterns (see Supplement: Figure S7). Both contrasts have pre-
viously been used to assess reactive inhibition (e.g. Aron & Poldrack, 2006; Boehler et al., 
2010; Zandbelt & Vink, 2010) and each has different strengths: the former (StopSuccess > 
StopFail) is better at filtering out activation related to perceptual and attentional processes 
triggered by the presentation of the stop-signal, the latter (StopSuccess > Go) is better at
controlling for response outcome and performance monitoring. We speculate that greater 
activation in left prefrontal and cerebellar cortex in older adults seen when contrasting 
successful stop trials with failed stop trials reflects an attempt to compensate for the 
diminished activation in regions associated with reactive stopping seen when contrasting 
successful stop trials with go trials.
Second, across age groups, reactive stopping was faster under high versus low information 
load and this was associated with diminished activation in left superior frontal gyrus. 
The behavioural effect size was remarkably small (5 ms in young people, 7 ms in older 
people), but more importantly, it differed in direction from previous studies, showing that 
information load had no effect on reactive stopping (Huizenga et al., 2012) or resulted in 
SSRT slowing (Ridderinkhof et al., 1999). This discrepancy may be due to a difference in 
tasks. Whereas previous studies used a standard stop-signal task in which fast reactive 
stopping is emphasized and response slowing is discouraged, we used a task that promotes 
not only fast reactive stopping but also proactive slowing. This may have shifted the bal-
ance between proactive and reactive control towards proactive control, leaving more room 
for SSRT improvement than in previous studies. Supporting this explanation, SSRT of young 
adults in our low information load condition (245 ms) is much slower than SSRT of young 
adults in a corresponding condition reported by Huizenga and colleagues and Ridderinkhof 
and colleagues (190 ms and 182 ms, respectively).
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Increased recruitment of the left superior frontal gyrus during reactive inhibition in level B 
versus C is in line with the observed increases in SSRT in level B versus C and might reflect 
difficulty when engaging in both re- and proactive response inhibition. The right inferior 
frontal gyrus is suggested to be the main locus of inhibition, by actively braking a motor 
plan (Aron et al, 2014).Other frontal regions, as amongst others the left superior frontal 
region, might be involved in different processes that contribute to successful inhibition, 
for example attention to object features such as motion and colour 
Third, proactive slowing decreased as information load increased, but more so in older 
than young adults. Under low information load, we found slightly more proactive slowing 
in older than young adults, replicating previous findings obtained under similar informa-
tion loads (van de Laar et al, 2011). Response slowing in aging has been shown to reflect 
a cautious attitude, indicated by response patterns favouring accuracy over speed even 
despite instructions directed towards speed (Forstmann et al, 2011; Rabbit, 1979; Starns 
and Ratcliff, 2010). In keeping with this idea, we found that older adults had lower levels of 
motor impulsivity than young adults, as measured with the BIS-11 motor subscale 
(see Table 1). In addition to slightly more age-related proactive slowing in level A, we 
found increased pre- and post-central gyrus activation at this low information load in older 
versus young adults. This concurs with a previous observation that right pre- and post-
central gyrus activation is increased during proactive response inhibition (Zandbelt and 
Vink, 2010).Under intermediate information load, older adults were still able to maintain 
proactive slowing levels similar to young adults, yet expressed greater activation in visual 
cortex and prefrontal cortex than young adults. This could mean that older adults, in order 
to maintain adequate levels of proactive slowing, resorted to enhanced visual processing 
of stimuli, such as the moving bar and colour cues. Under high information load, when 
older adults were less able to maintain the proactive slowing levels seen with intermediate 
information load compared with their younger peers, we saw a reduction of activation in 
regions commonly associated with both pro- and reactive inhibition, including dorsolateral 
prefrontal cortex, pre-SMA, and striatum (van Belle et al., 2014; Vink et al., 2015; Zandbelt 
et al., 2013). Thus, the tendency of older people to respond more cautiously collapses in 
situations of information overload and is associated with a failure to sustain activation in 
brain regions implicated in proactive inhibition. This conclusion is further strengthened 
by a negative correlation within older adults between the right middle occipital gyrus, 
involved in proactive inhibition across levels (see Figure 4B), and proactive behavioural 
slowing. This correlation may reflect unsuccessful recruitment of this region by older 
adults, attempting to engage in proactive response preparation. It was driven by low and 
intermediate information load levels, but was not present in the high information load 
level. This again indicates disengagement of older adults in the proactive part of the task 
under high information load. Our age-related comparisons confirm our hypothesis that 
aging affects proactive response inhibition as a function of information load due to failure 
of recruiting frontal regions. Moreover, our brain-behaviour correlation within older adults 
shows that occipital gyrus signal is unsuccessfully recruited in lower load levels, and not 
recruited during high information load.
Taken together, aging and information load appear to have opposing effects on the balance 
between proactive and reactive inhibition. Aging shifts the balance towards proactive 
inhibition, resulting in longer SSRT and a tendency towards more proactive slowing (under 
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low information load), whereas information load shifts the balance towards reactive 
inhibition, resulting in shorter SSRT and less proactive slowing, with the latter being more 
pronounced in older than young adults.
The impact of information load on proactive inhibition and reactive inhibition fits well with 
the dual mechanisms of control (DMC) framework (Braver, 2012; Braver et al, 2007) that 
puts forward the idea that cognitive control operates via proactive and reactive modes. 
According to this framework, proactive control is metabolically costly, and capacity 
demanding, so that proactive control is preferred primarily under low levels of informa-
tion load. In contrast, the effect of aging on proactive slowing and reactive inhibition we 
observed differs from predictions of the DMC framework. The DMC framework predicts 
that aging, like information load, produces a shift from proactive towards reactive control 
and subsequent studies confirmed this idea (Bugg, 2014; Jimura and Braver, 2010; Paxton 
et al, 2008). In fact we replicate previous behavioural findings showing excessive post-error 
slowing in older versus younger adults, which can also be viewed as a measure of proactive 
response inhibition (van de Laar et al, 2011). Therefore, it is possible that this discrepancy 
results from differences in the concepts of proactive and reactive control between the 
domain of response inhibition (e.g. Aron, 2011; Jahanshahi et al., 2015) and other cog-
nitive control domains from which the DCM originates (Braver, 2012; Braver et al, 2007). 
First, different measures are used: the response inhibition domain uses response time 
measures, whereas other domains tend to use accuracy measures (but see Bugg, 2014). 
Second, different brain structures appear to be involved: In the response inhibition domain 
primary regions of interest are the ventrolateral prefrontal cortex (e.g. rIFC), dorsomedi-
al frontal cortex (e.g. pre-SMA), and basal ganglia (e.g. striatum, subthalamic nucleus), 
whereas other cognitive control domains appear to focus mainly on dorsolateral frontal 
and parietal cortex. These discrepancies highlight the need for future research to examine 
the domain specificity and generality of the constructs of proactive and reactive control.
Several measures were taken to account for differences in the two age cohorts that are 
likely unrelated to the cognitive processes studied. A bias due to anatomical differences 
between age groups (e.g. cortical shrinkage) was minimized by normalizing participants to 
a sample-specific anatomical template (Ashburner, 2007) before normalizing to MNI space. 
Furthermore, as recommended when studying aging using neuroimaging (D’Esposito et al, 
2003; Samanez-Larkin and D’Esposito, 2008), the task compared different conditions and 
different levels. This experimental design allowed assessment of level- and condition-
specific age-related effects that are unlikely explained by a general physiological effect 
such as parenchymal volumetric differences and differences in BOLD signal evolution. 
These general cross-sectional differences would affect all task conditions in the same or 
nearby region equally. Indeed, we observed both hyper- and hypo-activation, accompanied 
by impairments in behaviour, for different conditions, i.e. reactive and proactive inhibition 
respectively. Thus, our age-related effects seem to reflect task- (i.e. type of response inhibi-
tion) specific effects instead of general physiological effects.  Another possible caveat could 
be an age-related difference in discrimination of the colours. However, this is unlikely given 
that both age groups showed colour- (i.e. stop-probability) related slowing within levels 
B and C. Moreover, both during practice and the exit interview, the subjects repeated the 
task instructions using the colours.
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In summary, this study investigated whether diminished response inhibition in older adults 
is accompanied by altered behavioural and neural preparation for inhibition, and wheth-
er this is particularly evident in situations of information overload. We demonstrate that 
under low information load diminished reactive stopping in older adults is accompanied by 
slightly increased proactive response slowing. Under high information load, this putative 
compensatory mechanism collapses in older adults, resulting in reduced inhibitory control 
more generally. Our neuroimaging findings indicate that this behavioural deficit reflects a 
failure to recruit a network of cortico-basal ganglia areas known to be involved in proactive 
and reactive control, including prefrontal cortex, pre-SMA, and striatum. Thus, in line with 
our hypothesis, aging is not only accompanied by deficits in outright stopping but also 
impaired preparation for stopping during information overload.    
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Supplementary Behavioural Results 
Race model assumptions 
RTs of trials with stop-signal probability >0% were slower than StopFailure RTs in all levels for young 
adults and for older adults, see Table S1 and Figure S1A. RTs were binned in lower and higher SSDs and 
StopFailure RTs in lower SSDs were faster than in higher SSDs for each level in young adults and in older 
adults, see Table S1 and Figure S1B. Consistent with the race model, individual inhibition functions 
increased as a function of normalized SSD (as measured with a Weibull function fitted to the data), see 
Figure S1C. 
 
Table S1. Results of the paired t-tests determining whether the data were in compliance with the race model assumptions.  
Race model assumption 1: >0%  RTs slower than StopFailure RTs  
Young adults t-statistic p-value 
Level A t(24)= 10.94  p<.001 
Level B t(24)= 9.07 p<.001 
Level C t(24)= 8.26 p<.001 
Older adults 
Level A t(22)=11.61 p<.001 
Level B t(22)=8.47 p<.001 
Level C t(22)=10.94 p<.001 
Race model assumption 2: StopFailure RTs of lower SSDs faster than higher SSDs  
Young adults 
Level A t(24)=-10.39 p<.001 
Level B t(24)=-7.40 p<.001 
Level C t(24)=-10.74 p<.001 
Older adults 
Level A t(22)=-5.26 p<.001 
Level B t(22)=-10.62 p<.001 
Level C t(22)=-7.40 p<.001 
 
Supplementary Behavioural Results
Race model assumptions
RTs of trials with stop-signal probability >0% were slower than StopFailure RTs in all levels 
for young adults and for older adults, see Table S1 and Figure S1A. RTs were binned in 
lower and higher SSDs and StopFailure RTs in lower SSDs were faster than in higher SSDs 
for each level in young adults and in older adults, see able S1 a d Figure S1B. Consistent 
wi h the race model, individual inhibition fu ctions increased as a functi n of norm lized 
SSD (as m asur d with a Weibull function fitted o the data), see Figure S1C.
Table S1. Results of the paired t-tests determining whether the data were in compliance with the race 
model assumptions.
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Figure S1. RT data satisfy race model assumptions. A: RTs were slower in mean >0% trials compared with mean StopFailure 
trials in all levels both for young (left) and older adults (right). B: StopFail RT increased linearly with SSD, as predicted by the 
independent race model. C: Individual and group mean normalized inhibition functions per level, for young adults in blue and 
for older adults in red. The normalized inhibition function plots the proportion of successfully stopped responses as a function 
of the relative finishing times (RFT) of the stop and response processes, expressed as a Z-score (ZRFT). ZRFT was calculated as 
described in (Zandbelt, 2011), collapsed across stop-signal probability levels. Positive ZRFT values represent early stop-signal 
onset, negative ZRFT values indicate late stop-signal onset. A cumulative Weibull function was fit to the group mean 
standardized inhibition function.  
 
 
 
 
 
Figure S1. RT data satisfy race model assumptions. A: RTs were slower in mean >0% trials compared 
with mean StopFailure trials in all levels both for young (left) and older adults (right). B: StopFail RT 
increased linearly with SSD, as predicted by the independent race model. C: Individual and group 
mean normalized inhibition functions per level, for young adults in blue and for older adults in red. 
The norm lized inhibition function plots the proportion of successfully stopped re ponses as a fu c-
tion of th relative finishing times (RFT) of the stop and response processes, expr ssed as  Z-score 
(ZRFT). ZRFT was calculated as described in (Zandbelt, 2011), collapsed across stop-signal probabil-
ity levels. Positive ZRFT values represent early stop-signal onset, negative ZRFT values indicate late 
stop-signal onset. A cumulative Weibull function was fit to the group mean standardized inhibition 
function.
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Supplementary Imaging results 
 
Task effects on reactive response inhibition (StopSuccess > StopFailure)  
Table S2. Cluster-level significant regions active and deactive during reactive response inhibition (StopSuccess > StopFailure) 
across Levels and Age. (Figure 4A, main text) 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in cluster 
Left superior occipital gyrus -16  -97  16  <.001 1805 
    Left middle occipital gyrus    -16 -91 -6 
  Right superior temporal gyrus  60  -21   4  <.001 2028 
    Right superior temporal gyrus      48  -16   3  
  Right superior occipital gyrus  20  -97  16  <.001 1973 
    Right inferior occipital gyrus      27  -93  -3  
      Right middle occipital gyrus      33  -91   6  
  Right caudate  10   12  -9  <.001 2361 
    Right putamen      30   -4   4  
  Left putamen -28   -9   3  <.001 1143 
Left middle temporal gyrus -60  -27   4  <.001 1743 
    Left superior temporal gyrus     -57   -6  -5 
  Right postcentral gyrus  40  -27  52  <.001 5336 
    Right supplementary motor area      12  -21  64  
  Right precuneus  26  -45  16  <.001 1310 
Left superior frontal gyrus -20   65   4  <.001 10110 
    Left middle frontal gyrus, orbital part     -45   50  -0  
  Left putamen -14    8  -9  0.034 311 
Right superior frontal gyrus  18   30  36  <.001 1798 
Left angular gyrus -45  -63  42  <.001 1596 
    Left inferior parietal gyrus     -51  -55  46  
  Left angular gyrus  39  -57  25  0.004 495 
    Right middle temporal gyrus      48  -64  30  
  Left middle temporal gyrus  -57  -42 -14 0.015 378 
 
  
Supplementary Imaging results
Task effects on reactive response inhibition (StopSuccess > StopFailure)
Table S2. Cluster-level significant regions active and deactive during reactive response inhibition 
(Stop ucce s > StopFa lure) acr ss Le ls and Ag . (F gu  4A, main t xt)
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Task effects on proactive response inhibition (Parametric regressor of Go) 
 
Table S3. Cluster-level significant regions active during proactive response inhibition (Parametric regressor of Go) across Levels 
and Age. (Figure 4B, main text) 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
cluster 
Right superior occipital gyrus  26  -88  22  <.001 19563 
    Right middle temporal gyrus     45  -63   7  
  Right superior frontal gyrus  22    3  66  <.001 8507 
    Right anterior cingulate gyrus       9   33  28  
      Right superior frontal gyrus       6   35  40  
  Right insula  32   23  -8  <.001 4420 
     Right inferior frontal triangle      42   23   6  
       Right inferior frontal gyrus, orbital part      38   27 -11  
  Right thalamus  9  -24   1  <.001 6937 
Left insula -28   21  -6  <.001 2055 
Right supramarginal gyrus  54  -39  28  <.001 1671 
    Right superior temporal gyrus      60  -36  16  
  Right middle frontal gyrus, orbital part  27   53  -9  0.002 422 
Left precuneus -14  -51  64  <.001 669 
    Left superior parietal gyrus     -21  -48  70  
  Left middle occipital gyrus -44  -75   6  0.001 488 
    Left middle temporal gyrus    -44  -66   7  
  Left superior temporal gyrus -48  -39  12  0.009 319 
    Left middle temporal gyrus     -48  -33  19  
   
 
 
Task effects on proactive response inhibition (Parametric regressor of Go)
Table S3. Cluster-level significant regions active during proactive response inhibition (Parametric 
regr ssor of Go) across Levels a d Age. (Figure 4B, main text)
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Task effects on reactive response inhibition (StopSuccess > Go)  
 
During reactive response inhibition, defined by the StopSuccess > Go contrast, the task activated a 
network consisting of medial frontal, and temporal regions as well as bilateral caudate and putamen, 
see Figure S2, Table S4. A large network was deactivated by the task, covering frontal, parietal, occipital, 
and motor cortex, where responses are suppressed.  
Figure S2. Task effects for reactive response inhibition (StopSuccess > Go) plotted across levels and age groups at a whole brain 
corrected threshold at p<.001 uncorrected, cluster-level (pFWE<.05) significant clusters of task activation are listed in Table S5. 
Task activation plotted in hot colours, deactivation in cold colours.  
 
Table S4. Cluster-level significant regions active and deactive during reactive response inhibition (StopSuccess > Go) across 
Levels and Age. 
Region Peak MNI 
coordinates 
pFWE value No. voxels in cluster 
Right insula  40  21   3  <.001 13146 
     Right caudate      12  11   9  
  Left insula -30  23  -3  <.001 4216 
Right supramarginal gyrus  63 -42  28  <.001 9666 
    Right superior temporal gyrus      64 -43  19  
      Right middle temporal gyrus      58 -46   9  
  Right supplementary motor area   9  12  57  <.001 5632 
    Left supplementary motor area      -9   8  48  
  Left middle temporal gyrus -56 -48  15  <.001 2933 
    Left supramarginal gyrus      -62 -39  28  
  Right lingual gyrus  21 -75  -8  0.043 256 
    Right fusiform gyrus       27 -69  -3  
  Left middle frontal gyrus -36  44  27  0.002 490 
 
 
  
Task effects on reactive response inhibition (StopSuccess > Go) 
During reactive response inhibition, defined by the StopSuccess > Go contrast, the task 
activated a network consisting of medial frontal, and temporal regions as well as bilateral 
caudate and putamen, see Figure S2, Table S4. A large network was deactivated by the 
task, covering frontal, parietal, occipital, and motor cortex, where responses are sup-
press d.
Figure S2. Task effects for reactive response inhibition (StopSuccess > Go) plotted across levels and 
age groups at a whole brain corrected threshold at p<.001 uncorrected, cluster-level (pFWE<.05) 
significant clusters of task activation are listed in Table S5. Task activation plotted in hot colours, 
deactivation in cold colours.
Table S4. Cluster-level significant regions active and deactive during reactive response inhibition 
(StopSuccess > Go) across Levels and Age.
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Task effects per age groups and per level for reactive response inhibition (StopSuccess > 
StopFailure) 
 A – Level A
B – Level B
C – Level C
Figure S3. Task effects for reactive response (StopSuccess > StopFailure) inhibition per level (A: Level A, B: Level B, C: Level C). 
The network is displayed in blue for young adults and in red for older adults (overlap in pink). Images are thresholded at p<.001 
uncorrected. 
 
 
 
 
 
  
Task effects per age groups and per level for reactive response inhibition 
(StopSuccess > StopFailure)
Figure S3. Task effects for reactive response (StopSuccess > StopFailure) inhibition per level (A: Level 
A, B: Level B, C: Level C). The network is displayed in blue for young adults and in red for older adults 
(overlap in pink). Images are thresholded at p<.001 uncorrected.
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Task effects per age groups and per level for reactive response inhibition (StopSuccess > Go) 
A – Level 
 
B – Level B
 
C – Level C
 
Figure S4. Task effects for reactive response inhibition (StopSuccess > Go) per level (A: Level A, B: Level B, C: Level C). The 
network is displayed in blue for young adults and in red for older adults (overlap in pink). Images are thresholded at p<.001 
uncorrected. 
 
 
 
  
Task effects per age groups and per level for reactive response inhibition 
(StopSuccess > Go)
Figure S4. Task effects for reactive response inhibition (StopSuccess > Go) per level (A: Level A, 
B: Level B, C: Level C). The network is displayed in blue for young adults and in red for older adults 
(overlap in pink). Images are thresholded at p<.001 uncorrected.
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Task effects per age groups and level for proactive response inhibition (Parametric regressor 
of Go) 
A - Level A 
B - Level B 
C - Level C
Figure S5. Task effects for proactive inhibition (Parametric regressors of Go) per level (A: Level A, B: Level B, C: Level C). The 
network is displayed in blue for young adults and in red for older adults (overlap in pink). Images are thresholded at p<.001 
uncorrected.  
 
 
 
 
 
 
 
  
Task effects per age groups and level for proactive response inhibition 
(Parametric regressor of Go)
Figure S5. Task effects for proactive inhibition (Parametric regressors of Go) per level (A: Level A, 
B: Level B, C: Level C). The network is displayed in blue for young adults and in red for older adults 
(overlap in pink). Images are thresholded at p<.001 uncorrected.
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Age effects on reactive response inhibition (StopSuccess > StopFailure)
The age effect on reactive response inhibition was driven by opposite effects. Some 
regions showed over-recruitment of the stop network for older > young adults (Figure S6 
in yellow, Table S5 in bold). These regions showed (partial) overlap between the contrast 
StopSuccess > StopFailure in older adults (in red) and the Age effect on StopSuccess > 
StopFailure, older > young (green). Other regions showed under-activation during StopSuc-
cess > StopFailure for young > older adults (Figure S6 in light blue, Table S5). These regions 
showed overlap between the reverse contrast StopFailure > StopSuccess in young adults 
(blue) and the Age effect on StopSuccess > StopFailure, older > young (green).
Figure S6. Regions showing over-recruitment of the stop network for older > young adults are visual-
ized in yellow (represents the overlap between the contrast StopSuccess > StopFailure in older adults 
(in red) and the Age effect on StopSuccess > StopFailure, older > young adults (green)). Regions show-
ing under-activation during StopSuccess > StopFailure for young > older adults are shown in light blue 
(represent the overlap between the reverse contrast StopFailure > StopSuccess in young adults (blue) 
and the Age effect on StopSuccess > StopFailure, old > young (green)).
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Age effects on reactive response inhibition (StopSuccess > StopFailure) 
 
The age effect on reactive response inhibition was driven by opposite effects. Some regions showed 
over-recruitment of the stop network for older > young adults (Figure S6 in yellow, Table S5 in bold). 
These regions showed (partial) overlap between the contrast StopSuccess > StopFailure in older adults 
(in red) and the Age effect on StopSuccess > StopFailure, older > young (green). Other regions showed 
under-activation during StopSuccess > StopFailure for young > older adults (Figure S6 in light blue, Table 
S5). These regions showed overlap between the reverse contrast StopFailure > StopSuccess in young 
adults (blue) and the Age effect on StopSuccess > StopFailure, older > young (green). 
 
Figure S6. Regions showing over-recruitment of the stop network for older > young adults are visualized in yellow (represents 
the overlap between the contrast StopSuccess > StopFailure in older adults (in red) and the Age effect on StopSuccess > 
StopFailure, older > young adults (green)). Regions showing under-activation during StopSuccess > StopFailure for young > older 
adults are shown in light blue (represent the overlap between the reverse contrast StopFailure > StopSuccess in young adults 
(blue) and the Age effect on StopSuccess > StopFailure, old > young (green)). 
 
Table S5. Cluster-level significant regions for older > young adults during reactive response inhibition (StopSuccess > 
StopFailure) (Figure S6, Figure 5, main text) 
Older > Young adults, Reactive response inhibition (StopSuccess > StopFailure) 
Region Peak MNI coordinates pFWE value No. voxels in 
cluster 
Right middle cingulate gyrus 
    Right anterior cingulate gyrus     
    Right supplementary motor area 
9 23 33 
    14 39 12  
    12 17 48 
< .001 2502 
Right pre-cuneus 
    Left pre-cuneus 
    Right superior occipital gyrus 
12 -66 36 
  -4 -69 40 
  21 -60 34  
< .001 1127 
Right cerebellum  
    Left cerebellum   
38 -58 -27 
-21 -76 -27    
< .001 2322 
Left middle frontal gyrus orbital part -30 45 -8   .003 488 
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Young > Older adults Reactive response inhibition (StopSuccess > Failure) 
No supra-threshold clusters 
    
 
 
 
  
Older > Young adults, Reactive response inhibition 
(StopSuccess > StopFailure)
Table S  Cluster-level s g ificant regions for older > young dults during reactive respon e inhibition 
(Sto Succ ss > StopFailure) (Figure S6, Figure 5, main text)
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Age effects on reactive response inhibition (StopSuccess > Go)  
An Age effect was observed during reactive response inhibition (StopSuccess > Go). BOLD signal in the 
left caudate and left middle frontal gyrus was increased in young compared to older participants, (MNI 
coordinates [-4 -3 13], p=.017, k=318, and [-39 44 16], p=.035, k=269 respectively) (Figure S7). 
 
 
Figure S7. Whole brain images of age effects for reactive inhibition (StopSuccess > Go) across levels, thresholded at p<.001 
uncorrected. Left caudate and left middle frontal gyrus are cluster level significant (MNI coordinates [-4 -3 13], p=.017, k=318, 
and [-39 44 16], p=.035, k=269 respectively). 
 
Level x Age interactions on proactive response inhibition (Parametric regressor of Go) 
Table S6. All cluster-level significant regions of the Level x Age interactions of proactive response inhibition and subsequent 
independent t-tests between Level and Age groups. (Figure 7, main text) 
Level x Age interaction C>B, Young>Older adults Proactive response inhibition (Parametric 
regressor of Go ) 
Region Peak MNI 
coordinates 
pFWE value No. voxels in 
cluster 
Left frontal inferior gyrus, opercular part -34  15  31  <.001 3520 
   Left middle frontal gyrus, orbital part    -39  47  -3  
    Left inferior frontal triangle    -39  21  27  
 Right superior frontal gyrus  24  63  13  <.001 999 
   Right anterior cingulate gyrus     10  53  12  
 Vermis  -2 -40  -2  <.001 4139 
    Right calcarine gyrus     16 -76 9 
      Left calcarine gyrus    -12 -84   9  
 Left thalamus  -3 -10   7  0.025 266 
Left inferior frontal gyrus, orbital part -28  27  -8  0.002 434 
    Left insula     -30  15 -11  
 Right middle temporal gyrus  57 -63  13  0.002 422 
Older > Young adults Level B Proactive response inhibition (Parametric regressor of Go) 
Left cerebellum  -6 -45   1  <.001 9403 
    Left calcarine gyrus     -4 -67  21  
 Right insula  34 -15   4  0.05 210 
Left inferior frontal gyrus, opercular part -30  18  28  0.037 226 
    Left inferior frontal triangle    -44  20  28  
 
Age effects on reactive response inhibition (StopSuccess > Go) 
An Age effect was observed during reactive response inhibition (StopSuccess > Go). BOLD 
signal in the left caudate and left middle frontal gyrus was increased in young compared 
to older participants, (MNI coordinates [-4 -3 13], p=.017, k=318, and [-39 44 16], p=.035, 
k=269 respectively) (Figure S7).
Level x Age interactions on proactive response inhibition 
(Parametric regressor of Go)
Figure S7. Whole brain images of age effects for reactive inhibition (StopSuccess > Go) across levels, 
thresholded at p<.001 uncorrected. Left caudate and left middle frontal gyrus are cluster level signifi-
cant (MNI coordinates [-4 -3 13], p=.017, k=318, and [-39 44 16], p=.035, k=269 respectively).
Table S6. All cluster-level significant regions of the Level x Age interactions of proactive response 
inhibition and subsequent independen  t-test  betw e  Level and Age groups. (Figure 7, main text)
Level x Age interaction C>B, Young>Older adults Proactive response inhibition 
(Parametric regr ssor of Go)
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Left inferior frontal triangle -40  32  10  <.001 750 
    Left middle frontal gyrus    -38  47   1  
  Right anterior cingulate gyrus  12  51  10  <.001 986 
    Right superior medial frontal gyrus     10  54  18  
     Right anterior cingulate gyrus      6  48   6  
  Young > Older adults Level B Proactive response inhibition (Parametric regressor of Go) 
No supra-threshold clusters    
Young > Older  adults Level C Proactive response inhibition (Parametric regressor of Go) 
Right middle frontal gyrus  33  57  18  <.001 996 
    Right superior frontal gyrus     26  57  15  
 Left inferior frontal gyrus, orbital part -33  27  -9  0.008 303 
Right superior frontal gyrus  27   2  58  <.001 710 
    Right middle frontal gyrus     24   8  51  
  Right supplementary motor area   8  12  57  <.001 1636 
    Left supplementary motor area     -2  23  54  
  Left precentral gyrus -32   0  55  0.002 375 
    Left middle frontal gyrus    -26   2  61  
  Right caudate   4   3   9  0.002 400 
Right middle frontal gyrus  43  38  21  0.036 221 
    Right inferior frontal triangle     48  32  24  
     Right middle frontal gyrus     36  33  22  
 Older > Young adults Level C Proactive response inhibition (Parametric regressor of Go) 
No supra-threshold clusters       
Level C > B young adults only Proactive response inhibition (Parametric regressor of Go) 
Left precuneus  -3 -52  13  <.001 6825 
Right middle temporal gyrus  46 -58  22  <.001 906 
Left middle temporal gyrus -44 -63  18  <.001 2501 
    Left middle occipital gyrus    -33 -72  40  
 Left precentral gyrus -30  21  52  <.001 1470 
    Left middle frontal gyrus    -32  18  42  
     Left inferior frontal triangle -36  21  24  
 Level B > C older adults only Proactive response inhibition (Parametric regressor of Go) 
Left lingual gyrus  -26  -79 -12 <.001 3100 
    Left cerebellum     -20  -75 -15 
     Left fusiform gyrus     -38  -81 -12 
 Left insula -30   23  -3  <.001 918 
Right insula  27   41   7  0.032 178 
Older > Young adults Level A Proactive response inhibition (Parametric regressor of Go) 
Right precentral gyrus 33 -12 66 .011 294 
     Right postcentral gyrus      52 -25 54 
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Age effects on reactive response inhibition (StopSuccess > Go)  
An Age effect was observed during reactive response inhibition (StopSuccess > Go). BOLD signal in the 
left caudate and left middle frontal gyrus was increased in young compared to older participants, (MNI 
coordinates [-4 -3 13], p=.017, k=318, and [-39 44 16], p=.035, k=269 respectively) (Figure S7). 
 
 
Figure S7. Whole brain images of age effects for reactive inhibition (StopSuccess > Go) across levels, thresholded at p<.001 
uncorrected. Left caudate and left middle frontal gyrus are cluster level significant (MNI coordinates [-4 -3 13], p=.017, k=318, 
and [-39 44 16], p=.035, k=269 respectively). 
 
Level x Age interactions on proactive response inhibition (Parametric regressor of Go) 
Table S6. All cluster-level significant regions of the Level x Age interactions of proactive response inhibition and subsequent 
independent t-tests between Level and Age groups. (Figure 7, main text) 
Level x Age interaction C>B, Young>Older adults Proactive response inhibition (Parametric 
regressor of Go ) 
Region Peak MNI 
coordinates 
pFWE value No. voxels in 
cluster 
Left frontal inferior gyrus, opercular part -34  15  31  <.001 3520 
   Left middle frontal gyrus, orbital part    -39  47  -3  
    Left inferior frontal triangle    -39  21  27  
 Right superior frontal gyrus  24  63  13  <.001 999 
   Right anterior cingulate gyrus     10  53  12  
 Vermis  -2 -40  -2  <.001 4139 
    Right calcarine gyrus     16 -76 9 
      Left calcarine gyrus    -12 -84   9  
 Left thalamus  -3 -10   7  0.025 266 
Left inferior frontal gyrus, orbital part -28  27  -8  0.002 434 
    Left insula     -30  15 -11  
 Right middle temporal gyrus  57 -63  13  0.002 422 
Older > Young adults Level B Proactive response inhibition (Parametric regressor of Go) 
Left cerebellum  -6 -45   1  <.001 9403 
    Left calcarine gyrus     -4 -67  21  
 Right insula  34 -15   4  0.05 210 
Left inferior frontal gyrus, opercular part -30  18  28  0.037 226 
    Left inferior frontal triangle    -44  20  28  
 
Contrasting neural effects of aging on proactive and reactive response inhibition

6.
Neurocognitive effects of 
acute tyrosine administration 
on reactive and proactive 
response inhibition in 
healthy older adults
This chapter is submitted as: 
Mirjam Bloemendaal, Monja I. Froböse, Bram B. Zandbelt, Ondine van de Rest, Roshan 
Cools, Esther Aarts. Neurocognitive effects of acute tyrosine administration on reactive 
and proactive response inhibition in healthy older adults.
Mirjam Bloemendaal, Monja I. Froböse, Bram B. Zandbelt, Ondine van de Rest, Roshan 
Cools, Esther Aarts
116
Abstract
The aging brain is characterized by decreased dopamine signaling. The amino acid tyros-
ine, a precursor of dopamine, is known to improve cognitive performance in young adults, 
especially during high environmental demands. Tyrosine administration might also in-
crease dopamine transmission in the aging brain, thereby improving cognitive functioning. 
In healthy older adults, we previously demonstrated impairments in two forms of response 
inhibition: reactive inhibition (outright stopping) and proactive inhibition (anticipatory 
response slowing) under high information load. Based on evidence implicating dopamine 
primarily in proactive response inhibition, we expected that tyrosine would modulate 
proactive inhibition signal in dopaminergically innervated fronto-striatal regions. We 
aimed to address this hypothesis in 24 healthy older adults (aged 61-72 years) using fMRI 
in a double blind, counterbalanced, placebo-controlled, within-subject design. Across the 
group, tyrosine did not alter reactive or proactive inhibition behaviourally, but did increase 
fronto-parietal proactive inhibition-related activation. When taking age into account, ty-
rosine affected proactive inhibition both behaviourally and neurally. Specifically, increasing 
age was associated with a greater detrimental effect of tyrosine compared with placebo 
on proactive slowing. Moreover, with increasing age, tyrosine decreased fronto-striatal 
and parietal proactive signal, which correlated with tyrosine’s effects on proactive slowing. 
Tyrosine also increased reactive occipital signal with advancing age, but these effects were 
not related to behaviour. To conclude, with increasing age, we show detrimental effects in 
both brain and behaviour of tyrosine administration. Tyrosine affected proactive response 
slowing and associated fronto-striatal activation in an age-dependent manner, highlighting 
the importance of dopamine for proactive response inhibition in older adults.
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Introduction
The aging brain is characterized by alterations in dopamine functioning (for an overview 
see Kaasinen and Rinne, 2002). Age-related reductions in frontal and striatal dopamine 
receptor and transporter binding have been linked to impairments in various cognitive 
functions such as attention, episodic and working memory (Backman et al, 2006). In aged 
experimental animals, administration of a D1 receptor agonist improved performance on 
working memory tasks (e.g. Cai and Arnsten, 1997). Similarly, enhancing dopamine levels 
in humans with the drug L-Dopa (the direct precursor of dopamine) improved age-related 
impairments in episodic memory performance and reinforcement learning (Chowdhury et 
al, 2012, 2013). 
Tyrosine is a large non-essential neutral amino acid (LNAA), naturally present in food such 
as beans, avocado and fish. Tyrosine is the precursor of dopamine, via L-Dopa and the 
enzymes tyrosine hydroxylase (TH) and aromatic l-amino acid decarboxylase (AADC) 
respectively (Molinoff and Axelrod, 1971). Research in rodents showed that tyrosine reach-
es the brain (Glaeser et al, 1983). Tyrosine administration increases dopamine metabolites 
in cerebrospinal fluid (CSF), like homovanillic acid (HVA), in rats (Scally et al, 1977) and in 
patients with Parkinson’s disease (Growdon et al, 1982). In young adults, tyrosine admin-
istration improved cognitive control functions such as response inhibition, task switch-
ing, and working memory, especially in demanding task or environmental situations (for 
reviews see  (Deijen, 2005; Jongkees et al, 2015b)). Tyrosine administration might thus 
counteract reductions in dopamine signaling in the aging brain, thereby improving 
dopamine-dependent cognitive functioning. 
In previous work, we and others have shown age-related impairments in two forms of 
response inhibition: reactive inhibition (outright stopping measured with stop-signal 
reaction time (SSRT)) and proactive inhibition (anticipatory response slowing based on 
cues held in working memory), particularly under high information load (Bloemendaal 
et al, 2016; Kleerekooper et al, 2016). So far, no study has directly compared the effects 
of dopamine on reactive and load-dependent proactive response inhibition. Evidence 
for dopamine’s contribution to reactive inhibition (SSRT) is inconclusive (Bari et al, 2011; 
Congdon et al, 2009; Ghahremani et al, 2012)(for review see (Eagle and Baunez, 2010). 
Conversely, evidence from work with experimental animals indicates that dopamine is 
implicated in a variety of processes that contribute to proactive response inhibition (Bari 
et al, 2009; Bari and Robbins, 2013),. Further indirect evidence for a role of dopamine in 
proactive inhibition comes from neuroimaging studies. Midbrain signal was associated 
with stop-signal probability and RT adjustments (Boehler et al, 2011; Zandbelt et al, 2013). 
Moreover, proactive, not reactive, response inhibition was positively associated with 
working memory span and reduced in schizophrenia patients, which was associated with 
reduced fronto-striatal signal (Zandbelt et al, 2011). Both working memory and schizophre-
nia are strongly associated with dopamine functioning in fronto-striatal regions (Braver et 
al, 1999; Cools and D’Esposito, 2011). 
We aimed to investigate the role of dopamine in different types of response inhibition. 
Moreover, we explored the potentially beneficial effects of tyrosine in aging by assessing 
the neurocognitive mechanisms of acute administration of a high dose of tyrosine in older 
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adults during reactive and (working memory) load-dependent proactive response inhibi-
tion. In this neuro-imaging study using tyrosine administration, we predicted that tyros-
ine administration would improve (load-dependent) proactive response inhibition and 
associated signal in dopamine-innervated fronto-striatal regions. We also considered the 
possibility that tyrosine’s effects would vary as a function of age, given differences in the 
effect of dopaminergic agents between young and older adults (Turner et al, 2003). 
Within a smaller age range, the effects of dopaminergic agents might vary as a function 
of age, while being less affected by large cross-sectional differences such as education. 
The oldest relative to the youngest older adults are presumably most dopamine deprived 
and, thus, may benefit most from tyrosine. However, in contrast to dopamine receptor 
and transporter binding, age-related up-regulating of (dorsal) striatal dopamine synthesis 
capacity has been observed, as well as an association between higher synthesis and lower 
cognitive functioning (in young adults) (Braskie et al, 2008). Therefore, administration of a 
high dose of a dopamine precursor with already up-regulated dopamine synthesis capacity 
in the oldest adults could also lead to detrimental neurocognitive effects.
Methods
Participants
Twenty-four healthy older adults were included in the analyses (mean age: 67.5, range 
61-72, 15 men). For inclusion criteria and information on exclusions, see Supplementary 
Methods. The experiment was approved by the local ethics committee (CMO 2014-1172), 
and all participants gave written informed consent. Subjects were recruited via adverts in 
local newspapers, websites, and associations for older adults. The study was preregistered 
at the Dutch trial register (www.trialregister.nl) under number NTR4938.
Intervention
Our subjects received a dosage of 150 mg/kg tyrosine or placebo, adjusted to body weight. 
The placebo product was a mixture of 54 mg/kg dextrine-maltose (i.e. carbohydrates; 
product name Fantomalt by Nutricia) with maizena (110 mg/kg). The tyrosine and placebo 
product were mixed with a carrier: banana-flavored yoghurt (Arla® Food Nederland). 
For more information, see Supplementary Methods. 
Physiological and mood measurements
To monitor well-being, subjects filled in mood ratings, assessing calmness, contentness, 
and alertness (Bond and Lader, 1974).  Moreover, we assessed levels of the catechola-
mine metabolites (HVA, vanillylmandelic acid (VMA), 3-methoxy-4-hydroxyphenylglycol 
(MOPEG) and 3,4-dihydroxyphenylacetic acid (DOPAC) in urine to measure peripheral 
effects. 
Procedure
Subjects were pre-screened in a separate session and trained on the tasks, 
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see Supplementary Methods, also for trait demographics. 
Testing started from 08:00 or 10:00 at the latest and took about 4.5 hours (Figure 1 and 
Supplementary Methods). On both test sessions, the same procedure was followed except 
for the supplement taken: tyrosine or placebo, counterbalanced across subjects. Scanning 
was timed to start when approaching maximal concentration of plasma elevation. Cogni-
tive effects are seen approximately after 1.5 hours and are normalized after 6-8 hours (e.g. 
Glaeser, Melamed, Growdon, & Wurtman, 1979).
Experimental Design: Load-Dependent Stop-Signal Anticipation Task 
Participants performed a stop-signal anticipation task consisting of three levels differing 
in information load, which were presented in alternating blocks (Bloemendaal et al, 2016) 
(Figure 2 and  Supplementary Methods).
Figure 1. Schematic of the two test sessions: placebo and tyrosine. 
Figure 2. Load-Dependent Stop-Signal Anticipation Task. In all levels, the Go task required timing 
of a fast moving bar on the middle line. Infrequently, the Go task had to be inhibited when the bar 
stopped moving (i.e. the stop signal). The colours of the middle horizontal plus vertical lines repre-
sented the stop probability (see percentages below the bars). Information load of these coloured 
stop-probability cues increased with level, in alternating blocks. For level B and C, stop-signal proba-
bility increased as a function of cue colour (i.e. two different colours in level A and 5 different colours 
in level B). In level C, an additional processing step was added, in which the colour of the middle 
line indicated which vertical coloured line was valid (blue=left, purple=right). Every level contained 
70 trials with 0% (green) and 270 trials with >0% (white) stop-signal probability. Of these 270 >0% 
trials, 70 were Stop trials, with a mean stop-signal probability of 26%. For Level B and C, each >0% 
trial type contained 50 Go trials, plus a varying amount of Stop trials per colour resulting in varying 
stop-signal probabilities (in between brackets): 10 yellow(17%), 14 amber(22%), 19 orange(28%) and 
27 red(35%).
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Behavioural data analysis 
Stop-signal task 
All data were in accordance with the main assumptions of the race model (Logan and 
Cowan, 1984), see Supplementary Results. Reactive response inhibition was measured by 
calculating the stop-signal reaction time (stopping latency), according to the integration 
method (Verbruggen and Logan, 2009c). Outliers on all outcome measure except proactive 
response slowing were determined using Grubbs’ test (i.e. they do not differ more than 
2.8*SD from the mean) (Grubbs, 1969). An ANOVA of SSRTs was used with the within-
subjects factors Level (A, B, C) and Intervention (tyrosine, placebo). 
RT slowing as a function of increasing stop-signal probability, indicated by the coloured 
cues, indexed proactive response inhibition. Task non-compliance was determined by a 
negative difference on median RTs between 0% (green) and >0% (white) trials during the 
lowest cognitive load (Level A). No subjects were excluded based on this criterion. 
For each level, the slope of RTs was calculated as a function of stop-signal probability using 
a general linear model, resulting in a beta value for the slowing slope. Hence, for level A, 
the slowing slope was calculated using the two proactive trial types (0% (green cues) and 
26% (white)). For level B and C, the five proactive trial types were included in the slowing 
slope (0% (green cues), 17% (yellow), 22% (orange), 28% (amber) and 35% (red)). 
Task instructions implied differential processing of 0% and >0% stop-signal probability 
trials, resulting in more slowing on >0% than 0% trials (i.e. a positive difference between 
these trial types). Level A consists of fewer cells than Levels B and C and was therefore 
not compared with the other levels. An ANOVA was performed using the within-subjects 
factors Level (Level B, C) and Intervention (tyrosine, placebo). Upon lack of an interaction 
effect between Level and Intervention, the effect of Intervention on slowing slope was 
assessed and reported on the average slowing slope irrespective of Level. For effects of 
Level independent of tyrosine manipulation, see (Bloemendaal et al, 2016). 
To assess the relation between age and tyrosine’s effects on reactive and proactive 
response inhibition, we added the covariate Age in an ANOVA using factors Intervention 
(tyrosine, placebo) and Level (A,B,C) for proactive RT slowing and SSRT. Upon significant 
effects or interactions with Intervention, we tested for a possible interaction between 
administration order and intervention.
Analysis on catecholamine metabolites, physiological and neuropsychological measures 
are reported in Supplementary Materials.  
MRI data acquisition and pre-processing
Whole-brain imaging was conducted on a Siemens TIM Trio 3T scanner, using a 32-chan-
nel head coil. Whole brain T2*-weighted BOLD fMRI data were acquired using multi-echo 
echo-planar imaging. Preprocessing and analyses were performed in SPM8. Preprocessing 
steps included realignment, echo combination, slice timing correction, coregistration, spa-
tial normalization to a sample-specific template, and spatial smoothing. Further scanning 
and preprocessing details are reported in Supplementary Methods. 
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fMRI task analysis
The general linear model was set up as in (Bloemendaal et al, 2016), including four regres-
sors per level: a Go regressor, a corresponding parametric regressor representing stop-
signal probabilities (i.e. proactive), a StopSuccess and a StopFailure regressor, resulting in 
twelve regressors of interest. Further details can be found in Supplementary Methods. 
At the subject-specific, first level we specified reactive and proactive contrasts within, 
across and between levels. The first level contrast images were subsequently used in a 
second level random effects analysis to assess consistent effects across subjects as well 
as the effects of intervention. Reactive response inhibition can be assessed using two 
different contrasts: StopSuccess > StopFailure or StopSuccess > Go. The contrast StopSuc-
cess > StopFailure provides better control for stimulus-driven processing (i.e. presentation 
of the stop signal), and is orthogonal by design to the proactive inhibition contrast (which 
also involves the Go trials). The contrast StopSuccess > Go provides better control for the 
timing of the Go responses (i.e. Go and StopSuccess RTs are both slower than Stop Failure) 
and the outcome of the trial (i.e. both successful in Go and StopSuccess). We report effects 
on both types of contrasts. The parametric proactive regressors constituted the contrast 
for proactive response inhibition.
We assessed the main task effects of proactive and reactive response inhibition using the 
contrasts across levels and intervention. We explored Level * Intervention interactions 
within reactive and proactive response inhibition. Upon non-significant interactions, we 
assessed the effects of intervention across levels, comparing tyrosine and placebo ses-
sions using a paired t-test. Upon whole-brain corrected significant results, we assessed 
brain-behaviour correlations in these clusters by extracting beta weights using Marsbar 
(Tzourio-Mazoyer et al, 2002).
Statistical inference (pFWE <.05) was performed at the cluster level, correcting for multiple 
comparisons over the whole brain. The intensity threshold necessary to determine the 
cluster-level threshold was set at p<.001, uncorrected. Upon significant cluster-level activa-
tion, we assessed simple effects using subsequent ANOVA’s or paired t-tests.
Results
Behavioural results 
Trait demographics and trait neuropsychological test scores are presented in Table S1.  
Reactive response inhibition
Upon non-significant tyrosine effects on SSRT between levels (F(2,46)=1.19, p=.31), we 
performed our analyses across levels. Tyrosine administration did not affect SSRT across 
levels (F(1, 23)<1) and when assessing whether the effect of tyrosine administration 
depended on age, no effect was observed either (F(1,22)<1) (Figure 3). Across inter-
vention sessions, increasing age was associated with a slower SSRT (main effect of Age: 
F(1,22)=4.3, p=.05, η2p = .16).
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Proactive response inhibition
Upon non-significant tyrosine effects on RT slowing between levels (F(2,46)<1), we per-
formed our analyses across levels. Across levels and subjects, tyrosine administration did 
not affect slowing beta values (reflecting increasing slowing with increasing stop chance) 
(F(1, 23)<1) . However, when adding age as a covariate, intervention did modulate pro-
active RT slowing (Intervention * covariate Age interaction: F(1, 22)=5.7,p=.03, η2p = .21; 
main Intervention:  F(1, 22)= 5.6, p=.03, η2p = .20), (Figure 3B). Specifically, increasing 
age was related to a greater detrimental effect of tyrosine administration on RT slowing. 
Administration order did not interact with tyrosine administration on proactive slowing 
(F(1,21)=2.4, p=.14). 
 
In sum, the effect of tyrosine administration on behavioural measures of reactive response 
inhibition (i.e. SSRT) was not significant. However, age negatively modulated the effect of 
tyrosine on proactive response slowing: increasing age was associated with a greater detri-
mental effect of tyrosine on proactive slowing compared with placebo. 
Figure 3. A: SSRT on placebo and tyrosine session across levels. B: proactive beta slowing slopes 
on placebo and tyrosine session. Data represents mean, error bars represent standard error of the 
mean. C: the effect of tyrosine compared with placebo on SSRT was not modulated by age (r=-.1, 
p=.96). D: With increasing age, tyrosine relative to placebo attenuated proactive RT slowing (r=-.45, 
p=.03), i.e. the degree to which subjects slowed their responses with increasing stop-signal probabil-
ity.
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fMRI results 
Reactive and proactive inhibition activate frontoparietal networks and basal ganglia 
At our whole-brain corrected threshold of pFWE<.05 (cluster-level), main task effects 
revealed responses in a frontoparietal and striatal task network for reactive and proactive 
response inhibition (Supplementary Figures 1,2,3, Tables S2, S3, S5), and deactivation of 
e.g. motor cortex in the reactive response inhibition network, as shown previously for the 
current task in young and older adults (Bloemendaal et al, 2016) and for similar paradigms  
(Kleerekooper et al, 2016; Zandbelt and Vink, 2010).
Tyrosine’s effects on reactive response inhibition (StopSuccess > StopFailure and 
StopSuccess > Go)
In accordance with the behavioural results, no Level * Intervention interactions were 
observed during reactive response inhibition. Hence, effects of intervention are reported 
across Level. Tyrosine did not affect neural signal during both contrasts of reactive inhibi-
tion (StopSuccess > StopFailure and StopSuccess > Go). A positive correlation between age 
and the effect of tyrosine on reactive response inhibition (StopSuccess > StopFailure) was 
observed in left rolandic operculum, left calcarine gyrus and bilateral lingual gyrus 
(Figure 4, Table S4). With increasing age, tyrosine increased occipital responses compared 
with placebo. None of these clusters demonstrated a brain-behaviour correlation between 
tyrosine’s effect on reactive inhibition beta values and SSRT. The reactive response inhibi-
tion contrast StopSuccess > Go did not yield a correlation with age.
Tyrosine’s effects on proactive response inhibition (Parametric regressor of Go)
Right middle cingulum, precentral and supramarginal gyrus signal increased after tyrosine 
administration compared with placebo (Figure 5A, Table S6). We did not observe brain-
behaviour correlations between the effect of tyrosine on beta values in these regions and 
the effect of tyrosine on proactive slowing. Concurrent with the behavioural results, age 
modulated the effect of tyrosine on neural signal during proactive response inhibition 
(parametric regressors) (Figure 5B, Table S7). With increasing age, tyrosine decreased sig-
nal in bilateral putamen, left middle and superior frontal gyrus, left inferior parietal gyrus, 
Figure 4. Positive correlation between age and effect of tyrosine on reactive response inhibition 
(StopSucces > StopFailure). Images are thresholded at cluster-level significant extent threshold 
(pFWE<.05; cluster-defining threshold: p<.001, uncorrected). AAL labels, p-values, peak MNI coor-
dinates and number of voxels are listed in Table S4. The position of the slices is labeled with the Z 
coordinates of the MNI atlas. 
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right supramarginal gyrus and left precuneus relative to placebo (depicted for illustration 
purposes in Figure 5C). Several of these regions (i.e. those with age-dependent tyrosine-
induced decreases in proactive signal) correlated positively with tyrosine’s effect on behav-
ioural RT slowing (Figure 5D). Tyrosine-related decreases in fMRI signals were associated 
with tyrosine-related decreases in RT slowing in left inferior parietal cortex (r=.43 p=.035), 
left middle frontal gyrus (r=.42 p=.042), and bilateral putamen (right: r=.52 p=.009; left: 
r=.41 p=.044).
Figure 5. A: Effect of tyrosine versus placebo during proactive response inhibition (parametric Proac-
tive regressor). Images are thresholded at cluster level significant extent threshold (pFWE<.05). AAL 
labels, p-values, peak MNI coordinates and number of voxels are listed in Table S6. B: Negative whole 
brain correlation between age and effect of tyrosine on proactive response inhibition (parametric 
Proactive regressor). Images are thresholded at cluster level significant extent threshold (pFWE<.05); 
cluster-defining threshold: p<.001, uncorrected). AAL labels, p-values, peak MNI coordinates and 
number of voxels are listed in Table S7. C: For illustration purposes, the negative correlation between 
proactive beta’s and age is plotted for the regions showing a brain-behaviour correlation (see below). 
D: Regions with enhanced proactive signal after tyrosine with increasing age, correlated positively 
with tyrosine’s effect on behavioural RT slowing. The position of the slices is labeled with the Z coordi-
nates of the MNI atlas.
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Additional measures (neuropsychological tests and physiological measures) are reported in 
Supplementary Materials.
In sum, tyrosine increased right middle cingulum, precentral and supramarginal signal 
during proactive response inhibition. With increasing age, tyrosine decreased fronto-
striatal and occipital proactive signal. Of these regions showing detrimental effects of 
tyrosine administration with increasing age, left inferior parietal cortex, left middle frontal 
gyrus and bilateral putamen demonstrated a relation with tyrosine’s effect on behaviour 
(i.e. proactive slowing). Moreover, with increasing age, tyrosine increased reactive occipital 
signal. However, tyrosine effects in these reactive inhibition regions did not show a relation 
with behaviour.
Discussion
The current study investigated the neurocognitive effects of acute tyrosine administration, 
a dopamine precursor, on reactive and proactive response inhibition in a healthy older 
sample (aged 61-72 years; mean age: 67.5). Behaviourally, across the group, no effects of 
tyrosine administration on measures of reactive (i.e. SSRT) and proactive response inhibi-
tion (i.e. response slowing) were observed, although – neurally – proactive neural signal 
in right middle cingulum, precentral and supramarginal gyrus was increased by tyrosine. 
When taking age into account, age was found to negatively modulate the effect of tyros-
ine on proactive behavioural response slowing independent of cognitive load (i.e. Level): 
increasing age was associated with a greater detrimental effect of tyrosine on proactive 
slowing compared with placebo. Functional imaging results were concomitant with the 
behavioural results: with increasing age, tyrosine decreased fronto-striatal and parietal 
proactive signal, but increased reactive occipital signal. Brain-behaviour correlations un-
derline the behavioural relevance of modulated signal in these areas involved in proactive 
inhibition: tyrosine’s effects on left inferior parietal cortex, left middle frontal gyrus and 
bilateral putamen signal correlated positively with tyrosine’s effect on proactive slowing. 
Such brain-behaviour correlations were not observed for reactive inhibition. 
The age-dependent detrimental effects of tyrosine on proactive slowing are surprising 
given that prior work has shown almost exclusively beneficial effects of tyrosine adminis-
tration on cognition (for a review see, Jongkees et al., 2015). Critically, these prior studies 
have all assessed young, not older adults. A study in adult schizophrenia patients (mean 
age 37.8 years, SD 6.8) displayed increased errors in a smooth pursuit saccades task in 
eight patients during three weeks supplementation of 10 g tyrosine daily (Deutsch et al, 
1994). Similarly, we have observed detrimental overdose effects of tyrosine administration 
on cognition in a recent study (chapter 4). In this study, working memory (i.e. n-back) per-
formance decreased with increasing tyrosine dose (from 100 to 150 to 200 mg/kg) in older 
adults (aged 60-75 years, mean age: 69.6) (van de Rest et al., submitted). This cognitive 
overdose effect of tyrosine, which has so far been observed only in older adults, may be 
at least partly caused by a larger effective dose in older adults due to increased peripheral 
supply of tyrosine. Earlier research found increased plasma tyrosine levels in fasting older 
versus young women (Caballero et al, 1991) and increased plasma response in older versus 
young adults receiving the same dose (van de Rest et al., submitted). Critically, in this latter 
study, we observed that dose-dependent increases in plasma response correlated with 
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dose-dependent decrements in working memory after tyrosine ingestion. Such enhanced 
bioavailability may result from an age-related reduced first pass effect in the liver (Klotz, 
2009), such that higher amounts of tyrosine enter the blood stream in older adults. 
Furthermore, age-related insulin resistance (Caballero et al, 1991) may contribute to 
reduced peripheral amino acid uptake from the blood, resulting in higher amounts that 
reach the blood-brain barrier. Mechanistically, the conversion of tyrosine to L-dopa by the 
rate-limiting enzyme tyrosine hydroxylase (TH) is inhibited by its final end products, i.e. 
the catecholamines dopamine and noradrenaline, present in the cytoplasm (Daubner et 
al, 2012). Indeed, a very high dose of phenylalanine, the conditional precursor of tyrosine, 
reduced dopamine release in the rat striatum, whereas lower doses increased dopamine 
release (During et al, 1988). The authors speculated that TH inhibition resulted in net 
reduced dopamine synthesis due to sudden high amounts of cytoplasmic catecholamines. 
Reduction of dopamine synthesis by inhibiting TH may also occur further in the dopamine 
signaling cascade, when an excess of dopamine increases dopamine D2 autoreceptor 
binding (Lindgren et al, 2001). The aging brain might be more sensitive to overshoots in 
auto-regulation, for example due to increased  inflammatory markers, such as cytokines, 
which increase with age (Michaud et al, 2013) and can alter TH availability and auto-
regulatory dopamine transporter expression (Felger and Miller, 2012). Detrimental effects 
of tyrosine may be less surprising when considering literature on increased dopamine 
synthesis in older adults, and negative relationship with performance on cognitive tasks 
(although the latter was observed in young adults) (Braskie et al, 2008). Administrating 
extra precursor to a system with already high dopamine synthesis capacity may result in its 
inhibition. The peripheral and central mechanisms underlying age-related changes in tyros-
ine effects on cognition should be investigated in future studies with larger age ranges and 
sample sizes. Moreover, the current results should be replicated using longitudinal designs, 
as cross-sectional designs cannot easily control for between-subject differences other than 
age, which could have contributed to the current results; even in this small age range. 
Previous studies that have used 150 mg/kg, similar to the current study, have observed 
positive effects of tyrosine administration on cognition in young adults (see Jongkees et 
al, 2015a). However, it must be noted that these studies subjected participants to a stress 
intervention such as acoustic noise or a cold bath. One study did not use an external stress 
intervention other than the task at hand (Thomas et al, 1999) and only found positive ef-
fects of 150 mg/kg tyrosine administration on demanding multitasking. Stress or demand-
ing circumstances increase neuronal firing and thereby catecholamine  metabolism (Bliss 
et al, 1968), making these neurons more sensitive to precursor availability such as tyrosine 
(Scally et al, 1977). For this reason, a relatively high dose may be optimal in a high neu-
ronal firing situation, but suboptimal during basal neuronal firing, even in young adults. 
In accordance with our predictions, effects of tyrosine administration were most promi-
nent on behavioural and neural measures of proactive response inhibition. Behaviourally, 
with increasing age, tyrosine modulated only proactive response slowing, not SSRT. Neu-
rally, tyrosine modulated signal in fronto-striatal and parietal regions during proactive inhi-
bition, which was associated with its behavioural effects. Previous studies found evidence 
for dopaminergic modulation of proactive-like processes in response inhibition (Bari et al, 
2009; Bari and Robbins, 2013) (such as post-error slowing and go accuracy), without 
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formally disentangling proactive and reactive response inhibition as in the current para-
digm. 
With noradrenaline being produced from dopamine, tyrosine administration could poten-
tially also have contributed to increased noradrenaline synthesis. We cannot fully exclude 
this possibility but given the presently observed tyrosine modulation of signal in the 
putamen, which is highly innervated by dopamine rather than noradrenaline (Nicola and 
Malenka, 1998), we hypothesize that the currently observed tyrosine effects are driven by 
dopaminergic neurons. Our hypothesis is strengthened by. literature stating shortage of 
especially dopamine in the aging brain (Finch, 1973; Ota et al, 2006), rather than noradren-
aline (Goldman-Rakic and Brown, 1981; Moretti et al, 1987). 
During reactive response inhibition, tyrosine modulated occipital signal with increasing 
age. These regions are not innervated by dopamine. Moreover, no behavioural effect of 
tyrosine on SSRT was observed, neither a correlation between tyrosine’s effect on these 
reactive regions and SSRT. Therefore, the observed occipital decrease in activation after 
tyrosine with increasing age might well reflect either an indirect result of tyrosine’s fron-
to-striatal effects on proactive inhibition or a noradrenergic effect in combination with a 
floor effect in SSRTs. 
In conclusion, we show (age-related) effects of tyrosine administration especially on pro-
active, not reactive, response inhibition, accompanied by signal changes in dopamine-rich 
fronto-striatal brain regions. Specifically, we observed that tyrosine’s effects on brain and 
cognition became detrimental with increasing age, questioning the cognitive enhancing 
potential of tyrosine in healthy aging. 
Our results provide support for the hypothesis that proactive but not reactive response 
inhibition is modulated by dopamine.
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Supplementary methods 
Participants
Participants met the following criteria: aged between 60 and 75, right handed, functioning 
within normal limits of general cognitive function (Mini-Mental State Examination (MMSE) 
(Folstein et al., 1975); cut-off ≥ 27 of 30), no depression or anxiety (Hospital Anxiety and 
Depression Scale (HADS) score <11 ) (Bjelland et al, 2002), an estimated verbal IQ >85 
(Schmand et al., 1991), not suffering from neurological or psychiatric disorders, no first 
degree relatives suffering from schizophrenia, bipolar disorder, or major depressive disor-
der, no history of alcohol or drug abuse, no habitual smoking defined as less than a pack 
of cigarettes a week for the last year, current or past (within last 12 months) participation 
in a specific cognitive training program, no contraindications for MRI, no daily use of beta 
blockers, no use of medication interfering with tyrosine’s action (monoamine oxidase 
inhibitors and other antidepressants, sympathomimetic amines, and opioids), no thyroid 
problems and no low-protein diet, no endocrine or metabolic disorders such as hepatic or 
renal problems, no repetitive strain injury (RSI) or sensorimotor handicaps, blindness or 
colourblindness. 
Thirty-three subjects were included after a pre-screen session. Twenty-nine participants 
completed two test sessions, three subjects were excluded during test day 1 (due to panic 
upon entering the scanner, high blood pressure and vomiting) and 1 after test day 1 (due 
to headache after the test day). Of the 29 participants who completed both test days, 2 
subjects did not finish the stop-task on one of the sessions. Three other subjects were ex-
cluded before statistical data analysis, two due to excessive movement (>4 mm translation) 
and one due to signal intensity spikes.
Intervention
The European Food Safety Authority determined in July 2011 that tyrosine is proven to 
contribute to the normal synthesis of catecholamines (EFSA Panel on Dietetic Products 
Nutrition and Allergies, 2011). In accordance with most previous studies in young vol-
unteers (Magill et al, 2003; Mahoney et al, 2007; Neri et al, 1995; Shurtleff et al, 1994; 
Thomas et al, 1999) but see (Colzato et al, 2013, 2014a, 2014b; Steenbergen et al, 2015), 
our subjects received a dosage of 150 mg/kg tyrosine or placebo, adjusted to body weight. 
For reference, a daily required intake of phenylalanine and tyrosine for adults was estimat-
ed at 14 mg/kg per day (World Health Organization, 1985) or 39 mg/kg/d in a more recent 
study (Basile-Filho et al, 1998). 
The placebo product was a mixture of 54 mg/kg dextrine-maltose (i.e. carbohydrates; 
product name Fantomalt by Nutricia) with maizena (110 mg/kg, ratio Fantomalt/corn-
starch = ~1/2). The ratio of Fantomalt: cornstarch was adjusted such that the placebo and 
tyrosine mixture have an equal energy value, similar structure and aftertaste. Equal taste 
experience for tyrosine and placebo was ensured in a formal sensory experiment by a spe-
cialized dietician from the Division of Human Nutrition of Wageningen University (unpub-
lished pilot data). 
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The tyrosine and placebo product were mixed with a carrier: banana-flavored yoghurt 
(Arla® Food Nederland). 
Procedure
During a 4 hour pre-screen session, subjects signed informed consent, were screened on 
all the in- and exclusion criteria, and completed several neuropsychological measures: 
verbal IQ as measured with the Dutch version of the NART (NLV) (Schmand et al, 1991), 
Hospital Anxiety and Depression Scale (HADS, (Bjelland et al., 2002), and the Barratt Impul-
siveness Scale (BIS-11; Patton et al., 1995) (see Table 1). Moreover, subjects were trained 
on the three tasks they were going to perform during the test sessions, visited the MRI 
scanner and were weighted. The day before the test session from 10pm onwards, subjects 
were asked to refrain from eating and drinking anything but water until arriving at the cen-
tre the next morning, and to refrain from taking any medication that they would not take 
during both testing sessions, to avoid an unbalanced influence of this medication. 
The overnight fast prevents large variability in plasma LNAA levels between subjects 
caused by the previous meal (Fernstrom et al., 1979). A similar fasting procedure has been 
adopted in other research using tyrosine supplementation (Banderet & Lieberman, 1989; 
Colzato, Jongkees, Sellaro, & Hommel, 2013; Lieberman & Wurtman, 1985; Mahoney, Cas-
tellani, Kramer, Young, & Lieberman, 2007; Shurtleff, Thomas, Schrot, Kowalski, & Harford, 
1994). 
The test day started with assessing subjective feelings of wellbeing measured with Bond 
and Lader visual- analogue ratings. Blood pressure and heart rate were assessed, and a 
urine sample was provided. Next, subjects started re-familiarization with all three tasks 
(always in the same order). The yoghurt mixture (with tyrosine or placebo) was provided 
such that subjects entered the scanner 90 minutes after ingestion. Maximal concentration 
of plasma elevation and cognitive effects are seen approximately after 1.5 hours and are 
normalized after 6 to 8 hours (e.g. Glaeser, Melamed, Growdon, & Wurtman, 1979). The 
stop-signal task (described below) was the first task performed in the scanner, followed by 
a working memory task. Scanning took approximately 100 minutes. Upon exiting the scan-
ner, a second urine sample was provided. After scanning, subjects performed the third task 
measured effort discounting and completed a neuropsychological test battery assessing: 
immediate and delayed story recall (Wilson et al., 1985), digit span forward and backward 
(Wechsler, 1997), Stroop cards (Stroop, 1935), verbal fluency (Tombaugh et al., 1999). 
Subjects’ blood pressure, heart rate and wellbeing were monitored three times during the 
test session.
Experimental Design: Load-Dependent Stop-Signal Anticipation Task 
The paradigm consisted of Go trials and Stop trials. On every trial, a bar moved at a 
constant speed from a lower horizontal line towards an upper horizontal line, reaching a 
middle line (flanked by two vertical lines) in 800 milliseconds (ms) (Figure 2 main text). 
The Go task was to bring the bar to a halt as close to the middle line as possible, by press-
ing a button with the right index finger. A minority of trials were Stop trials. On Stop trials 
the bar stopped moving automatically before reaching the middle line (the Stop-signal). 
This stop signal instructed the subjects to withhold the planned Go response.  
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The middle horizontal line and the two vertical lines represented cues that indicated 
stop-signal probability context by varying in colour. To manipulate information load, the 
task consisted of three levels that were alternated in short blocks (see below). Between 
levels, stop-signal probability cues were varied in amount as well as in complexity. The 
stop-signal probability could be anticipated on the basis of the colour of the cues (i.e. 
horizontal and vertical lines, presented 500 ms before the onset of the moving bar). Level 
A was the level with the least information load, with only white cues (stop probability of 
26%) and green cues (stop probability of 0%). In Level B, there were 5 types of Go trials 
with varying stop-signal 
probability, using an intuitive colour range for the cues (Zandbelt and Vink, 2010): green, 
0%; yellow, 17%; amber, 22%; orange, 28%; and red, 35%, with a mean of 26% stop proba-
bility. The non-green trials are collectively called >0% trials. Level C consisted of the same 
types and numbers of stop-signal probability cues as Level B. However, in level C only one 
of the vertical lines signaled the correct stop-signal probability context. The correct side 
could be identified by the colour of the middle line: a blue middle line indicated that the 
left vertical line colour was valid, whereas a purple middle line indicated that the right 
vertical line colour was valid. 
We instructed participants that going and stopping were equally important and that it 
would not always be possible to suppress a response when a stop signal occurred. Partic-
ipants were not informed of the exact stop-signal probabilities, but were told that stop 
signals in all levels would not occur on trials with a green cue, and that stop signals in  
level B and C were least likely in the context of a yellow cue and most likely in the context 
of a red cue, with the amber and orange cues coding intermediate, and respectively de-
creasing, stop-signal probabilities.
To ensure roughly equal numbers of successful and unsuccessful Stop trials, a staircase 
procedure adjusted stop-signal delay by 25 ms depending on stopping performance. Levels 
were presented in 34 blocks, each lasting 27 seconds and consisting of 10 trials, with an 
inter-trial interval of 1000 ms. The sequence of trials and blocks were pseudo randomized 
(ensuring that the first three blocks of the task were always in order of levels A-B-C). Every 
level contained 70 trials with 0% (green) and 270 trials with >0% (white) stop-signal prob-
ability. Of these 270 >0% trials, 70 were Stop trials, with a mean stop-signal probability of 
26%. For Level B and C, each >0% trial type contained 50 Go trials, plus a varying amount 
of Stop trials per colour resulting in varying stop-signal probabilities (in between brackets): 
10 yellow (17%), 14 amber (22%), 19 orange (28%) and 27 red (35%). Two rest blocks of 20 
s each were implemented at one-third and two-thirds of the task, respectively. The total 
task duration was approximately 45 minutes. During the pre-screening, each level was 
explained and practiced separately for 48 trials (Level A) and 72 trials (Levels B and C). 
Subjects were asked to repeat task instructions to ensure sufficient understanding. Then 
they practiced the task (levels were presented in alternating blocks) for 10 minutes. On 
each test day, instructions were rehearsed and the 10 minute practice was repeated.
Catecholamine metabolites, physiological and neuropsychological measures
Outliers on any outcome measure were determined using Grubbs’ test (Grubbs, 1969), 
resulting in exclusion one outlier on the homovanillic acid (HVA) and one on 3,4-dihydroxy-
phenylacetic acid (DOPAC) urine levels. The effect of tyrosine administration on  
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catecholamine metabolites HVA, vanillylmandelic acid (VMA), 3-methoxy-4-hydroxyphe-
nylglycol (MOPEG) and DOPAC in urine was determined using four ANOVA’s with with-
in-subject factors Time (T0, T2) and Intervention (tyrosine, placebo). Performance on 
neuropsychological tasks (digit span, verbal fluency, story recall, Stroop, box completion, 
letter cancellation) was assessed using paired t-tests comparing scores on the tyrosine 
session with the placebo session. The effect of Time on blood pressure, heart rate, and 
subjective wellbeing was assessed using  ANOVA’s with factor Time (T-20, T90, T240). The 
effect of tyrosine administration on these measures during the baseline corrected thera-
peutic window 
(T1 minus T0) was assessed with a paired t-test. Possible modulation of tyrosine’s effect 
on catecholamine metabolites, physiological and neuropsychogological measures by age 
was determined by adding the covariate Age in an ANOVA on these measures using factors 
Intervention (tyrosine, placebo). Upon significant effects, the influence of administration 
order was assessed in a separate ANOVA using within-subjects factor Intervention (tyros-
ine, placebo), between subjects factor administration order (tyrosine on first or second 
test day) and covariate age.
MRI data acquisition and pre-processing
Whole-brain imaging was performed on a 3 Tesla MR scanner (Magnetrom Skyra Tim, 
Siemens Medical Systems, Erlangen, Germany). Functional data were obtained using a 
multi-echo gradient T2*-weighted echo-planar scanning sequence (Poser et al., 2006) with 
blood oxygen level-dependent (BOLD) contrast (34 axial-oblique slices, repetition time, 
2070 ms; echo-times, 9.0, 19.3, 30.0 and 40.0 ms; in plane resolution, 3.5x3.5 mm; slice 
thickness, 3 mm; distance factor, 0.17; field of view, 224 mm; flip angle, 90º). Visual stimuli 
were projected on a screen and were viewed through a mirror attached to the head coil. 
In addition, a high-resolution T1-weighted magnetization-prepared rapid-acquisition gra-
dient echo anatomical scan was obtained from each subject (192 sagittal slices; repetition 
time, 2.3 s; echo time, 3.03 ms; voxel size 1.0 x 1.0 x 1.0 mm; field of view 256 mm). 
Preprocessing and mass-univariate data analysis were performed using SPM8 software 
(Statistical Parametric Mapping; Wellcome Trust Centre for Cognitive Neuroimaging, 
London, UK). Realignment parameters were estimated for the images acquired at the first 
echo-time and subsequently applied to images resulting from the 3 other echoes. 
The echo images were combined by weighting with a parallel-acquired inhomogeneity-
desensitized algorithm, assessing the signal-to-noise ratio as described by Poser et al. 
(2006). Thirty volumes, acquired before the task,were used as input for this algorithm. 
After data quality check (i.e., for signal intensity spikes), the echo combined and realigned 
images were slice time corrected to the middle slice. The functional images were coregis-
tered to the T1 scan. A sample-specific templatewas created by segmenting each individ-
ual T1 and using diffeomorphic anatomical registration to place each subject’s gray and 
white matter images in a study-specific space (Ashburner, 2007). Deformation parameters 
were stored in a subject-specific flow field. The coregistered fMRI images and anatomical 
T1 scan were nonlinearly normalized to the sample-specific anatomical template (using the 
subject-specific flow field), affine-aligned into a Montreal Neuro- logical Institute template, 
and finally smoothed using an 8.0-mm full width at half maximum Gaussian filter. 
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fMRI task analysis 
Twelve regressors of interest were included in a general linear model. For each Level, 
we included a regressor modeling all Go trials (i.e. containing 0% and >0% stop-signal 
probability trials) and a corresponding parametric regressor modeling stop-signal proba-
bility (6 regressors: Go Level A, Proactive Level A, Go Level B, Proactive Level B, Go Level C, 
Proactive Level C). In Level A, the parametric regressor consisted of 2 trial types. In Level B 
and C, the parametric regressors consisted of 5 trial types. An actual stop-signal appeared 
on a proportion of >0% trials. These Stop trials were separately modeled as StopSuccess 
trials and StopFailure trials, based on whether or not the behavioural response was inhib-
ited (6 regressors: StopSuccess level A, StopFailure level A, StopSuccess level B, StopFailure 
level B, StopSuccess level C, StopFailure level C). As regressors of non-interest, we included 
a regressor for missed trials across all levels (i.e. no button box response on a Go trial), as 
well as a regressor modeling task instructions at the beginning of each mini-block. 
Moreover, twenty four realignment parameters were modeled as regressors of non-
interest (6 rigid-body movement parameters, plus Volterra expansion of these: first 
derivatives and quadratic derivatives of the original as well as first derivatives (Lund et al, 
2005). Finally, to prevent contribution of global signal changes, we included signal from 
segmented out-of-brain voxels in the model as regressor of non-interest. All regressors of 
interest were modeled as delta functions at the onset of the trial and were convolved with 
a canonical hemodynamic response function. Time series were high-pass filtered (128s 
cut-off) and serial correlations were corrected using an autoregressive (AR)1 model during 
classical (ReML) parameter estimation. Parameter estimates for the regressors of interest, 
derived from the mean least-squares fit of the model to the data, were used to estimate 
contrasts on the first level. 
Supplementary behavioural results 
Race model assumptions
Data were in compliance with the main assumptions of the race model (Logan and Cowan, 
1984). For each level and age group separately, mean response times (RTs) were faster on 
StopFailure versus >0% trials (paired t-test, all p<.05) and mean RTs were faster for Stop-
Failure RTs for short versus long SSDs (paired t-test, all p<.05). Inhibition functions repre-
sent the probability of successfully inhibiting a response for every SSD, where the probabil-
ity to inhibit decreases as the stop-signal is presented more closely to the moment that the 
response is made (Logan and Cowan, 1984). For each level, individual inhibition functions 
were calculated and displayed decreasing inhibition probability as a function of SSD.
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Demographics and trait neuropsychological tests 
 
Table S1. Trait Demographics and Neuropsychological tests 
Variable 
 Age (years) 67.5 (.6) 
Sex (women/men) W: 9 M: 15  
Verbal IQ 114.5 (2.0) 
HADS total  3.5 (0.5) 
HADS anxiety  2.3 (.4) 
HADS depression 1.2 (.3) 
MMSE  29.1 (0.3) 
BIS-11 motor  20.9 (0.6) 
BIS- 11 cognitive  14.8 (0.6) 
BIS- 11 non-planning  21.7 (.7) 
BIS-11 total) 57.4 (1.1) 
Note. Data represent mean (standard error of the mean) except for the variable Sex, for which data reflect frequencies. Verbal 
IQ is defined by scores on the Dutch version of the NART, MMSE = Mini-Mental State Examination, BIS-11 = Barratt 
Impulsiveness Scale subscales and total score. Men and women are equally distributed across the whole group. 
 
Demographics and trait neuropsychological tests
Table S1. Trait Demographics and Neuropsychological tests
Note. Data represent mean (standard error of the mean) except for the variable Sex, for which 
data reflect frequencies. Verbal IQ is defined by scores on the Dutch version of the NART, MMSE = 
Mini-Mental State Examination, BIS-11 = Barratt Impulsiveness Scale subscales and total score. Men 
and women are equally distributed across the whole group.
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Supplementary imaging results 
Task effects across levels and age on reactive response inhibition (StopSuccess > StopFailure) 
 
Figure S1. Main task effects across test sessions and level for reactive response inhibition – StopSuccess > Fail. Images are 
thresholded at p<.001 uncorrected (for illustration purposes), cluster-level (pFWE<.05) significant clusters are listed in Table S2. 
 
Table S2. Whole brain cluster-level significant task regions during reactive response inhibition across levels (StopSucces > 
StopFailure). 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
cluster 
Right putamen  30  -9   6  <.001 14378 
   Right anterior cingulum     14  33   4    
Left middle frontal gyrus -38  17  55  <.001 2047 
   Left superior frontal gyrus    -18  30  46    
   Left medial superior frontal gyrus     -9  32  42    
 
Supplementary imaging results
Task effects across levels and age on reactive response inhibition 
(StopSuccess > StopFailure)
Task effects across levels and age on reactive response inhibition 
(StopSuccess > Go)
Table S2. Whole brain cluster-level significant task regions during reactive response inhibition across 
levels (StopSucces > StopFailure).
Figure S2.Main task effects across test sessions and level for reactive response inhibition – StopSuc-
cess > Go. Images are thresholded at p<.001 uncorrected (for illustration purposes), cluster-level 
(pFWE<.05) significant clusters are listed in Table S3.
Figure S1. Main task effects across test sessions and level for reactive response inhibition – StopSuc-
cess > Fail. Images are thresholded at p<.001 uncorrected (for illustration purposes), cluster-level 
(pFWE<.05) significant clusters are listed in Table S2.
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Task effects across levels and age on reactive response inhibition (StopSuccess > Go) 
Figure S2.Main task effects across test sessions and level for reactive response inhibition – StopSuccess > Go. Images are 
thresholded at p<.001 uncorrected (for illustration purposes), cluster-level (pFWE<.05) significant clusters are listed in Table S3. 
 
Table S3. Whole brain cluster-level significant task regions during reactive response inhibition across levels (StopSuccess > Go). 
Region Peak MNI coordinates pFWE value No. voxels in 
cluster 
Right insula  33  23  -3  <.001 5615 
   Right inferior frontal triangle     45  24   7    
   Right inferior frontal operculum     51  18   7    
Left insula -30  21  -5  <.001 1809 
Right caudate  14  11  10  <.001 614 
Right supramarginal gyrus  52 -40  28  <.001 1867 
    Right superior temporal gyrus     58 -42  19    
    Right middle temporal gyrus     52 -42   3    
Right supplementary motor area   8  17  48  <.001 2230 
   Right medial superior frontal gyrus      8  42  34    
Right superior frontal gyrus  28  54  16  <.001 965 
   Right middle frontal gyrus     26  51  24    
Left caudate -10  11   6  0.006 388 
 
Table S3. Whole brain cluster-level significant task regions during reactive response inhibition across 
levels (StopSuccess > Go).
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Positive correlation between age and effect of tyrosine in reactive response inhibition 
(StopSuccess > StopFailure) 
 
Table S4. Whole brain cluster-level significant regions yielding a positive correlation between age and effect of tyrosine during 
reactive response inhibition (StopSuccess > StopFailure). 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
cluster 
Left rolandic operculum -46  -1  16  .008 268 
Left rolandic operculum -38 -30  27  <.001 2216 
   Left precuneus    -15 -57  37    
Right Lingual gyrus  21 -63  42  <.001 2252 
    Right superior parietal gyrus     15 -49  55    
    Right precuneus     16 -51  25    
Left calcarine gyrus -10 -45   7  .023 216 
   Left lingual gyrus    -10 -49  15    
Left lingual gyrus -14 -63  -6 .007 273 
   Left inferior temporal gyrus    -46 -51  -5   
   Left fusiform gyrus    -34 -58  -5   
 
Task effects across levels and age on proactive response inhibition  
 
Figure S3. Main task effects across test sessions and level for proactive response inhibition (Parametric regressors of Go). 
Images thresholded at p<.001 uncorrected (for illustration purposes), cluster-level (pFWE<.05) significant clusters are listed in 
Table S5. 
 
Table S5. Whole brain cluster-level significant task regions during proactive response inhibition across levels (Parametric 
regressors of Go). 
Positive correlation between age and effect of tyrosine in reactive response inhi-
bition (StopSuccess > StopFailure)
Table S4. Whole brain cluster-level significant regions yielding a positive correlation between age and 
effect of tyrosine during reactive response inhibition (StopSuccess > StopFailure).
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Region Peak MNI 
coordinates 
pFWE value No. voxels in 
cluster 
Right superior temporal gyrus  51 -37  12  .005 286 
Right superior parietal gyrus  18 -55  60  .012 242 
Right insula  30  27  -3  .016 228 
Left inferior frontal gyrus, orbital part -28  29  -6  .004 300 
   Left insula    -26  20 -14    
 
Effect of tyrosine on proactive response inhibition (Parametric regressors) 
Table S6. Whole-brain cluster-level significant regions for tyrosine versus placebo during proactive response inhibition 
(parametric regressors). 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
cluster 
Right middle cingulum 12  20 31  .001 290 
    Right anterior cingulum     15  29 22    
Right precentral gyrus 26 -12 54  .001 324 
Right supramarginal gyrus 61 -34 42  .002 272 
 
Negative correlation between age and effect of tyrosine in proactive response inhibition 
(Parametric regressors) 
Table S7. Whole-brain cluster-level significant regions yielding a negative correlation between age and effect of tyrosine during 
proactive response inhibition (parametric regressors). 
Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
cluster 
Right putamen  26   9  -9  <.001 441 
Left middle frontal gyrus -27  -4  51  .029 159 
    Left precentral gyrus     -34  -6  54    
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(Parametric regressors) 
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Region Peak MNI 
coordinates 
pFWE 
value 
No. voxels in 
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Right putamen  26   9  -9  <.001 441 
Left middle frontal gyrus -27  -4  51  .029 159 
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Task effects across levels and age on proactive response inhibition 
Effect of tyr sine on proactive response inhibition (Parametric regressors)
Figure S3. Main task effects across test sessions and level for proactive response inhibition (Paramet-
ric regressors of Go). Images thresholded at p<.001 uncorrected (for illustration purposes), clus-
ter-level (pFWE<.05) significant clusters are listed in Table S5.
Table S5. Whole brain cluster-level significant task regions during proactive response inhibition across 
levels (Parametric regressors of Go).
Table S6. Whole-brain cluster-level significant regions for tyrosine versus placebo during proactive 
response inhibition (parametric regressors).
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Region Peak MNI 
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Region Peak MNI 
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No. voxels in 
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Left inferior parietal gyrus -33 -43  52  .011 195 
Left superior frontal gyrus -22  57   4  <.001 402 
    Left middle frontal gyrus     -24  50   7    
Right supramarginal gyrus  49 -22  31  .001 277 
    Right superior temporal gyrus     52 -30  33    
Left putamen -27   5  -6  .005 227 
    Left pallidum    -22   0   1    
Left precuneus -3 -61  42  .027 162 
 
Negative correlation between age and effect of tyrosine in proactive response 
inhibition (Parametric regressors)
Table S7. Whole-brain cluster-level significant regions yielding a negative correlation between age 
and effect of tyrosine during proa tive response inhibition (parametric regr ssors).
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Additional measures 
Tyrosine administration did not affect neuropsychological measures (Table S8), nor was there an 
interaction between age and the effect of tyrosine administration on these measures.  
Effect of intervention on stop-signal task and neuropsychological tests 
Table S8. Effect of intervention on stop-signal task and neuropsychological tests  
Variable Placebo  Tyrosine  p-value p-value age 
Story immediate recall (points) 9.5 (0.6) 10.2 (0.7) .3 .68 
Story delayed recall (points) 9.0 (0.6) 9.2 (0.6) .8 .47 
Digit span forward (points) 7.5 (0.4) 7.21 (0.4) .14 .75 
Digit span backward (points) 6.1 (0.4) 6.25 (0.5) .84 .93 
Stroop effect (secs) 81.4 (11.1) 95.88 ( 12.5)    .18 .38 
Stroop effect (errors)  .7 (0.2) 1.32 (0.3) .14 .43 
Verbal Fluency DAT (items) 45.26 (2.3) 44.13 (2.3) .8 .09 
Block completion 92.23 (7.83) 83.42 (4.17) .36 .84 
Letter cancellation 249.29 (7.07) 250.17 (7.39) .61 .35 
Note. Data represent mean (standard error of the mean). The first column with p-values reflect the outcome of the paired t-
tests between tyrosine and placebo on the behavioural measure, the second column with p-values reflects the interaction 
between tyrosine’s effect on the behavioural measure and age.  Bold reflects a significant result (p<.05). 
 
Catecholamine metabolites in urine 
 
At the beginning of the test day (T0) as well as approximately three hours after ingestion of tyrosine or 
placebo (T2), a urine sample was provided by the participants. As expected when consuming yoghurt 
after a night’s fast, HVA, MOPEG and VMA concentrations in urine were increased approximately 3 
hours after ingestion of the mixture (T2) relative to the start of the test day (T0) (main effects of Time on 
HVA: F(1,22)= 20.98, p<.001; MOPEG: F(1,23)= 48.77, p<.001; VMA: F(1,23)= 52.87, p<.001) (Table S9). 
Tyrosine administration affected catecholamine metabolites. VMA concentrations were lower after 
tyrosine compared with placebo (Time * Intervention interaction, F(1,23)= 9.1, p=.006), driven by 
Intervention differences in concentrations on T2 (t(23)= 2.2, p=.036) not T0 (t(23)= -.078, p=.94). 
However, DOPAC concentrations were higher after tyrosine compared with placebo (Time * 
Intervention interaction F(1,22)= 8.8, p=.007), not driven by Intervention effects on either T2 (t(22)= -.43, 
p=.67) or T0 (t(23)= 1.3, p=.2). 
Independent of intervention and time of measurement, VMA and DOPAC levels were modulated by age 
(main effect of Age, VMA: F(1,22)=8.98, p=.007; DOPAC: F(1,21)=5.5, p=.024); increasing age was 
associated with higher urine levels of VMA and DOPAC. MOPEG and VMA levels interacted between 
time of measurement and age; increasing age was associated with a larger increase from time point T0 
to T2 independent of tyrosine or placebo administration (MOPEG: F(1,22)=5.61, p=.027; VMA: 
F(1,22)=4.92, p=.037). 
 
 
Additional measures
Tyrosine administration did not affect neuropsychological measures (Table S8), nor was 
there an interaction between age and the effect of tyrosine administration on these meas-
ures.
Effect of intervention on stop-signal task and neuropsychological tests
Catecholamine metabolites in urine
At the beginning of the test day (T0) as well as approximately three hours after ingestion 
of tyrosine or placebo (T2), a urine sample was provided by the participants. As expected 
when consuming yoghurt after a night’s fast, HVA, MOPEG and VMA concentrations in 
urine were increased approximately 3 hours after ingestion of the mixture (T2) relative to 
the start of the test day (T0) (main effects of Time on HVA: F(1,22)= 20.98, p<.001; MOPEG: 
F(1,23)= 48.77, p<.001; VMA: F(1,23)= 52.87, p<.001) (Table S9). Tyrosine administra-
tion affected catecholamine metabolites. VMA concentrations were lower after tyrosine 
compared with placebo (Time * Intervention interaction, F(1,23)= 9.1, p=.006), driven by 
Intervention differences in concentrations on T2 (t(23)= 2.2, p=.036) not T0 (t(23)= -.078, 
p=.94). However, DOPAC concentrations were higher after tyrosine compared with placebo 
(Time * Intervention interaction F(1,22)= 8.8, p=.007), not driven by Intervention effects on 
either T2 (t(22)= -.43, p=.67) or T0 (t(23)= 1.3, p=.2).
Independent of intervention and time of measurement, VMA and DOPAC levels were 
modulated by age (main effect of Age, VMA: F(1,22)=8.98, p=.007; DOPAC: F(1,21)=5.5, 
p=.024); increasing age was associated with higher urine levels of VMA and DOPAC. 
MOPEG and VMA levels interacted between time of measurement and age; increasing age 
was associated with a larger increase from time point T0 to T2 independent of tyrosine or 
placebo administration (MOPEG: F(1,22)=5.61, p=.027; VMA: F(1,22)=4.92, p=.037).
Table S8. Effect of intervention on stop-signal task and neuropsychological tests
Note. Data represent mean (standard error of the mean). The first column with p-values reflect the 
outcome of the paired t-tests between tyrosine and placebo on the beh vioural measure, the second 
column with p-values reflects the interaction between tyrosine’s effect on the behavioural measure 
and age.  Bold reflects a significant r sult (p<.05).
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Table S9. Effect of tyrosine administration on catecholamine metabolites in urine  
Variable  Placebo Tyrosine  
 (mmol/M kr) T0 T2 T0 T2 p-value 
HVA 2.80 (.22) 3.36 (.30) 2.74 (.24) 3.20 (.25) .43 
MOPEG 1.08 (.06) 1.34 (.06) 1.14 (.07) 1.3 (.07) .097 
VMA 1.75 (.11) 2.1 (.12) 1.75 (.1) 2.0 (.12) .006 
DOPAC 1.21 (.11) 1.25 (.13) 1.10 (.1) 1.28 (.12) .013 
Note. Metabolite concentrations are expressed in mini-mol per mol creatinine, to correct for sample volume. P-values reflect 
the interaction between Drug and Time from the ANOVA on Tyrosine Administration (tyrosine, placebo) and Time (T0, T2). The 
effect of tyrosine on catecholamine metabolites did not interact with age.  
 
 Wellbeing, blood pressure and heart rate 
 
Wellbeing ratings were assessed at the beginning of the test day (T0), at the assumed peak of tyrosine 
plasma level (T1) and at the end of the test day, about 4 hours after ingestion (T2). At the same time, 
systolic and diastolic blood pressure as well as heart rate were measured (see Table S10).  
Over the course of the test day, changes in wellbeing as measured on the Bond & Lader Total and 
Contentness subscales were observed (main effect of Time, Total: F(2,44)=4.00, p=.025;Contentness: 
(F(2,44)=9.4, p<.001 respectively). Wellbeing decreased on T1 compared with T0 (Total: F(1,23)=8.6, 
p=.008; Contentness: (F(1,23)=12.8, p=.002), and increased to baseline again on T2 compared with T1 
and T0 (T2 vs T1 Total: F(1,23)=4.5, p=.045 and Contentness: F(1,23)=10.53, p=.004, T2 vs T0 Total: 
F(1,23)<1 and Contentness: F(1,23)<1). The subscales Calmness and Alertness did not change over time. 
The effect of tyrosine on the Bond & Lader subscale scores during the baseline corrected therapeutic 
window (T1 minus T0) did not interact with Age.  
Systolic and diastolic blood pressure changed over the course of the test day (main effect of Time 
systolic: F(2,44)=8.7, p=.001 and diastolic: (F(2,44)=20.7, p<.001). Diastolic pressure decreased on T1 
compared with T0 (F(1,23)=18.1, p<.001), and both systolic and diastolic blood pressure increased on T2 
compared with T1 (systolic: F(1,22)=8.4, p=.008 and diastolic: (F(1,23)=27.6, p<.001). No effects of 
tyrosine administration or age were observed on systolic and diastolic blood pressure or heart rate 
during the baseline corrected therapeutic window (T1 minus T0). Heart rate did not change over time. 
 
Table  S10. Wellbeing scales, blood pressure and heart rate. 
Variable Placebo Tyrosine p-value 
 T0 T1 T2 T0 T1 T2  
B&L  Total 8.1 (.3) 7.7 (.3) 8.1(.3) 8.0 (.2) 7.6 (.4) 8.0 (.3) .97 
B&L Calmness 7.7 (.4) 7.2 (.5) 7.7(.4) 8.1 (.3) 7.3 (.5) 7.6 (.4) .58 
B&L Contentness 8.4 (.25) 7.6 (.4) 8.5 (.3) 8.3 (.2) 7.6 (.4) 8.3 (.3) .99 
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and T0 (T2 vs T1 Total: F(1,23)=4.5, p=.045 and Contentness: F(1,23)=10.53, p=.004, T2 vs T0 Total: 
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systolic: F(2,44)=8.7, p=.001 and diastolic: (F(2,44)=20.7, p<.001). Diastolic pressure decreased on T1 
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Table  S10. Wellbeing scales, blood pressure and heart rate. 
Variable Placebo Tyrosine p-value 
 T0 T1 T2 T0 T1 T2  
B&L  Total 8.1 (.3) 7.7 (.3) 8.1(.3) 8.0 (.2) 7.6 (.4) 8.0 (.3) .97 
B&L Calmness 7.7 (.4) 7.2 (.5) 7.7(.4) 8.1 (.3) 7.3 (.5) 7.6 (.4) .58 
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Wellbeing, blood pressure and heart rate
Wellbeing ratings were assessed at the beginning of the test day (T0), at the assumed peak 
of tyrosine plasma level (T1) and at the end of the test day, about 4 hours after ingestion 
(T2). At the same time, systolic and diastolic blood pressure as well as heart rate were 
measured (see Table S10). 
Over the course of the test day, changes in wellbeing as measured on the Bond & Lader 
Total and Contentness subscales were observed (main effect of Time, Total: F(2,44)=4.00, 
p=.025;Contentness: (F(2,44)=9.4, p<.001 respectively). Wellbeing decreased on T1 
compared with T0 (Total: F(1,23)=8.6, p=.008; Contentness: (F(1,23)=12.8, p=.002), and 
increased to baseline again on T2 compared with T1 and T0 (T2 vs T1 Total: F(1,23)=4.5, 
p=.045 and Contentness: F(1,23)=10.53, p=.004, T2 vs T0 Total: F(1,23)<1 and Contentness: 
F(1,23)<1). The subscales Calmness and Alertness did not change over time. The effect of 
tyrosine on the Bond & Lader subscale scores during the baseline corrected therapeutic 
window (T1 minus T0) did not interact with Age. 
Systolic and diastolic blood pressure changed over the course f the test day (main 
effect of Time systolic: F(2,44)=8.7, p=.0 1 a stolic: (F( ,44)=20.7, p<.001). Diastolic 
pres ur  decreased on T1 compared with T0 (F(1,23)=18.1, p<.001), and both systolic and 
diastolic blood pr ssure increased on T2 compared with T1 (sys olic: F(1,22)=8.4, p=.008 
and diastolic: (F(1,23)=27.6, p<.001). No effects of tyrosine administration or age were ob-
served on systolic and diastolic blood pressure or heart rate during the baseline corrected 
therapeutic window (T1 minus T0). Heart rate did not change over time.
Table S9. Effect of tyrosine administration on catecholamine metabolites in urine
Note. Metabolite co centrations are expressed in mini-mol per mol creatini e, to correct for sample 
volume. P-values reflect the interaction betwee  Drug and Time from the ANOVA on Tyrosine Admin-
istration (tyrosine, placebo) and Time (T0, T2). The effect of tyrosine on catecholamine metabolites 
did not interact with age.
Table  S10. Wellbeing scales, blood pressure and heart rate.
Note. B&L = Bond and Lader. P-values reflect the outcome of the paired t-tests between tyrosine and 
placebo on the baseline corrected physiological measure (T1 minus T0). No interactions between 
tyrosine administration and time or age were observed.
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Supplementary discussion 
Discussion urine metabolites
Results from the current study in urine metabolites support the idea of increased periph-
eral catecholamine precursor levels in older adults (see main Discussion). Irrespective of 
intervention, we observed higher amounts of VMA and DOPAC across time and a higher 
increase of MOPEG and VMA metabolites with time, as a function of age. Thus, increased 
peripheral supply of tyrosine to the blood-brain barrier might have resulted in the cur-
rently observed age-dependent overdose effects on proactive response inhibition, despite 
the same oral dose per kg bodyweight in every subject and despite increased dopamine 
deficits with aging. 
The majority of the catecholamine metabolites increased to a lesser extent after tyrosine 
compared with placebo administration (VMA significantly and MOPEG and HVA numer-
ically). Only DOPAC levels increased after tyrosine compared with placebo. However, for 
unknown reasons, large baseline (T0) differences between intervention sessions were 
observed on this measure. This complicates the interpretation of the intervention effect 
on DOPAC levels. The tyrosine-related decrease in VMA (and numerically in MOPEG and 
HVA) confirms the interpretation that dopamine production was reduced after tyrosine 
(see main Discussion). These results should be interpreted with caution though, as urine 
measures reflect mostly peripheral metabolites.
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General Discussion 
In this thesis, the neurocognitive underpinnings of the cognitive control processes working 
memory  and response inhibition were studied. These cognitive processes were challenged 
by cognitive load, age as well as dopaminergic interventions. Using these interventions, I 
aimed to increase the understanding of cognitive control processes in varying circumstanc-
es as well as the potential role of dopamine herein.
Firstly the role of dopamine in cognitive control is discussed and how this relates to cogni-
tive aging deficits. Next, I will discuss the modulations of response inhibition by load and 
age and consider interpretations of, and difficulties in, imaging the aging brain. Further-
more, I discuss whether load, age and dopamine modulate response inhibition according 
to predictions of neural models of aged cognition, specifically the dual mechanisms of 
control model. A common source for the effects of aging on working memory and re-
sponse inhibition is considered, and how fronto-striatal rather than only prefrontal cortex 
(PFC) deficits in aging may explain the non-selective impairments of working memory and 
response inhibition. The aging brain was probed with the dopamine precursor tyrosine. 
I consider the kinetics of treating the aging brain with tyrosine and under which conditions 
tyrosine is suitable to probe the dopaminergic system. Lastly, I discuss to what extent 
tyrosine can work as a cognitive enhancer. 
The role of dopamine in (aged) cognitive control
In Chapter 2, D2 receptor stimulation by bromocriptine modulated PFC signal during dis-
tracted working memory maintenance, resulting in altered distractor resistance. 
Hereby, empirical evidence was provided for the role of dopamine D2 receptors in the 
human PFC in distractibility of working memory maintenance. This finding concurs with 
models predicting that D2 receptor stimulation influences working memory maintenance 
by disrupting the ‘closed’ PFC state that is important to maintain working memory rep-
resentations and bringing the PFC in an ‘open’ state in which other items can be processed 
(Durstewitz and Seamans, 2008). Chapter 2 also showed that working memory mainte-
nance depends on the connectivity strength between PFC and sensory areas, which was 
disrupted by the D2 receptor agonist. Another region important for cognitive control, 
which is also likely influenced by D2 receptor stimulation, is the striatum. Striatal involve-
ment was not observed during this delay phase analysis. Possibly, striatal D2 modulation 
may have occurred at the moment of distraction or when responding to the probe, rather 
than during the maintenance phase (Wang et al, 2004). As the current design was opti-
mized to study maintenance signal, future studies may assess striatal involvement during 
distraction of working memory. 
In Chapter 3 I hypothesized greater working memory maintenance deficits in healthy aging 
relative to working memory updating. This hypothesis was inspired by behavioural data 
showing larger effects of distraction in older compared with young adults (Weeks and 
Hasher, 2014). Moreover, age-related deficits in working memory have been often ascribed 
to the maintenance part of working memory due to impaired prefrontal functioning (and 
dopamine functioning in this area) (Hasher and Zacks, 1988; West, 1996). Hence, larger 
age-related deficits may be expected for working memory maintenance relative to working 
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memory updating. However, I did not find a selectively larger maintenance impairment 
relative to updating in older compared with young adults in a delay-match-to-sample task 
measuring working memory distractibility as well as working memory updating. In fact, in 
the experiments by Weeks and Hasher (2014), not working memory, but priming was facil-
itated. This was achieved for example in a task that required detecting a common theme 
among three words (May, 1999). Correctly associating the theme between the words 
occurred more often when they were simultaneously presented with another word, which 
was introduced to the subjects as distractors, but actually primed the correct answer. 
This effect was stronger for older compared with young adults. This increased priming 
effect may not be easily translated to working memory, given that priming occurred simul-
taneously with the presentation of the to-be-primed items. In contrast, a beneficial effect 
of increased distractibility on working memory should occur during item-specific mainte-
nance, by definition in absence of the to-be-maintained item. When considering effects of 
aging on e.g. dopamine receptor density, lack of a relative updating benefit in older adults 
may not be surprising. Dopamine receptor-specific contributions to working memory have 
been extensively proven (Cools, 2016; Durstewitz and Seamans, 2008);  stimulation of D1 
receptors strengthens, whereas stimulation of D2 receptors weakens stability of working 
memory representations. Thus, in case of a selective age-related decline in D1 receptors, 
working memory maintenance would be expected to be disproportionally impaired rela-
tive to working memory updating and vice versa for a larger decline of D2 receptors. How-
ever, an equal decline of D1 and D2 receptors is observed in aging (Seeman et al, 1987) 
explaining the lack of a relative working memory updating benefit (Chapter 3), despite ev-
idence for a beneficial effect of increased distractibility in other tasks (Weeks and Hasher, 
2014). Hence, when not probing specific receptor systems, as was the case in Chapter 3, 
a pattern of general decline of dopamine-dependent cognition in aging may be observed. 
Similar to dopamine receptor-specific contributions to working memory processes and 
other executive functions in adulthood, age-related decline in receptor densities likely also 
contribute in a selective way. Consequently, to disentangle the role of dopamine in (aged) 
working memory processes, targeting specific dopamine receptor types using a(nta)gonists 
may provide more insight than using general dopamine modulators (such as levodopa 
and tyrosine). Moreover, regional differences in dopamine receptor contributions to aged 
cognition may be observed. For example, dopamine D1 receptor decline in aging was 
associated with prefrontal BOLD signal during load-dependent working memory (Bäckman 
et al, 2011).  Dopamine receptor and regional contributions therein to working memory 
maintenance and updating were never dissociated. The contribution of the PFC to age-
related working memory updating may be smaller than the striatum, where D2 receptors 
are more abundant relative to the PFC (Lidow et al, 1991). Using PET tracers D1 and D2 
receptor abundance in PFC and striatum could be measured in older and young adults 
(such as [11C]SCH23390 for D1 receptors and [11C]FLB 457 for D2 receptors, following 
(Aalto et al, 2005; Volkow et al, 1998)). These measures could be related to their working 
memory maintenance and updating performance in a task that allows dissociation be-
tween the two working memory processes. This way, regional contributions and dopamine 
receptor contributions to working memory in aging may be elucidated. 
Furthermore, I observed in this thesis that effects of dopamine modulation on response in-
hibition varied with age (Chapter 6). The dopamine precursor tyrosine increased proactive 
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response slowing and associated fronto-striatal BOLD signal in the youngest older adults 
(age range 61-72), but decreased both in the oldest adults. This may reflect modulation 
as a function of the age-related alteration of the dopamine system (Kaasinen and Rinne, 
2002), for example as a function of compensatory up-regulation of dopamine synthesis 
capacity in remaining neurons (Braskie et al, 2008). Good proxies for the degree of aging of 
the dopamine system would be valuable. Dopamine synthesis capacity e.g. in the striatum, 
receptors and transporter density all contribute to a certain degree to the state of the do-
pamine system, and its measures may be combined as one proxy or compared to identify 
the best predictor for cognitive functioning.   
Response inhibition modulation by load and age
In this thesis, behaviour and neural correlates of two forms of response inhibition were 
studied: reactive (outright stopping in response to the stop-signal) and proactive response 
inhibition (cautious response slowing in anticipation of a stop-signal). These forms of 
response inhibition were modulated by information load, age (Chapter 5) and dopamine 
(Chapter 6). In Chapter 5, both proactive and reactive response inhibition were found to 
be affected by information load. Proactive slowing declined under increasing information 
load. Although this wasn’t formally tested, reactive response inhibition seems to benefit 
from reduced proactive slowing: as proactive slowing reduced with increasing information 
load, reactive stopping latency became faster and left superior frontal signal decreased 
with increasing load level. This may seem counter intuitive, because proactive preparation 
should reduce effort upon actual inhibition and increase chances for timely inhibition. 
Thus, reduced proactive preparation usually also results in reactive response inhibition 
decrements (e.g. Chikazoe et al, 2009). However, when preparatory cues are (too) effortful 
to process in time, attending these cues may even impair inhibition. Hence, in this case, 
more resources may be available for inhibition if preparatory cues are not attended to. 
For example in traffic, less resources may be available to timely spot and take your exit 
when there is a lot of information to process, e.g. during heavy traffic on a road under 
construction with many traffic signs. 
As expected, age-related decline in proactive response slowing was load dependent, 
associated with over- and under-activation in widespread frontal, temporal and occipital 
regions, as a function of increasing information load (Chapter 5). Under low information 
load, proactive response inhibition was numerically increased (see also van de Laar et 
al, 2011). This finding is in accordance with increased cautiousness commonly seen in 
aging (Forstmann et al, 2011; Starns and Ratcliff, 2010), but see (Kleerekooper et al, 2016; 
Smittenaar et al, 2015), who did not observe increased proactive response inhibition 
under low information load.  Using the information load manipulation, I showed that when 
processing capacity is challenged as a function of increasing information load, involvement 
in proactive response inhibition declines in older compared with younger adults. This was 
accompanied by widespread occipital and frontal regions displaying over-activation under 
low information load. Consistently, Kleerekooper et al. (2016) observed age-related signal 
increases during proactive response inhibition in similar regions. Under high information 
load, under-activation was observed in frontal and striatal regions. Moreover, a brain-
behaviour correlation in the right occipital gyrus was present in low, but absent in high 
information load. These results show that cognitive load affects the proactive response 
General Discussion
7.
149
inhibition network, determining the degree of proactive preparation. This goes especially 
for older adults, which are affected to a larger extent by cognitive load, compared to young 
adults.
By looking at the relation between effects of aging on behaviour and effects of aging on 
BOLD signal, we can gain insight in neural mechanisms of aged cognition. For example, 
I observed left middle frontal and cerebellar over-activation in older compared with young 
adults during behaviourally impaired reactive response inhibition (Chapter 5). According 
to the Compensation-Related Utilization of Neural Circuits Hypothesis (CRUNCH) model 
(Reuter-Lorenz and Cappell, 2008; Reuter-Lorenz and Park, 2014), this reflects unsuccessful 
compensation for reduced capacity. On the other hand, occipital and frontal over-
activation during behaviourally intact proactive response inhibition under lower infor-
mation loads (Chapter 5, also reported by (Kleerekooper et al, 2016)) seems to reflect 
successful compensation for reduced capacity. Third, fronto-striatal under-activation under 
proactive high information load (in Chapter 5) may be interpreted as a reflection of task 
disengagement under capacity exceeding demands, according to the CRUNCH model. 
Another indication of task (dis)engagement is a relationship between BOLD signal and 
behavioural slowing  (Adleman et al, 2016). I showed, in older adults, an intact associa-
tion between occipital BOLD signal and RT as a function of stop-signal probability in lower 
information load levels, but absent BOLD modulation with RT under high information 
load. Together, these results suggest that whereas reactive response inhibition is impaired 
despite increased BOLD signal, proactive response inhibition under low information load is 
successfully executed due to increased BOLD signal. Third, under-activation accompanied 
by impaired cognition and a lack of BOLD-behaviour relationship during proactive response 
inhibition suggests (involuntary) task-disengagement.
Task disengagement may be strategic rather than caused by incapacity. Indeed older adults 
are shown to be effort averse (Westbrook et al, 2013). Whether the apparent task disen-
gagement in older adults under high information load proactive response inhibition ob-
served in this thesis is caused by incapacity or strategic withdrawal cannot be dissociated. 
Computational models can help to formally dissociate between these options, in a similar 
way as (Forstmann et al, 2011) showed that in older adults a failure to implement speed 
over accuracy instructions was related to reduced white matter integrity. This suggests that 
a strategy adjustment may not be always be voluntary, as reduced white matter strength 
may disable speedy responses. 
By identifying the underlying source of behaviour change in aging (incapacity or voluntary 
strategy),  the understanding of aged response inhibition will improve, which may also 
guide attempts for improvement of this cognitive function. For example, effort aversion 
to process high information load may be overcome with a different kind of training than 
general response slowing (e.g. strategy training versus process training, see (Lustig et al, 
2009)). Also new approaches such as studying BOLD variability rather than mean signal 
may increase knowledge on the mechanism of aged cognition (Garrett et al, 2013, 2015; 
Grady and Garrett, 2014). Altered dopamine availability, amongst other factors, is said 
to contribute to a reduced BOLD variability in aging, which in turn is related to cognitive 
impairment on e.g. delayed match-sample performance (Garrett et al, 2011; Guitart-Masip 
et al, 2015). Future research on response inhibition in aging may e.g. study whether older 
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adults exhibit reduced BOLD variability, specifically  during high information load.
Generally, there is increased awareness of the pitfalls when imaging the aging brain, for 
example considering non-task specific changes in brain volume or vascular deterioration 
influencing the BOLD signal when interpreting imaging results (D’Esposito et al, 2003; 
Samanez-Larkin and D’Esposito, 2008). Various methods as well as guidelines for experi-
mental design are developed to correct for non-task specific factors and to prevent false 
negatives as well as false positives. In this thesis, corrections were applied for anatomical 
differences between older and young adults, to prevent misplacement of results. Also the 
design of the stop-signal task allowed for age times level interactions, reducing the chance 
of non-task specific influences in our results. Indeed, I observed increased and decreased 
BOLD signal as a function of level in similar regions (Chapter 5), that cannot be caused 
by e.g. general age-related vascular influences on the BOLD signal. Still, interpretation of 
age-related BOLD differences between studies remains a challenge, because implementa-
tion of these methods varies and (hence) results vary greatly. 
Neural models of aged cognition 
The Dual Mechanisms of Control framework (Braver, 2012; Braver et al, 2007) states that 
cognitive control is organized in two forms: proactive and reactive control. Proactive con-
trol is an anticipatory, internally driven process resulting in goal directed behaviour. 
It is supported by dopamine mediated, top-down, sustained lateral PFC signal that is 
needed for goal maintenance. On the other hand, reactive control reactivates task goals 
transiently and externally driven. Its neural architecture is less focally organized by the 
lateral PFC, including ACC and posterior sensory and medial temporal regions, involved in 
monitoring conflict and processing bottom-up information. Cognitive control is exerted 
with a pro- or reactive bias, allowing adjustments to internal and external challenges. 
For example, proactive control is favoured when the subject has enough capacity to main-
tain internal goals, as reactive control is more prone to interference. However, maintaining 
a proactive bias may not be beneficial or even possible, e.g. in case of complex cues or due 
to age-related capacity decline. In that case, responding reactively enables a subject to 
maintain functioning and save resources. The Dual Mechanisms of Control model predicts 
the influence of several factors studied in this thesis (task demands, age and dopaminer-
gic involvement). Increasing task demands should induce a cognitive load that is too high 
to proactively maintain and hence produce a shift from proactive to reactive control. In 
aging, reduced PFC resources needed for proactive control are predicted to force a shift to 
reactive control. Lastly, the model anticipates proactive control, sustained by the dopamin-
ergically innervated lateral PFC, to be regulated by (phasic) dopamine. 
The effects of increasing information load on response inhibition (Chapter 5) are in accord-
ance with the Dual Mechanisms of Control model predictions. In other cognitive control 
tasks, a proactive to reactive shift under high information load was also observed (Czerno-
chowksi et al, 2010), or a reactive strategy was motivated by unreliable proactive cues (e.g. 
Grandjean et al, 2012; Marklund and Persson, 2012). 
In terms of aging, reactive and proactive response inhibition did not completely follow the 
predictions of Braver’s model. Proactive response inhibition declined as a function of infor-
mation load, as to be expected under reduced prefrontal capacity (Chapter 5). 
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Indeed, under high information load, frontal and striatal signal decline was observed in 
older compared with younger adults. However, according to the Dual Mechanisms of Con-
trol model, older adults are predicted to shift to a more reactive control strategy, improv-
ing its behavioural output measure relative to young adults (Braver, 2012). In this thesis, 
I observed impaired reactive stopping latency and no load effect on reactive response 
inhibition, which contradicts a direct trade-off between proactive and reactive response 
inhibition. However, I also observed left middle frontal cortex activation during reactive re-
sponse inhibition, where usually the right inferior frontal cortex is recruited. This indicates 
non-specific over-recruitment of the reactive response inhibition network, as predicted by 
the Dual Mechanisms of Control model. This was, however, unsuccessful in producing an 
effective shift to improved reactive control. In contrast, some studies did find age-related 
results in accordance with the Dual Mechanisms of Control model, using task-switching 
and working memory tasks (Czernochowksi et al, 2010; Paxton et al, 2008). However, our 
experimental design measuring reactive and proactive response inhibition differs from the 
former tasks measuring reactive and proactive control. For example, in the response inhi-
bition task, the subject doesn’t balance equally between two strategies, but executes both 
or saves resources by no longer proactively preparing a possible upcoming stop based on 
proactive cues. Moreover, the design of the stop-signal task and functional analysis meth-
od I used didn’t allow the study of temporal dynamics of response inhibition. Possibly, 
an (unsuccessful) reactive strategy bias may have been observed using EEG measures on 
the current stop-signal paradigm. Despite these experimental and analytical differences, 
there is a likely reason why the Dual Mechanisms of Control model predictions regarding 
aging didn’t come true for response inhibition: in the  Dual Mechanisms of Control model, 
both reduced proactive and increased reactive control are associated with PFC signal and 
extended medial frontal changes. The Dual Mechanisms of Control model does not actively 
consider striatal involvement. However, one may expect that when shifting to reactive 
control, regions important for bottom-up processing such as the striatum are recruited. 
Indeed, I did observe also age-related striatal signal decline during high load proactive re-
sponse inhibition. Hence, when the Dual Mechanisms of Control model would incorporate 
more regions important for reactive control, predictions for proactive and reactive control 
in aging may change, possibly varying with the degree of striatal involvement in the type 
of control exerted. Although I did not observe age effects in the striatum during reactive 
response inhibition, striatal involvement in both proactive and reactive response inhibition 
(Leunissen et al, 2016; Zandbelt et al, 2012b; Zandbelt and Vink, 2010) and other control 
functions (Marklund and Persson, 2012) has been often proven. 
Lastly, proactive response inhibition, not reactive response inhibition was modulated by 
dopamine in aged adults (Chapter 6). This is in accordance with the predictions of the Dual 
Mechanisms of Control model, stating that dopamine is needed for proactive, sustained 
PFC goal-maintenance signal. The effect of dopamine (i.e. tyrosine intervention) did not 
vary with information load, possibly because goal-maintenance is supported by dopamine 
at all loads. 
Similar to the Dual Mechanisms of Control model, other theories and views on aging also 
attribute cognitive deficits in aging to PFC dysfunctioning: for example due to a lack of 
top-down control or  inhibitory deficit originating in the PFC (Cabeza and Dennis, 2012; 
Gazzaley et al, 2005a; Hasher and Zacks, 1988; Nyberg et al, 2010). Based on the results 
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in this thesis, age-related impairments in cognitive control do not seem to be attributable 
only to the PFC. Chapter 3 does not show a selective, relative maintenance impairment, 
but also impaired working memory updating. Although there is no neural data accompa-
nying this effect, the role of the striatum in working memory updating is widely known 
(Hazy et al, 2006). Therefore, it is unlikely that this pattern of results would have emerged 
in case of a selective prefrontal deficit. Due to reduced striatal functioning in older adults 
(Backman et al, 2010), working memory updating may not be possible. In Chapter 5, age 
comparisons in BOLD signal during proactive response inhibition revealed fronto-striatal 
and well as widespread occipital differences. Chapter 6 revealed dopamine modulation of 
frontal and striatal regions during proactive response inhibition. Hence, cognitive control 
deficits in aging seem to be caused by fronto-striatal deficits, which can be remediated 
with a dopamine precursor working on these areas.
 
Using the amino acid and dopamine precursor tyrosine to modulate the aged 
brain 
Chapters 4 and 6 strongly suggest that the optimal dose of tyrosine decreases with 
increasing age. Peripheral blood plasma levels seem to contribute to this effect, as they 
increased more than two fold in older (60-75 years) compared with young (18-35 years) 
adults after the same dose. Within older adults, larger increases in plasma level with 
increasing dose resulted in larger detrimental effects on cognition (Chapter 4). In another 
group of older adults (60-72 years), detrimental effects of tyrosine relative to placebo were 
observed on cognition with increasing age (Chapter 6). Also here, peripheral supply may 
have increased with age, leading to a higher effective dose in these individuals. 
Detrimental effects of tyrosine with increasing age seem surprising when considering the 
decline in dopamine signalling in aging (Kaasinen and Rinne, 2002) and given the feedback 
mechanism of the tyrosine hydroxylase (TH) enzyme (Daubner et al, 2012). The TH enzyme 
converts tyrosine to levodopa and dopamine and is saturated by its end-product dopa-
mine. This mechanism elegantly prevents both an excess and a shortage of dopamine, that 
results in respectively over- and under-stimulated dopaminergic post-synaptic receptors, 
known to negatively influence cognition (Cools and D’Esposito, 2011). Indeed, detrimental 
effects of tyrosine on cognition have hardly been observed before, as all of these studies 
were performed in young adults. The detrimental effects of tyrosine on cognitive perfor-
mance (i.e. reduced proactive slowing) were observed in the oldest of the healthy older 
adult sample. 
When considering up-regulated dopamine synthesis in older adults and negative relation 
between up-regulated synthesis and cognitive performance as observed by (Braskie et 
al, 2008), the age-dependent detrimental effects of tyrosine are less surprising. Negative 
effects of tyrosine in the oldest adults may be caused by over-stimulation of dopamine 
producing neurons in an already increased state. Overall, it seems that due to extremely 
high peripheral supply of tyrosine, the regulatory mechanism of dopamine did not work 
as usually observed after tyrosine administration in younger adults (Acworth et al, 1988; 
Melamed et al, 1980; Scally et al, 1977). A surge of precursor converted to dopamine in a 
system with already up-regulated dopamine synthesis may completely shut down TH activ-
ity, via cytoplasmic dopamine or D2 receptors (Lindgren et al, 2001). 
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This would result in reduction of dopamine synthesis and subsequently too low dopamine 
levels for optimal cognition. In favour of this interpretation is the observed relation be-
tween reduced BOLD signal after tyrosine with increasing age as well as detrimental effect 
of tyrosine on proactive response inhibition (Chapter 6), indicating a reduced dopamine 
availability for optimal fronto-striatal functioning (see e.g.(Knutson and Gibbs, 2007) for 
the relation between dopamine release and BOLD signal). A cognitive overdose of tyrosine 
may have been demonstrated before in a study including schizophrenia patients (Deutsch 
et al, 1994). Eight patients displayed increased errors in a smooth pursuit saccades task 
during a three week supplementation of 10 g tyrosine daily. These patients have increased 
dopamine synthesis (Abi-Dargham, 2004). Thus, especially in a system with already high 
dopamine synthesis, administrating extra precursor may result in its inhibition. Note that 
reduced TH expression, as observed in Parkinson’s disease (Tabrez et al, 2012), would 
result in a lack of effect of tyrosine administration rather than detrimental effects because 
the dopamine precursor would not be converted to excessive levels. 
Despite the detrimental effect on cognitive function in the oldest adults observed in 
this Chapter 6, the age-related increase in plasma tyrosine levels observed in Chapter 4 
suggests that lower doses may potentially work as a cognitive enhancer also in the oldest 
adults. In these oldest adults, lower doses may prevent an excessive amount of peripheral 
supply of tyrosine at the blood-brain-barrier and potentially a subsequent over-stimulation 
of dopamine producing neurons that shuts down dopamine production. 
These results underline the importance of dose adjustments of (cognitive) medication in 
aging. Balancing dose adjustments for an optimal cognitive effect is complex given the 
amount of factors influencing in opposing ways. Body composition, metabolism, liver 
function, insulin resistance, intestinal permeability, immunological markers (i.e. degree of 
immune-aging) and genetic predisposition are all factors that affect the baseline levels, 
maximal concentration and/or time course of any administered compound (Bischoff et al, 
2014; Caballero et al, 1991; Felger and Miller, 2012; Fernstrom, 2000; Klotz, 2009; Linden-
berger et al, 2008; Michaud et al, 2013; Witte et al, 2010). 
Probing the dopaminergic system using tyrosine 
Tyrosine has proven to be a suitable compound to probe the dopaminergic system. 
Tyrosine is well tolerated, in contrast to some other dopamine agents such as levodopa 
and bromocriptine. After administration of these agents nausea and headaches are more 
often reported, for which peripheral dopamine blockers are often co-administered (see 
e.g. Müller et al, 1998). A disadvantage of using tyrosine is that effects of receptor types 
cannot be isolated. Targeting specific dopaminergic regulators, for example D1 or D2 
receptors, is crucial to separate dopaminergic influence on different forms of cognition. 
Tyrosine’s value as a dopaminergic modulator would improve with better understanding of 
its modulators. For example, by understanding how and under which conditions dopamin-
ergic feedback mechanisms may not prevent detrimental cognitive effects of tyrosine: via 
the TH enzyme, or by regulators acting further downstream after dopamine synthesis, such 
as pre-synaptic D2 receptors. 
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Tyrosine is the precursor of dopamine as well as noradrenaline, which is converted from 
dopamine.  Tyrosine administration indeed affects the release of both dopamine and 
noradrenaline and their metabolites under circumstances of environmental or pharma-
cological stress (Conlay et al, 1981; Gibson and Wurtman, 1978; Melamed et al, 1980; 
Reinstein et al, 1985). Still it seems that, due to its high baseline firing rate (Hallman and 
Jonsson, 1984), under un-stressed conditions the dopamine system is more susceptible 
to fluctuations in its precursor levels. Indeed, under baseline firing conditions tyrosine ad-
ministration increases dopamine but not noradrenaline levels and metabolites (Growdon 
et al, 1982; McTavish et al, 1999b; Scally et al, 1977). Dissociating between mediation of 
tyrosine’s effects on cognitive performance by dopamine or noradrenaline is not straight-
forward. For example, tyrosine has been shown to improve stress-induced cognitive defi-
cits (for reviews see Jongkees et al, 2015; van de Rest et al, 2013). Whether amelioration 
of these stress-induced deficits is mediated by dopamine or noradrenaline is unclear, given 
that stress increases both dopamine and noradrenaline synthesis (Bliss et al, 1968). 
Also dopamine- and noradrenaline-producing nuclei are reciprocally connected, and both 
these catecholamines are known to be involved in cognitive control processes such as 
attention and working memory (Sara, 2009). The neuronal firing rate of noradrenergic and 
dopaminergic neurons (influenced by a stressor) may partly determine whether tyrosine 
acts on dopaminergic or noradrenergic neurons. Neuroimaging may help in dissociating 
when effects of tyrosine are noradrenergic or dopaminergic. In this thesis, effects of ty-
rosine was observed (amongst other areas) in the dopaminergically, not noradrenergically 
innervated  putamen (Agster et al, 2013; Nicola and Malenka, 1998), suggesting dopamin-
ergic modulation of proactive response inhibition. Expanding evidence for mediation of 
dopamine or noradrenaline by tyrosine on specific cognitive functions may be done e.g. by 
comparing the effects of tyrosine on response inhibition with agents selectively blocking 
dopamine or noradrenaline synthesis or receptors.  
Experimentally, tyrosine is an accessible candidate for experiments aiming to increase 
catecholamine production versus other systems, such as serotonin. Especially when more 
specific modulators within the dopamine system are yet unknown, tyrosine would be a 
good starting point inspiring further experiments.
Tyrosine as a cognitive enhancer?
When using a compound available without prescription to study the dopaminergic system, 
an application for the non-patient population, such as aging, is likely closer by than when 
using an experimental compound or a prescribed drug. The results of acute tyrosine 
administration observed in this thesis suggest that, to obtain beneficial effects, the dose 
should be carefully chosen. Also, before widespread use by the aged population, the 
effects of long-term use of tyrosine to enhance age-related cognition need to be studied 
as they are currently unknown. Varying effects of long-term use of tyrosine have been 
observed when exploring therapeutic use for several clinical disorders implicating the 
dopamine system, such as attention deficit hyperactivity disorder (ADHD), schizophrenia, 
depression, phenylketonuria, Alzheimer’s and Parkinson’s disease (for reviews see Deijen, 
2005; Jongkees et al, 2015). At a dose of 2.24 gram tyrosine taken daily for 6 months up to 
3 years, about half of the sample of 10 patients with Parkinson’s disease experienced posi-
tive effect on disease symptoms that remained present over time (Lemoine et al, 1989).  
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At a higher dose of 150 mg/kg given for 8 weeks to adults with attention deficit disorder,  
positive effects in 8 of the 12 patients observed after about 2 weeks disappeared after 
week 6 (Reimherr et al, 1987). Long term-use of dopaminergic medication, such as levo-
dopa, is associated with reduced efficacy and disabling side effects in Parkinson’s disease 
(Thanvi and Lo, 2004). These effects cannot be translated directly to long-term use of 
tyrosine in aging, due to the differences in the dopamine system between patient groups 
and healthy older adults. In patients with Parkinson’s disease, the progressive loss of dopa-
mine neurons contributes to the detrimental effects of long term use, whereas the effects 
of aging on the dopamine system are much more subtle, seem to affect more dopamine 
regulators throughout the brain, and even results in up-regulation rather than reduced 
dopamine synthesis (Backman et al, 2010; Jagust, 2013).  
Due to changes in eating patterns and processing of proteins with increasing age (Klotz, 
2009; Tieland et al, 2012), plasma tyrosine levels may differ as a function of diet. As such, 
dietary habits may affect cognitive functioning and is a potential modulator for successful 
cognitive aging (see e.g. Bowman et al, 2012). Understanding how diet may help older 
adults preserve health may reduce health care costs.
The results of trials in clinical disorders have not been groundbreaking (Jongkees et al, 
2015). As the authors suggest, this may be due to impairments in one of the conversion 
steps. However, tyrosine supplementation in clinical disorders has not been studied 
enough in sound experiments to rule out therapeutic possibility (Jongkees et al, 2015). 
Not enough commercial interest may exist to thoroughly study conditions that allow ben-
eficial effects of a patent-free amino acid. So far, most evidence exists for beneficial effects 
of short term tyrosine use; in adults during various demanding circumstances (for review, 
see Deijen, 2005). Improving cognitive performance in the aging population has so far 
shown to be not as straightforward, possibly due to changes in dopamine production (see 
above). 
Conclusions
In this thesis, the neural mechanisms of cognitive control processes were probed by 
dopamine, cognitive load and age. The work in this thesis extends knowledge on cogni-
tive control processes such as working memory and response inhibition in several ways. 
Firstly, I provided evidence for the role of the dopamine D2 receptor stimulation in working 
memory distractibility, its accompanying delay-related PFC signal and connectivity with 
posterior sensory areas. Secondly, both working memory maintenance and updating 
were shown to be impaired in aging. Third, working memory performance in older adults 
decreased as a function of increasing doses of the dopamine precursor tyrosine, associat-
ed with increased plasma tyrosine responses, suggesting that altered intestinal processing 
with age contributes to over-stimulation of dopaminergic neurons. Fourth, aging was as-
sociated with impaired reactive as well as proactive response inhibition, specifically under 
increasing information load and associated with load dependent BOLD signal alterations in 
fronto-striatal regions. Fifth, the effects of tyrosine administration in healthy older adults 
implicate dopamine in proactive response inhibition, influencing fronto-striatal regions. 
Furthermore, I showed that tyrosine can enhance as well as impair proactive control in 
healthy older adults, depending on age.
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In sum, cognitive control processes, such as working memory and proactive response in-
hibition, are challenged by cognitive load and age and affect cortical as well as subcortical 
cognitive control regions. Beneficial effects of the dopamine precursor tyrosine depend on 
dose and age, where a high dose and high age result in negative effects on neurocognitive 
measures.
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Nederlandse samenvatting
Om te overleven en succesvol te functioneren in onze drukke en informatie-dichte wereld 
is het nodig om controle te hebben over je gedrag. Deze vaardigheid, tijdig controle 
hebben over je gedrag op basis van aanwezige of onthouden informatie, wordt cognitieve 
controle genoemd. Onder andere in het verkeer is het soms nodig om je huidige bezigheid 
aan te passen. Bijvoorbeeld als je voorganger plotseling remt, moet je stoppen met gas 
geven en remmen. Dit proces wordt response inhibitie genoemd. Wanneer je te laat of 
onverwachts reageert kun je ongelukken veroorzaken. 
Gelukkig is het vaak mogelijk om voorbereid te zijn op een dergelijke situatie; zo is veel 
invoegend verkeer een indicatie dat er mogelijk een file zal ontstaan. Je kunt dan extra 
alert zijn en langzamer rijden om te zorgen dat je zeker op tijd kan reageren. Op sommige 
informatie uit je omgeving moet je niet direct, maar juist even later reageren. Bijvoorbeeld 
als jouw afslag wordt aangekondigd is het handig om deze informatie te onthouden in je 
werkgeheugen zodat je voorbereid bent op het nemen van de afslag. Voorbereiding op een 
actie helpt zo om deze op tijd en efficiënt uit te voeren. Helaas lukt het mensen soms niet 
om hun gedrag op tijd aan te passen aan de omgeving. Dit wordt bijvoorbeeld veroorzaakt 
doordat de hoeveelheid te verwerken informatie groter is dan de beschikbare cognitieve 
capaciteit, zoals kan gebeuren in druk verkeer of bij gezonde veroudering. 
In dit proefschrift zijn de neuro-cognitieve mechanismen van twee vormen van cognitieve 
controle onderzocht: werkgeheugen en response inhibitie. Deze cognitieve controle pro-
cessen werden gemanipuleerd met behulp van oplopende informatie-belasting, leef-
tijdsvergelijkingen en dopaminerge interventies. Het doel hiervan was om de invloed van 
verschillende interne en externe omstandigheden op deze vormen van cognitieve controle, 
en de rol van hersenstof dopamine hierin beter te begrijpen. 
De volgende technieken zijn gebruikt in dit proefschrift: in Hoofdstuk 2, 5 en 6 is hersenac-
tiviteit gemeten met behulp van functionele magnetische beeldvorming, ofwel ‘functional 
Magnetic Resonance Imaging’ (fMRI). fMRI is een techniek om indirect hersenactiviteit te 
meten door te kijken waar in het brein zuurstofrijk bloed het MRI signaal verstoord. Bij het 
gebruik van deze techniek voeren proefpersonen een computertaak uit terwijl hun herse-
nactiviteit gemeten wordt in de MRI scanner. Op deze manier kan hersenactiviteit gelinkt 
worden aan cognitieve processen. In hoofdstuk 2, 4 en 6 werd gebruik gemaakt van farma-
cologische interventies, waarbij prestatie op een cognitieve (computer)taak (en hersenac-
tiviteit) werd vergeleken na het toedienen van verschillende actieve of placebo stoffen. 
In Hoofdstuk 1 is de rol van D2 dopamine receptoren op de afleidbaarheid van werkge-
heugen onderzocht. Werkgeheugen wordt omschreven als de vaardigheid informatie voor 
korte tijd vast te houden en te bewerken (zoals eerder genoemd, onthouden dat jouw 
afslag wordt aangekondigd, maar bijvoorbeeld ook hoofdrekenen). Onder andere uit dier-
onderzoek is de cruciale rol van de prefrontaal cortex (‘voorhersenen’) in werkgeheugen 
gebleken, zowel voor het vasthouden van informatie in het werkgeheugen, maar ook voor 
het beschermen van deze informatie tegen afleiding uit de omgeving. In tegenstelling tot 
de rol van de prefrontaal cortex draagt een groep van kernen dieper in het brein gelegen, 
het striatum, juist bij aan het vernieuwen van informatie in het werkgeheugen. 
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Het samenspel van de prefrontaal cortex en het striatum zorgt ervoor dat informatie in het 
werkgeheugen afwisselend vastgehouden en vernieuwd wordt, afhankelijk van wat nodig 
is. 
De neurotransmitter dopamine speelt een grote rol in werkgeheugen. Deze hersenstof 
wordt diep in het brein aangemaakt en vervoerd naar de prefrontaal cortex en het stria-
tum. Daar beïnvloedt dopamine de stabiliteit en activiteit van neuronen. Afhankelijk van 
het type receptor waar het op aangrijpt heeft dopamine tegengestelde effecten: stimulatie 
van ‘D1 familie’ receptoren door dopamine zorgt voor stabiele neurale activiteit die vast-
houden van informatie vergemakkelijkt. Stimulatie van ‘D2 familie’ receptoren resulteert 
juist in instabiele activiteit, waardoor nieuwe informatie makkelijker de oude kan vervan-
gen. Daarmee faciliteert D2 receptor stimulatie flexibiliteit van werkgeheugen. Zo draagt 
dopamine bij aan de balans tussen informatie onthouden en vernieuwen. Theoretische 
modellen en simulatie experimenten voorspelden dat neurale activiteit in de prefrontaal 
cortex tijdens het vasthouden van informatie op deze manier beïnvloed wordt. Maar veel 
empirisch bewijs liet tot nu toe vooral de rol van D1 receptoren in de prefrontaal cortex 
in informatie vasthouden zien, doordat deze veel D1 type receptoren bevat. Het stria-
tum, waar juist veel D2 type receptoren te vinden zijn, staat bekend om zijn rol in nieuwe 
informatie in het werkgeheugen laten. Empirisch bewijs voor de bijdrage van D2 type 
receptoren in de prefrontaal cortex tijdens het onthouden van informatie was er nog niet. 
In Hoofdstuk 1 is getest of in mensen D2 dopamine receptor stimulatie afleidbaarheid van 
werkgeheugen beïnvloedt en in welke hersengebieden dit effect heeft. Gezonde volwas-
senen namen een stof die D2 receptoren stimuleerde, waarna ze in de MRI scanner een 
werkgeheugen taak uitvoerden die de invloed van afleidende informatie op de werkgeheu-
gen prestatie testte. Na D2 receptor stimulatie zagen we een verhoogde afleidbaarheid, 
vergeleken met een placebo pil. Dit gedragseffect hing samen met signaal in de prefrontaal 
cortex tijdens het onthouden van informatie en met de connectiviteit tussen de prefron-
taal cortex en visuele gebieden die inkomende informatie verwerken. Hiermee hebben we 
laten zien dat D2 receptoren in de prefrontaal cortex afleidbaarheid van werkgeheugen 
beïnvloeden tijdens het vasthouden van informatie en dat de prefrontaal cortex samen-
werkt met sensorische gebieden om deze afleidbaarheid te moduleren. Deze resultaten 
ondersteunen de modellen die voorspellen dat D2 receptoren de staat van de prefrontaal 
cortex aanpassen, ofwel in een gesloten staat waarin nieuwe informatie minder snel in 
staat is de activiteit van de prefrontaal cortex te doorbreken, ofwel in een open staat 
waarin dit makkelijker gebeurt. 
Bij veroudering werken de hersenen minder goed. Hersencellen sterven af en ook de kwal-
iteit van de witte stof banen, de verbindingen tussen hersengebieden, neemt af. Vooral in 
de prefrontaal cortex heeft gezonde veroudering een groot effect. De afnemende werking 
van de prefrontaal cortex is vaak gelinkt aan een achteruitgang in het vasthouden van in-
formatie in het werkgeheugen. Problemen met werkgeheugen, het kortdurend onthouden 
van informatie, is een van de kenmerken van gezonde veroudering. Aangezien de werking 
van de prefrontaal cortex achteruit gaat bij veroudering, en informatie vasthouden in 
werkgeheugen hier vanaf hangt, gaat wellicht dit aspect van werkgeheugen sterker ach-
teruit dan het vernieuwen van informatie. In Hoofdstuk 3 testten we de hypothese dat bij 
gezonde veroudering het vasthouden van informatie in het werkgeheugen meer achteruit 
gaat dan het vernieuwen van informatie in het werkgeheugen. Vergelijkbare resultaten 
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worden bijvoorbeeld gezien bij het associëren van meerdere woorden tot een samen-
hangend thema; bij het kort tonen van irrelevante woorden die te maken hebben met het 
juiste gezamenlijke thema waren ouderen hierdoor beter in het herkennen van het thema 
dan jongeren. Ouderen lijken dus in sommige situaties een voordeel te hebben bij vergrote 
afleidbaarheid. In Hoofdstuk 3 deden ouderen en jongeren een taak die zowel het vast-
houden als het vernieuwen van informatie in het werkgeheugen test. Hoewel we een se-
lectieve achteruitgang van informatie vasthouden ten opzichte van vernieuwen in ouderen 
(vergeleken met jongeren) verwachtten, hebben we hiervoor geen aanwijzingen gevonden. 
Wellicht kan het voordelige effect van een vergrote afleidbaarheid niet plaatsvinden als de 
items niet gelijktijdig verwerkt kunnen worden, maar even moeten worden onthouden. 
Gelijke achteruitgang van informatie vasthouden en vernieuwen bij veroudering is niet 
onlogisch gezien de bevindingen in Hoofdstuk 2, waar we lieten zien dat D2 receptoren in 
de prefrontaal cortex afleidbaarheid van werkgeheugen beïnvloeden. 
Bij gezonde veroudering is naast een verminderde werking van werkgeheugen ook een 
verslechtering van response inhibitie gezien. Deze vorm van cognitieve controle is zoals 
hierboven genoemd cruciaal bijvoorbeeld in het verkeer. Ouderen hebben hier soms 
moeite mee, en reageren soms in het verkeer te laat of onverwachts, bijvoorbeeld op een 
drukke of onbekende weg. Response inhibitie kan worden opgedeeld in twee vormen: 
reactieve en proactieve response inhibitie. Reactieve inhibitie gebeurt bijvoorbeeld als je 
voorligger ineens remt, dus als directe reactie op een ‘stop-signaal’. Hoe snel je bent in 
het afbreken van je huidige actie (gas geven), bepaald onder andere of je een ongeluk kan 
voorkomen. In experimentele computertaken wordt de duur van dit proces gemeten en is 
bij veroudering een achteruitgang gezien in reactieve inhibitie: ouderen zijn langzamer in 
het stoppen van hun actie. Maar vaak is het mogelijk om op basis van cues uit je omgeving 
voorbereid te zijn op een mogelijke stop. Voorbereiding op een mogelijke stop vergroot de 
kans dat deze stop op tijd plaats vindt. Het uitvoeren van de huidige taak (bijvoorbeeld gas 
geven) gaat hierdoor langzamer, wat ook gemeten kan worden in een computertaak. Deze 
vorm van response inhibitie wordt proactieve response inhibitie genoemd, en gebeurt op 
basis van informatie uit je omgeving. Bij volwassenen zijn bij zowel reactieve als proactieve 
response inhibitie frontale en striatale gebieden betrokken. Het effect van veroudering op 
reactieve en proactieve response inhibitie is nog niet eerder vergeleken. Omdat proactieve 
response inhibitie gebeurt op basis van cues uit de omgeving, zou het goed kunnen dat dit 
proces beïnvloedt wordt door de complexiteit van deze cues. Hoe complexer de proactieve 
cues, hoe groter de belasting om deze voor korte tijd te onthouden. We voorspelden dat 
dit voor ouderen, bij wie de werking van de prefrontaal cortex achteruitgaat, extra moeilijk 
zou zijn. 
Dit is inderdaad wat we gezien hebben in Hoofdstuk 5. In deze studie hebben gezonde 
ouderen en jongeren een computertaak uitgevoerd terwijl ze in de MRI-scanner lagen. 
De taak was zo ontworpen dat deze naast reactieve response inhibitie, ook proactieve re-
sponse inhibitie als functie van informatie-belasting kon onderscheiden. Zoals eerder gem-
eten waren ouderen minder snel in reactieve response inhibitie. Daarnaast zagen we, zoals 
we al verwachtten, dat de informatie-belasting van de proactieve cues een grotere impact 
had op de reactiesnelheid van ouderen dan jongeren. Aan de reactietijden zag we dat hoe 
hoger de informatie-belasting was, hoe minder ouderen de proactieve cues gebruikten 
om voor te bereiden. Dit was ook in de hersenactiviteit terug te zien: bij een lage infor-
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matie-belasting hadden ouderen in veel gebieden die betrokken zijn bij cognitieve con-
trole meer activiteit dan jongeren (namelijk in frontale, striatale en occipitale gebieden). 
Maar bij een hoge informatie-belasting, als in korte tijd verschillende denkstappen gedaan 
moesten worden om de proactieve cues te verwerken, zagen we het tegenovergestelde. 
Ouderen hadden hier minder hersenactiviteit in frontale gebieden dan jongeren. Het leek 
er op dat ouderen bij deze hoge belasting niet meer in staat zijn om de proactieve cues te 
verwerken, of dit niet meer willen. Uit deze bevindingen blijkt dat de moeilijkheden die ou-
deren soms hebben in het verkeer kunnen komen door een afname in de twee genoemde 
vormen van response inhibitie: reactieve en proactieve inhibitie. 
Dat cognitieve controle (werkgeheugen en response inhibitie) bij gezonde veroudering 
achteruit gaat, is onder andere te verklaren doordat in het oudere brein de werking van 
dopamine verandert. Er zijn minder dopamine producerende cellen en minder receptor-
en om de hersenactiviteit te beïnvloeden. Tegelijkertijd lijken, wellicht ter compensatie, 
de overgebleven dopamine producerende cellen meer dopamine te produceren. Deze 
veranderingen in de dopamine huishouding in het oudere brein zijn gelinkt aan slechtere 
prestaties op onder andere werkgeheugen taken. Het aminozuur tyrosine is een voorloper 
van dopamine en komt voor in eiwitrijk voedsel. Uit experimenten met jongeren bleek 
dat het eenmalig nemen van tyrosine de prestatie op werkgeheugen taken verbeterde 
(onder stress en veeleisende omstandigheden). Bij ouderen zou cognitieve controle ook 
(wellicht positief) beïnvloed kunnen worden met behulp van tyrosine. Maar bij ouderen 
verandert echter niet alleen de dopamine huishouding in het brein, maar ook de perifere 
verwerking van tyrosine in de lever, darmen, en insuline huishouding die weer de opname 
van aminozuren naar spieren beïnvloedt. Al deze zaken kunnen de effecten van tyrosine in 
het brein beïnvloeden. In hoofdstuk 4 hebben we gekeken de effecten van drie oplopende 
doseringen tyrosine op het werkgeheugen van ouderen. Gezonde ouderen namen drie 
doses tyrosine (100, 150 en 200 mg/kg lichaamsgewicht). 
Er werd ook een groep jongeren getest na de inname van 150 mg/kg, de dosis die eerder 
positieve resultaten gaf ten opzichte van placebo. We keken naar de tyrosine niveaus in 
het bloedplasma en de prestatie op werkgeheugentaken. Op deze manier konden we ki-
jken of de werkgeheugenprestatie afhing van bloedplasma niveaus van tyrosine. In tegen-
stelling tot onze verwachting verslechterde de prestatie van de ouderen op de werkgeheu-
gentaak met oplopende dosis, vooral op het moeilijkste niveau van de werkgeheugentaak. 
Deze verslechtering hing samen met het tyrosine niveau in het bloed; de ouderen waarbij 
het tyrosine niveau sterk opliep met de oplopende doseringen hadden ook een slechtere 
werkgeheugen prestatie met oplopende doseringen. Daarnaast zagen we dat bij dezelfde 
dosis ouderen veel hogere tyrosine niveaus hadden in het bloed plasma, wat suggereert 
dat de verwerking van tyrosine bij ouderen inderdaad anders verloopt dan bij jongeren. 
Deze resultaten laten ook zien dat hogere bloed plasma niveaus van tyrosine bij ouder-
en een negatief effect hebben op cognitief functioneren. Dit is verassend omdat werd 
aangenomen dat tyrosine geen negatief effect kan hebben op cognitie, doordat dopamine 
niveaus gebalanceerd worden door feedback mechanismen van tyrosine in de verwerking 
van tyrosine naar dopamine. In gezonde volwassenen is een negatief effect op cognitie ook 
nooit eerder gevonden. In gezonde ouderen is dit nadelige effect van hogere doses tyros-
ine op cognitief functioneren voor het eerst aangetoond.
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Veranderingen in de dopamine huishouding zouden er ook voor kunnen zorgen dat ouder-
en in druk verkeer informatie op de verkeersborden niet meer goed verwerken of te laat 
zijn met remmen. In hoofdstuk 6 hebben we ouderen eenmalig een dosis van 150 mg/kg 
lichaamsgewicht tyrosine gegeven en een placebo pil. Hierna keken we naar de prestatie 
op reactieve en proactieve response inhibitie taak en naar de hersenactiviteit tijdens het 
maken van deze taak. Zo konden we zien welke vorm van response inhibitie beïnvloed zou 
worden door de dopamine precursor tyrosine. We zagen dat tyrosine proactieve, maar niet 
reactieve response inhibitie beïnvloedde. Ook zagen we dat het effect van tyrosine afhing 
van leeftijd: hoe ouder, hoe minder ouderen de proactieve cues gebruikten na tyrosine 
en hoe minder hersenactiviteit in frontale en striatale gebieden te zien was. De resultaten 
van dit experiment ondersteunen de hypothese dat proactieve, en niet reactieve response 
inhibitie ondersteunt wordt door dopaminerg geïnnerveerde gebieden. Daarnaast laten 
we zien dat hoge leeftijd het effect van tyrosine op response inhibitie negatief beïnvloedt. 
Vergelijkend met Hoofdstuk 4 zou dit kunnen komen door hogere perifere aanvoer van 
tyrosine in de oudere ouderen ten opzichte van de jongere ouderen binnen het experi-
ment. Verhoogde aanvoer van tyrosine leidt wellicht tot inhibitie van het feedback mech-
anisme. Het zou kunnen dat hierdoor de productie van dopamine achteruit gaat, wellicht 
zodanig dat er te weinig dopamine beschikbaar is voor de huidige taak: het gebruiken van 
proactieve cues ter voorbereiding op mogelijke inhibitie. Verder onderzoek zou moeten 
uitwijzen of in deze groep ook positieve effecten op cognitie gevonden kunnen worden bij 
aangepaste, lagere doseringen tyrosine. 
Conclusies
In dit proefschrift is cognitieve controle gemoduleerd door informatie belasting, leeftijd en 
dopaminerge interventies. Het werk in dit proefschrift vergroot de kennis over de neurale 
mechanismen onderliggend aan cognitieve controle processen zoals werkgeheugen en 
response inhibitie. Als eerste heb ik laten zien dat D2 dopamine receptoren een rol spelen 
in afleidbaarheid van werkgeheugen door activiteit in de prefrontaal cortex en connectiv-
iteit met visuele gebieden te moduleren. Als tweede zagen we dat bij veroudering zowel 
vasthouden als het vernieuwen van informatie in het werkgeheugen achteruit gaat.  
Ten derde zagen we dat werkgeheugen prestatie in oudere volwassenen achteruit ging bij 
hogere doseringen van tyrosine, de precursor van dopamine, en dat deze verslechtering 
samenhing met verhoogde bloed plasma niveaus tyrosine in het bloed. Deze resultaten 
suggereren een veranderde perifere verwerking van het aminozuur tyrosine bij verouder-
ing, die bijdraagt aan overstimulatie van centrale dopamine productie. Ten vierde zagen 
we dat veroudering samen gaat met een achteruitgang van zowel reactieve als proactieve 
response inhibitie onder hoge informatie-belasting, die samenging met veranderingen in 
frontale en striatale hersensignalen. Als laatste zagen we dat eenmalige tyrosine adminis-
tratie in gezonde ouderen proactive response inhibitie en hersenactiviteit in bijbehoren-
de dopaminerge frontale en striatale gebieden moduleerde en dat tyrosine proactieve 
response inhibitie zowel kan verbeteren als verslechteren, afhankelijk van leeftijd.
Cognitieve controle processen zoals werkgeheugen en response inhibitie worden 
uitgedaagd en gemoduleerd door zowel informatie-belasting als leeftijd en beïnvloeden 
zowel corticale als subcorticale gebieden. Positieve effecten van de dopamine precursor 
tyrosine hangen af van leeftijd en dosering, waarbij zowel hoge dosering als leeftijd een 
negatief effect heeft op neurocognitieve maten van cognitieve controle.
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